Edgar Filing: GNC HOLDINGS, INC.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

(Rule 14a-101)

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

(Amendment No. )

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

☐	Preliminary Proxy Statement

☐	Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

☒	Definitive Proxy Statement

☐	Definitive Additional Materials

☐	Soliciting Material Pursuant to §240.14a-12

GNC HOLDINGS, INC.

(Name of Registrant as Specified in Its Charter)

(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

Payment of Filing Fee (Check the appropriate box):

☒	No fee required.

☐	Fee computed on table below per Exchange Act Rules 14a-6(i) (1) and 0-11.

	(1)	Title of each class of securities to which transaction applies:

	(2)	Aggregate number of securities to which transaction applies:

	(3)	Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

	(4)	Proposed maximum aggregate value of transaction:

	(5)	Total fee paid:

☐	Fee paid previously with preliminary materials:

☐	Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the form or schedule and the date of its filing.

	(1)	Amount previously paid:

	(2)	Form, Schedule or Registration Statement No.:

	(3)	Filing Party:

	(4)	Date Filed:

300 Sixth Avenue

Pittsburgh, Pennsylvania 15222

April 10, 2018

Dear Stockholder,

You are cordially invited to attend the Annual Meeting of Stockholders of GNC Holdings, Inc. (the “Company”) to be held on Tuesday, May 22, 2018 at 8:00 a.m. Eastern Time at the Omni William Penn Hotel, 530 William Penn Place, Pittsburgh, Pennsylvania 15219.

The agenda for the Annual Meeting includes:

•

The election of eight directors named in the attached proxy statement to our Board of Directors (Proposal 1);

•

An advisory vote to approve the compensation paid to our Named Executive Officers disclosed in the attached proxy statement (commonly known as a “say-on-pay” proposal) (Proposal 2);

•

The approval of adoption of our 2018 Stock and Incentive Plan (Proposal 3); and

•

The ratification of the appointment of PricewaterhouseCoopers LLP as independent auditors for our 2018 fiscal year (Proposal 4).

Our Board of Directors recommends that you vote FOR Proposals 1, 2, 3, and 4.

Your interest in the Company and your vote are very important to us. The enclosed proxy materials contain detailed information regarding the business that will be considered at the Annual Meeting. We encourage you to read the proxy materials and vote your shares as soon as possible. You may vote your proxy via the Internet or telephone or, if you received a paper copy of the proxy materials, by mail by completing and returning the proxy card.

On behalf of the Company, I would like to express our appreciation for your ongoing interest in the Company.

	Very truly yours,

	Kenneth A. Martindale
	Chief Executive Officer

GNC HOLDINGS, INC.

NOTICE OF

2018 ANNUAL MEETING OF STOCKHOLDERS

TO BE HELD ON MAY 22, 2018

DATE AND TIME	8:00 a.m. on Tuesday, May 22, 2018

PLACE	Omni William Penn Hotel
	530 William Penn Place
	Pittsburgh, Pennsylvania 15219

ITEMS OF BUSINESS	(1) To elect eight directors named in these proxy materials to hold office until our 2019 annual meeting of stockholders and until their successors are duly elected and qualified or until their earlier resignation or removal (Proposal 1).

	(2) To approve, by non-binding vote on an advisory basis, the compensation paid to our Named Executive Officers in 2017, as disclosed in these proxy materials (commonly known as a “say-on-pay” proposal) (Proposal 2).

	(3) To approve the adoption of our 2018 Stock and Incentive Plan (Proposal 3).

	(4) To ratify the appointment of PricewaterhouseCoopers LLP as independent auditors for our 2018 fiscal year (Proposal 4).

	(5) To transact such other business as may properly be brought before the Annual Meeting or any adjournment or postponement thereof.

RECORD DATE	You are entitled to vote only if you were a stockholder of record at the close of business on March 26, 2018.

PROXY VOTING	It is important that your shares be represented and voted at the Annual Meeting. Whether or not you plan to attend the Annual Meeting, we urge you to vote online at www.proxyvote.com or via telephone by calling 1-800-690-6903, or to complete and return a proxy card (no postage is required).

REQUIRED VOTE	The affirmative vote of a majority of the votes cast by our stockholders in person or represented by proxy at the Annual Meeting is required to approve each of the Proposals described in these proxy materials.

Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting of Stockholders to be Held on May 22, 2018: As permitted by rules adopted by the Securities and Exchange Commission, rather than mailing a full paper set of these proxy materials, we are mailing to many of our stockholders only a notice of Internet availability of proxy materials containing instructions on how to access these proxy materials and submit their respective proxy votes online. This proxy statement, our 2017 Annual Report to stockholders and the proxy card are available at www.proxyvote.com. You will need your notice of Internet availability or proxy card to access these proxy materials.

April 10, 2018


	Kevin G. Nowe
	Senior Vice President, Chief Legal Officer and Secretary

TABLE OF CONTENTS

PROXY STATEMENT	1
ELECTION OF DIRECTORS (PROPOSAL 1)	5
OTHER BOARD INFORMATION	8
EXECUTIVE OFFICERS	17
ADVISORY VOTE ON EXECUTIVE COMPENSATION (PROPOSAL 2)	19
COMPENSATION DISCUSSION AND ANALYSIS	20
NAMED EXECUTIVE OFFICER COMPENSATION	39
APPROVAL OF THE ADOPTION OF THE 2018 STOCK AND INCENTIVE PLAN (PROPOSAL 3)	57
RATIFICATION OF APPOINTMENT OF AUDITORS (PROPOSAL 4)	71
AUDIT COMMITTEE REPORT	73
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT	74
SECTION 16(A) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE	77
STOCKHOLDER PROPOSALS FOR 2019 ANNUAL MEETING	79
OTHER INFORMATION	79

Table of Contents

300 Sixth Avenue

Pittsburgh, Pennsylvania 15222

PROXY STATEMENT

2018 ANNUAL MEETING OF STOCKHOLDERS

May 22, 2018

The Board of Directors (the “Board”) of GNC Holdings, Inc., a Delaware corporation (the “Company,” “we,” “us,” or “our”), has prepared this document to solicit your proxy to vote upon certain matters at our 2018 annual meeting of stockholders (the “Annual Meeting”).

These proxy materials contain information regarding the Annual Meeting, to be held on Tuesday, May 22, 2018, beginning at 8:00 a.m. Eastern Time at the Omni William Penn Hotel, 530 William Penn Place, Pittsburgh, Pennsylvania 15219, and at any adjournment or postponement thereof. As permitted by the rules adopted by the Securities and Exchange Commission (the “SEC”), rather than mailing a full paper set of these proxy materials, we are mailing to many of our stockholders only a notice of Internet availability of proxy materials (the “Notice”) containing instructions on how to access and review these proxy materials and submit their respective proxy votes online. If you receive the Notice and would like to receive a paper copy of these proxy materials, you should follow the instructions for requesting such materials located at www.proxyvote.com.

QUESTIONS ABOUT THE ANNUAL MEETING AND THESE PROXY MATERIALS

It is anticipated that we will begin mailing this proxy statement, the proxy card, our Annual Report to Stockholders for the year ended December 31, 2017 (the “Annual Report”) and the Notice, and that these proxy materials will first be made available online to our stockholders, on or about April 10, 2018. The information regarding stock ownership and other matters in this proxy statement is as of March 26, 2018 (the “Record Date”), unless otherwise indicated.

What may I vote on?

You may vote on the following proposals:

•

the election of eight directors to serve until our 2019 annual meeting of stockholders (the “2019 Annual Meeting”) and their respective successors have been duly elected and qualified, or their earlier resignation or removal (Proposal 1);

•

the approval, by non-binding vote, on an advisory basis of the compensation paid to our Named Executive Officers in 2017, as disclosed in these proxy materials (commonly known as a “say-on-pay” proposal) (Proposal 2);

•

the approval of the adoption of the 2018 Stock and Incentive Plan (Proposal 3); and

•

the ratification of the appointment of PricewaterhouseCoopers LLP (“PwC”) as independent auditors for our 2018 fiscal year (Proposal 4).

Table of Contents

THE BOARD RECOMMENDS A VOTE (1) FOR THE ELECTION OF EACH OF OUR DIRECTORS (PROPOSAL 1), (2) FOR THE APPROVAL, BY NON-BINDING VOTE ON AN ADVISORY BASIS, OF THE COMPENSATION PAID TO OUR NAMED EXECUTIVE OFFICERS IN 2017 (“SAY-ON-PAY”) (PROPOSAL 2), (3) FOR THE APPROVAL OF THE 2018 STOCK AND INCENTIVE PLAN (PROPOSAL 3), AND (4) FOR THE RATIFICATION OF THE APPOINTMENT OF PWC AS INDEPENDENT AUDITORS (PROPOSAL 4).

Who may vote?

Stockholders of record of our Class A common stock, par value $0.001 per share (“Common Stock”), at the close of business on the Record Date are entitled to receive the Notice and these proxy materials and to vote their respective shares at the Annual Meeting. Each share of Common Stock is entitled to one vote on each matter that is properly brought before the Annual Meeting. As of the Record Date, there were 83,661,965 shares of Common Stock issued and outstanding.

How do I vote?

We encourage you to vote your shares via the Internet. How you vote will depend on how you hold your shares of Common Stock.

Stockholders of Record

If your Common Stock is registered directly in your name with our transfer agent, American Stock, Transfer & Trust Company, LLC, you are considered a stockholder of record with respect to those shares, and a full paper set of these proxy materials is being sent directly to you. As a stockholder of record, you have the right to vote by proxy.

You may vote by proxy in any of the following three ways:

Internet. Go to www.proxyvote.com to use the Internet to transmit your voting instructions and for electronic delivery of information. Have your proxy card in hand when you access the website.

Phone. Call 1-800-690-6903 using any touch-tone telephone to transmit your voting instructions. Have your proxy card in hand when you call.

Mail. Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided, or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717.

Voting by any of these methods will not affect your right to attend the Annual Meeting and vote in person. However, for those who will not be voting in person at the Annual Meeting, your final voting instructions must be received by no later than 11:59 p.m. Eastern Time on May 21, 2018.

Beneficial Owners

Most of our stockholders hold their shares through a stockbroker, bank or other nominee, rather than directly in their own names. If you hold your shares in one of these ways, you are considered the beneficial owner of shares held in street name, and the Notice is being forwarded to you by your broker, bank or nominee who is considered, with respect to those shares, the stockholder of record. As the beneficial owner, you have the right to direct your broker, bank or nominee on how to vote. Your broker, bank or nominee has enclosed a voting instruction form for you to use in directing the broker, bank or

Table of Contents

nominee on how to vote your shares. If you hold your shares through a New York Stock Exchange (“NYSE”) member brokerage firm, that member brokerage firm has the discretion to vote shares it holds on your behalf with respect to Proposal 4 (the ratification of PwC as independent auditors for our 2018 fiscal year), but not with respect to Proposal 1 (the election of directors), Proposal 2 (the “say-on-pay” proposal) or Proposal 3 (the approval of the 2018 Stock and Incentive Plan) as more fully described under “What is a broker ‘non-vote’?” below.

Can I change my vote?

Yes. If you are the stockholder of record, you may revoke your proxy before it is exercised by doing any of the following:

•

voting again over the Internet or by telephone prior to 11:59 p.m., Eastern Time on May 21, 2018;

•

timely sending a letter to us stating that your proxy is revoked;

•

signing a new proxy and timely sending it to us; or

•

attending the Annual Meeting and voting by ballot.

Beneficial owners should contact their broker, bank or nominee for instructions on changing their votes.

How many votes must be present to hold the Annual Meeting?

A “quorum” is necessary to hold the Annual Meeting. A quorum is a majority of the votes entitled to be cast by the stockholders entitled to vote at the Annual Meeting. They may be present at the Annual Meeting or represented by proxy. Abstentions and broker “non-votes” are counted as present and entitled to vote for purposes of determining a quorum.

How many votes are needed to approve the proposals?

At the Annual Meeting, a “FOR” vote by a majority of votes cast is required for each of the proposals described in this proxy statement: Proposal 1 (the election of directors), Proposal 2 (the “say-on-pay” proposal), Proposal 3 (the approval of the 2018 Stock and Incentive Plan) and Proposal 4 (the ratification of PwC as independent auditors for our 2018 fiscal year).

For Proposals 1, 2 and 4, a “FOR” vote by a “majority of votes cast” means that the number of shares voted “FOR” exceeds the number of shares voted “AGAINST.” For Proposal 3, a “FOR” vote by a “majority of votes cast” means that the number of shares voted “FOR” exceeds the number of shares voted “AGAINST,” plus abstentions.

What is an abstention?

An abstention is a properly signed proxy card that is marked “ABSTAIN.” In the case of Proposals 1, 2 and 4, abstentions do not constitute votes “FOR” or votes “AGAINST” and, therefore, will have no effect on the outcome of any of those proposals. However, under NYSE rules abstentions will have the effect of a vote “AGAINST” Proposal 3.

What is a broker “non-vote?”

A broker “non-vote” occurs when a nominee holding shares for a beneficial owner does not vote on a particular proposal because the nominee does not have discretionary voting power for that particular item and has not received timely instructions from the beneficial owner. Under current applicable rules,

Table of Contents

Proposal 4 (the ratification of PwC as independent auditors for our 2018 fiscal year) is a “discretionary” item upon which NYSE member brokerage firms that hold shares as nominee may vote on behalf of the beneficial owners if such beneficial owners have not furnished voting instructions by the tenth day before the Annual Meeting.

However, NYSE member brokerage firms that hold shares as a nominee may not vote on behalf of the beneficial owners on Proposal 1 (the election of directors), Proposal 2 (the “say-on-pay” proposal) or Proposal 3 (the approval of the 2018 Stock and Incentive Plan) unless you provide voting instructions. Therefore, if a NYSE member brokerage firm holds your Common Stock as a nominee, please instruct your broker how to vote your Common Stock on each of these proposals. This will ensure that your shares are counted with respect to each of these proposals. Broker “non-votes” do not constitute votes “FOR” or votes “AGAINST” and therefore will have no effect on the outcome of any of the proposals.

Will any other matters be acted on at the Annual Meeting?

If any other matters are properly presented at the Annual Meeting or any adjournment or postponement thereof, the persons named in the proxy will have discretion to vote on those matters. As of December 12, 2017, the date by which any proposal for consideration at the Annual Meeting submitted by a stockholder must have been received by us to be presented at the Annual Meeting, and as of the date of these proxy materials, we did not know of any other matters to be presented at the Annual Meeting.

Who pays for this proxy solicitation?

We will pay the expenses of soliciting proxies. In addition to solicitation by mail, proxies may be solicited in person or by telephone or other means by our directors or associates for no additional compensation. We will reimburse brokerage firms and other nominees, custodians and fiduciaries for costs incurred by them in mailing these proxy materials to the beneficial owners of Common Stock held of record by such persons.

Whom should I call with other questions?

If you have additional questions about these proxy materials or the Annual Meeting, please contact: GNC Holdings, Inc., 300 Sixth Avenue, Pittsburgh, Pennsylvania, 15222, Attention: Kevin G. Nowe; Telephone: (412) 288-4600.

Table of Contents

ELECTION OF DIRECTORS

(PROPOSAL 1)

The Board proposes that each of the eight director nominees described below (the “Nominees”), who currently are members of our Board, be re-elected for a one-year term expiring at our 2019 Annual Meeting and to serve until the due election and qualification of his or her successor, or until his or her earlier resignation or removal.

All of the Nominees have indicated their willingness to serve if elected. If, at the time of the meeting, any Nominee is unable or unwilling to serve, shares represented by properly executed proxies will be voted at the discretion of the persons named therein for such other nominee as the Board may designate, or the Board may elect to decrease the size of the Board.

Set forth below is information concerning each Nominee, and the key experience, qualifications and skills he or she brings to the Board.

Recommendation

THE BOARD RECOMMENDS THAT THE STOCKHOLDERS VOTE FOR THE ELECTION OF THE NOMINEES AS DIRECTORS.

The Nominees

Robert F. Moran, 67, became one of our directors in June 2013 and served as our Interim Chief Executive Officer from July 2016 through September 10, 2017. In September 2017, he was elected as Non-Executive Chairman of the Board. Mr. Moran most recently served as Chairman and Chief Executive Officer of PetSmart, Inc., a leading specialty provider of pet products, services and solutions (“PetSmart”), from February 2009 to June 2013. Prior to being appointed Chairman, Mr. Moran was PetSmart’s President and Chief Executive Officer from June 2009 to January 2012 and its President and Chief Operating Officer from December 2001 to June 2009. Before joining PetSmart in 1999, Mr. Moran was President of Toys “R” Us Canada. Mr. Moran served on the boards of directors of Collective Brands, Inc. from March 2005 to October 2012 and of PetSmart from September 2009 to June 2013. He currently serves on the boards of directors of Hanesbrands, Inc., for which he chairs the audit committee, and the USA Track & Field Foundation. Mr. Moran’s more than 40 years of executive leadership experience, both domestically and internationally, and extensive retail experience and expertise led to the conclusion that he should serve as a director on the Board.

Kenneth A. Martindale, 58, became our Chief Executive Officer and a director on September 11, 2017. Mr. Martindale was previously CEO of Rite Aid Stores, a position held since August 3, 2015, and President of Rite Aid Corporation, a position held since June 2013. He previously served as Rite Aid’s Chief Operating Officer since June 2010. From December 2008 until June 2010, he served as Rite Aid’s Senior Vice President and Chief Merchandising, Marketing and Logistics Officer. He served as co-President and Chief Merchandising and Marketing Officer for Pathmark Stores, Inc. from January 2006 until its acquisition by the Great Atlantic & Pacific Tea Company in December 2007. Mr. Martindale serves as a director of Fairway Group Holdings Corporation. Mr. Martindale’s years of executive leadership experience in retail operations led to the conclusion that he should serve as a director on the Board.

Table of Contents

Jeffrey P. Berger, 68, became one of our directors in March 2011. Mr. Berger currently is a private investor. From 2008 until April 2013, Mr. Berger served as a consultant to H. J. Heinz Company, a leading producer and marketer of healthy and convenient foods (“Heinz”). From 2007 to 2008, Mr. Berger was the Chairman of Global Foodservice of Heinz. From 2005 to 2007, Mr. Berger was the Executive Vice President, President and Chief Executive Officer of Heinz Foodservice. From 1994 to 2005, Mr. Berger was President and Chief Executive Officer of Heinz North America Foodservice. Mr. Berger currently serves on the board of directors of Big Lots, Inc., a discount retailer (“Big Lots”), for which he chairs the nominating/corporate governance committee and serves as a member of the compensation committee. Mr. Berger’s years of experience as an executive officer at Heinz, in addition to his public company board experience, led to the conclusion that he should serve as a director on the Board.

Alan D. Feldman, 66, became one of our directors in June 2013. Mr. Feldman most recently served as Chairman, President and Chief Executive Officer of Midas, Inc., a provider of retail automotive services, from May 2006 until its merger with TBC Corporation in May 2012 and as its President and Chief Executive Officer from January 2003 until May 2006. From 1994 through 2002, Mr. Feldman held senior management posts at McDonald’s Corporation and, prior to that, with the Pizza Hut and Frito-Lay units of PepsiCo, Inc. Mr. Feldman also currently serves on the board of directors of Foot Locker, Inc., for which he chairs the compensation and management resources committee and serves as a member of the executive committee and the finance and strategic planning committee, and of John Bean Technologies Corporation, for which he chairs the audit committee and serves as a member of the nominating and governance committee. Mr. Feldman also serves as Chair of the University of Illinois Foundation. Mr. Feldman’s recognized leadership skills and years of broad-based experience in independent, franchised retail operations, brand management and customer relations led to the conclusion that he should serve as a director on the Board.

Michael F. Hines, 62, became one of our directors in November 2009. He served as Chairman of our Board from August 2014 to September 2017, and prior to that, served as our Lead Independent Director since July 2012. Mr. Hines was the Executive Vice President and Chief Financial Officer of Dick’s Sporting Goods, Inc., a sporting goods retailer, from 1995 to March 2007. From 1990 to 1995, he held management positions with Staples, Inc., most recently as Vice President, Finance. Earlier, he spent 12 years in public accounting, the last eight years with the accounting firm Deloitte & Touche, LLP in Boston. Mr. Hines serves on the board of directors of The TJX Companies, Inc., a retailer of apparel and home fashions (“TJX”), and is the chair of its audit committee and a member of its finance committee. He also serves on the board of directors of Dunkin Brands Group, Inc., the parent company of Dunkin’ Donuts and Baskin-Robbins, for which he chairs the audit committee and is a member of the nominating and corporate governance committee. Mr. Hines’s experience as a financial executive and certified public accountant, coupled with his extensive knowledge of financial reporting rules and regulations, evaluating financial results and generally overseeing the financial reporting process of large retailers, led to the conclusion that he should serve as a director on the Board.

Amy B. Lane, 65, became one of our directors in June 2011. Ms. Lane was a Managing Director and Group Leader of the Global Retailing Investment Banking Group at Merrill Lynch & Co., Inc., an investment bank, from 1997 until her retirement in 2002. Ms. Lane previously served as a Managing Director at Salomon Brothers, Inc., an investment bank, where she founded and led the retail industry investment banking unit. Ms. Lane serves on the board of directors of TJX, and is the chair of its finance committee and a member of its audit and executive committees. Additionally, she serves on the board of directors of Nextera Energy, Inc., an electric utility holding company, and as a member of its finance committee and on the board of directors of Urban Edge Properties, a REIT spun off from Vornado Realty Trust. Ms. Lane’s experience as the leader of two investment banking practices covering the global retailing industry has given her substantial experience with financial services, capital markets, finance

Table of Contents

and accounting, capital structure, acquisitions and divestitures in the retail industry as well as management, leadership and strategy, which led to the conclusion that she should serve as a director on the Board.

Philip E. Mallott, 60, became one of our directors in July 2012. Mr. Mallott retired as Vice President, Finance and Chief Financial Officer of Intimate Brands, Inc., a clothing retailer and former subsidiary of Limited Brands, Inc., and is currently a director of Big Lots, for which he served as non-executive chair until May 2017 and currently serves as the chair of the audit committee. He most recently provided retail stock research as an independent consultant to Westminster Research Associates LLC and, prior to that, as an analyst for Coker & Palmer, Inc. Mr. Mallott previously served as a director of Tween Brands, Inc. from 2000 to 2009. Mr. Mallott’s experience as a certified public accountant, his service on the boards of other public companies and charitable organizations, and his experience in leadership roles with other retailers led to the conclusion that he should serve as a director on the Board.

Richard J. Wallace, 66, became one of our directors in July 2010. Mr. Wallace served as a Senior Vice President for Research and Development at GlaxoSmithKline, a global pharmaceutical company (“GSK”), from 2004 until his retirement in 2008. Prior to that, he served in various executive capacities for GSK and its predecessor companies and their subsidiaries from 1992 to 2004. Mr. Wallace is also a director of ImmunoGen, Inc., for which he serves as a member of the audit and nominating and governance committees, and served as a director of Clinical Data Inc. from September 2007 to April 2011. Mr. Wallace’s years of experience at several large pharmaceutical and consumer products companies and his significant corporate governance experience through his service on the boards of directors of other companies led to the conclusion that he should serve as a director on the Board.

The affirmative vote of the holders of a majority of the votes cast by our stockholders in person or represented by proxy and entitled to vote at the Annual Meeting is required to approve this Proposal 1.

Table of Contents

OTHER BOARD INFORMATION

Board Composition

The Board is currently composed of Robert F. Moran, Kenneth A. Martindale, Jeffrey P. Berger, Alan D. Feldman, Michael F. Hines, Amy B. Lane, Philip E. Mallott, and Richard J. Wallace.

The Board has adopted Corporate Governance Guidelines, which are available on the Corporate Governance page of the Investor Relations section of our website located at www.gnc.com and will be provided to any stockholder free of charge upon request. The Corporate Governance Guidelines provide that in the event the Chairperson of the Board is not an independent director, the Lead Independent Director of the Board is to serve as the chairperson of any meetings of the Board in executive session. Mr. Moran, an independent director, currently serves as Non‑Executive Chairman of the Board.

Board Meetings in 2017

The Board held 12 meetings during our fiscal year ended December 31, 2017.

Director Attendance

During our fiscal year ended December 31, 2017, each of our incumbent directors attended at least 75% of the total number of meetings of the Board and committees on which he or she served during the period in which he or she served. We encourage, but do not require, our directors to attend our annual meetings of stockholders. All of our current directors who were serving on the Board at the time of our 2017 Annual Meeting attended the meeting.

Director Independence

Our Common Stock is listed for trading on the NYSE under the symbol “GNC”. The Board, upon the findings of the Nominating Committee, has determined that each of Ms. Lane and Messrs. Moran, Berger, Feldman, Hines, Mallott, and Wallace is “independent” within the meaning of Rule 303A.02 of the NYSE Listed Company Manual, and no family relationships exist among such Nominees and any of our executive officers.

Leadership Structure

The Board has adopted guidelines that provide the Board with the discretion and flexibility to decide if the roles of the Chief Executive Officer and Chairperson of the Board are to be separate or combined. Currently, the roles are separate, with Mr. Martindale serving as Chief Executive Officer and Mr. Moran, an independent director, serving as Non‑Executive Chairman of the Board. The Board has determined that this is currently the appropriate leadership structure due to the fact that the separation of these positions allows for better independence and accountability.

Risk Oversight

The Board plays an active role in overseeing management of our risks. The Board regularly reviews information regarding our credit, liquidity and operations, as well as the risks associated with each. The Audit Committee and the Finance Committee each have responsibilities related to the oversight and management of financial risks. The Compensation and Organizational Development Committee of the Board (the “Compensation Committee”) is responsible for overseeing the management of risks relating to

Table of Contents

our executive compensation policies and arrangements. The Nominating and Corporate Governance Committee of the Board (the “Nominating Committee”) is responsible for managing risks relating to our director compensation policies and arrangements, the independence of the Board and other corporate governance matters. While each of the Committees is responsible for evaluating certain risks and overseeing the management of such risks, the Board as a whole is regularly informed of the conclusions of such evaluations through reports of the Committees. The risk oversight function does not impact the structure of the Board.

Board Committees

Each of the following Committees is a standing committee of the Board. The Board has adopted written charters for the Audit Committee, the Compensation Committee, the Finance Committee and the Nominating Committee, each of which is available on the Corporate Governance page of the Investor Relations section of our website located at www.gnc.com and will be provided to any stockholder free of charge upon request. Further, each member of the Audit Committee, the Compensation Committee, the Finance Committee and the Nominating Committee has been determined by the Board to be independent under the NYSE’s current listed company standards.

Audit Committee

The Audit Committee, which is established in accordance with Section 3(a)(58)(A) of the Exchange Act, held nine meetings during our fiscal year ended December 31, 2017 and currently consists of Jeffrey P. Berger, Michael F. Hines, and Philip E. Mallott, who acts as its chair. The Board has determined that each of Messrs. Berger, Hines and Mallott qualifies as an “audit committee financial expert” as defined in Item 407(d)(5)(ii) of Regulation S-K and has the attributes set forth in such section. The Committee consists entirely of directors who meet the independence requirements of the listing standards of the NYSE and Rule 10A-3 under the Exchange Act.

The principal duties and responsibilities of the Audit Committee are to:

•

approve, review, and monitor our financial reporting process and internal control system;

•

appoint and replace our independent registered public accounting firm from time to time, determine its compensation and other terms of engagement and oversee its work;

•

oversee our audit and financial statements and related disclosures;

•

oversee the performance of our internal audit function; and

•

oversee our compliance with legal, ethical and regulatory matters.

The Audit Committee has the power to investigate any matter brought to its attention within the scope of its duties. It also has the authority to retain counsel and advisors to fulfill its responsibilities and duties.

Compensation and Organizational Development Committee

The Compensation Committee, which held six meetings during our fiscal year ended December 31, 2017, currently consists of Amy B. Lane, Philip E. Mallott, and Richard J. Wallace, who acts as its chair.

The principal duties and responsibilities of the Compensation Committee are to:

•

oversee the development and implementation of our executive compensation policies and objectives;

•

determine the structure of our executive compensation packages generally;

•

determine the annual compensation paid to each of our senior executives;

Table of Contents

•

evaluate the performance of our Chief Executive Officer and other senior executives;

•

determine stock ownership guidelines for the Company’s directors and executives and monitor compliance with those guidelines;

•

review potential risk to the Company from its compensation policies and program, including incentive compensation plans;

•

review and recommend to the Board for approval the frequency with which the Company will conduct stockholder advisory votes on executive compensation, taking into account the results of the most recent stockholder advisory vote;

•

work with the Company’s Chief Executive Officer to develop succession plans for the Company and development initiatives for our senior executives; and

•

review and evaluate the implementation and effectiveness of such succession plans and development initiatives.

Compensation Committee Interlocks and Insider Participation. For our fiscal year ended December 31, 2017, (i) no member of the Compensation Committee (a) served as one of our officers or employees during or preceding their tenure on the Compensation Committee or (b) had any relationship requiring disclosure under Item 404 of Regulation S-K, and (ii) none of our executive officers served as a director or member of the compensation committee of another entity whose executive officers served on the Board or the Compensation Committee. During our fiscal year ended December 31, 2017, our Compensation Committee included Amy B. Lane, Philip E. Mallott, and Richard J. Wallace.

Finance Committee

The Finance Committee, which held eleven meetings during our fiscal year ended December 31, 2017, currently consists of Alan D. Feldman, Michael F. Hines and Amy B. Lane, who acts as its chair.

The principal duties and responsibilities of the Finance Committee are to:

•

review and make recommendations to the Board with respect to the Company’s financial condition and long-range financial plans and strategies, including as they relate to the management of financial risk;

•

review and make recommendations to the Board with respect to the Company’s capital structure and the principal terms and conditions of significant proposed borrowings and issuances of debt or equity securities by the Company and its subsidiaries;

•

review and make recommendations to the Board with regard to the Company’s proposed dividend policies and the repurchase or redemption of Company securities;

•

review and oversee the Company’s investment and cash management policies;

•

review and oversee the Company’s foreign currency exchange and other hedging policies;

•

review and make recommendations to the Board with respect to capital investment criteria, capital expenditures and annual lease commitments for the Company;

•

review and make recommendations to the Board with respect to the Company’s insurance and self-insurance programs (including directors’ and officers’ liability policies);

•

review and make recommendations to the Board with respect to the Company’s defense profile, strategies and plans for significant mergers, acquisitions, divestitures, joint ventures and other investments and strategic plans; and

•

review the Company’s stock ownership profile and the performance of the Company’s Common Stock.

Table of Contents

Nominating and Corporate Governance Committee

The Nominating Committee, which held four meetings during our fiscal year ended December 31, 2017, currently consists of Jeffrey P. Berger, Richard J. Wallace and Alan D. Feldman, who acts as its chair.

The principal duties and responsibilities of the Nominating Committee are as follows:

•

to establish criteria for board and committee membership and recommend to the Board proposed nominees for election to the Board and for membership on committees of the Board;

•

to oversee the evaluation of the Board and its committees;

•

to make recommendations to the Board regarding board governance matters and practices; and

•

to determine the structure and oversee the development and implementation of the Company’s compensation policies, objectives and administrative practices and all other matters relating to the compensation of the Company’s non-employee directors.

Director Qualifications; Nominating Committee Process. The Nominating Committee’s policy is to identify potential director nominees from any properly submitted nominations, including any properly submitted nominations from our stockholders, and subsequently evaluate each potential nominee. Stockholders may nominate director candidates for consideration by the Nominating Committee as set forth below.

In accordance with the Company’s amended and restated by-laws, to be timely for consideration by the Nominating Committee, notice of a proposed nomination must be delivered to or mailed and received at the Company’s principal executive offices not earlier than the opening of business on the 120^th day nor later than the close of business on the 90^th day prior to the one year anniversary of the date of the preceding year’s annual meeting of its stockholders; provided, however, that if the date of the annual meeting is more than 30 days prior to or delayed by more than 70 days after the anniversary of the preceding year’s annual meeting, the nomination must be received not earlier than the opening of business on the 120^th day prior to the date of such annual meeting nor later than the later of the close of business on the (i) 90^th day prior to the date of such annual meeting or (ii) 10^th day following the day on which public announcement of such meeting date is first made.

In addition to information regarding the nominating stockholder as set forth in the Company’s amended and restated by-laws, in accordance with the Company’s corporate governance guidelines, such stockholder’s notice must set forth as to each individual whom the stockholder proposes to nominate for election or reelection as a director:

•

the name, age, business address and residence address of such individual;

•

the class, series and number of any shares of stock of the Company that are beneficially owned by such individual;

•

the date such shares were acquired and the investment intent of such acquisition;

•

whether such stockholder believes any such individual is, or is not, “independent” as set forth in the requirements established by the NYSE or any other exchange or automated quotation service on which the Company’s securities are listed, and information regarding such individual that is sufficient, in the discretion of the Board or any committee thereof or any authorized officer of the Company, to make either such determination; and

•

all other information relating to such individual that is required to be disclosed in solicitations of proxies for election of directors in an election contest (even if an election contest is not involved), or is otherwise required, in each case pursuant to Regulation 14A (or any successor provision) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and the rules and regulations promulgated thereunder.

Table of Contents

Any such submission must be accompanied by the written consent of the individual whom the stockholder proposes to nominate to being named in the proxy statement as a nominee and to serving as a director if elected.

The Nominating Committee may, but is not required to, consider nominations not properly submitted in accordance with the Company’s Corporate Governance Guidelines, and the Committee may request further information and documentation from any proposed nominee or from any stockholder proposing a nominee. All nominees properly submitted to the Company (or which the Nominating Committee otherwise elects to consider) will be evaluated and considered by members of the Nominating Committee using the same criteria as nominees identified by the Nominating Committee itself.

In evaluating the suitability of individual candidates (both new candidates and current Board members), in recommending candidates for election, and in approving (and, in the case of vacancies, appointing) such candidates, the Nominating Committee considers, in addition to such other factors as it shall deem relevant, the desirability of selecting directors who:

•

are of high character and possess fundamental qualities of intelligence, honesty, good judgment, integrity, fairness and responsibility;

•

have the ability to make independent analytical inquiries and possess a general understanding of marketing, finance, and other elements relevant to the success of a publicly traded company;

•

are accomplished in their respective fields, with superior credentials and recognition;

•

understand our business on a technical level and have relevant expertise and experience upon which to be able to offer advice and guidance to management;

•

have sufficient time available to devote to the affairs of our Company;

•

are able to work with the other members of the Board and contribute to our success;

•

can represent the long-term interests of our stockholders as a whole; and

•

are selected such that the Board represents a range of backgrounds and experience.

In addition to the considerations set forth above, the Nominating Committee considers a candidate’s background and accomplishments and candidates are reviewed in the context of the current composition of the Board and the evolving needs of our businesses. The Nominating Committee conducts the appropriate and necessary inquiries (as determined by the Nominating Committee) with respect to the backgrounds and qualifications of any potential nominees, without regard to whether a potential nominee has been recommended by our stockholders, and, upon consideration of all relevant factors and circumstances, recommends to the Board for its approval the slate of director nominees to be nominated for election at our annual meeting of stockholders. The Nominating Committee considers potential nominees without regard to race, color, creed, religion, national origin, age, gender, sexual orientation or disability. The Nominating Committee has not adopted a formal policy with respect to diversity.

Table of Contents

Director Compensation

The following table presents information regarding the compensation of our non-employee directors with respect to our fiscal year ended December 31, 2017 and should be read in conjunction with “Narrative to the Director Compensation Table” below. No director who is or was at any time during 2017 an employee of the Company receives or has ever received any compensation for serving on the Board during his or her time of employment. Compensation received by Mr. Moran, in his role as an employee of the Company is discussed under “Compensation Discussion and Analysis” and “Named Executive Officer Compensation” below.

Name	Fees Earned or Paid in Cash ($)			Stock Awards ($) (1) (2)		All Other Compensation ($)		Total ($)

Jeffrey Berger		102,500	(3)		110,000		—		212,500
Alan Feldman		112,500	(4)		110,000		—		222,500
Michael Hines		171,731	(5)		110,000		—		281,731
Amy Lane		112,500	(6)		110,000		—		222,500
Philip Mallott		120,000	(7)		110,000		—		230,000
Robert Moran (8)		57,884	(9)		—		—		57,884
Richard Wallace		115,000	(10)		110,000		—		225,000

(1)

Reflects the approximate aggregate grant date fair value of the 2017 annual restricted stock awards granted to each of the directors computed in accordance with FASB ASC Topic 718. For the assumptions underlying the calculation of the aggregate grant date fair value, see Note 14, “Stock-Based Compensation,” to our audited consolidated financial statements included in the Annual Report. The 2017 annual awards were granted on May 22, 2017, had an approximate aggregate grant date fair value of $110,000 for each director and the restrictions with respect to the restricted stock is scheduled to lapse on the first anniversary of the grant date, provided the director has remained in service until the vesting date.

(2)

The table below sets forth the number of stock awards and the exercisable and unexercisable stock options received for services as a director and held by the listed directors as of December 31, 2017, and does not include the stock awards and option awards granted to Mr. Moran in his capacity as Interim Chief Executive Officer, which are reflected in the Outstanding Equity Awards as of December 31, 2017 table set forth below.

			Option Awards Outstanding
Name	Stock Awards Outstanding		Exercisable		Unexercisable

Jeffrey Berger		14,765		14,000		—
Alan Feldman		14,765		—		—
Michael Hines		14,765		36,920		—
Amy Lane		14,765		30,500		—
Philip Mallott		14,765		—		—
Robert Moran		—		—		—
Richard Wallace		14,765		35,000		—

Table of Contents

(3)	Reflects aggregate annual retainers paid to Mr. Berger, including $80,000 for his service as a director, $10,000 for his service as a member of the Nominating Committee and $12,500 for his service as a member of the Audit Committee.

(4)

Reflects aggregate annual retainers paid to Mr. Feldman, including $80,000 for his service as a director, $10,000 for his service as a member of the Nominating Committee, $12,500 for his service as Chairperson of the Nominating Committee and $10,000 for his service as a member of the Finance Committee.

(5)	Reflects aggregate annual retainers paid to Mr. Hines, including $80,000 for his service as a director, $12,500 for his service as a member of the Audit Committee, $10,000 for his service as a member of the Finance Committee and $69,231 for his service as Chairman of the Board until September 2017.

(6)	Reflects aggregate annual retainers paid to Ms. Lane, including $80,000 for her service as a director, $10,000 for her service as a member of the Compensation Committee, $12,500 for her service as Chairperson of the Finance Committee and $10,000 for her service as a member of the Finance Committee.

(7)	Reflects aggregate annual retainers paid to Mr. Mallott, including $80,000 for his service as a director, $12,500 for his service as a member of the Audit Committee, $17,500 for his service as Chairperson of the Audit Committee and $10,000 for his service as a member of the Compensation Committee.

(8)

Reflects amounts received by Mr. Moran in his role as a director following his service as the Interim Chief Executive Officer of the Company. Mr. Moran did not receive any compensation in his role as a director for the period during his service as the Interim Chief Executive Officer of the Company. The amounts received by Mr. Moran in his role as Interim Chief Executive Officer are set forth in the Compensation Discussion and Analysis section of this proxy statement and the tables that follow.

(9)	Reflects aggregate annual retainers earned by Mr. Moran, including $24,615 for his service as a director and $33,269 for his service as Chairman of the Board beginning in September 2017.

(10)

Reflects aggregate annual retainers paid to Mr. Wallace including $80,000 for his service as a director, $15,000 for his service as Chairperson of the Compensation Committee, $10,000 for his service as a member of the Compensation Committee and $10,000 for his service as a member of the Nominating Committee.

Narrative to the Director Compensation Table. In July 2013, based in part on recommendations of Hay Group, a predecessor of Korn Ferry Hay Group, we adopted a director compensation policy (the “Director Compensation Policy”) pursuant to which each non-employee director is entitled to receive an annual cash retainer for his or her service as a member of our Board, as well as additional cash retainers for his or her service as a member and/or Chairperson of one of the various Committees of the Board and an annual equity award. The Board believes that payments of retainer fees provide an appropriate balance of incentives for active participation and ease of administration, while the grant of annual equity awards aligns the long-term financial interests of our directors and our stockholders. Specifically, each of our directors currently is entitled to (i) an annual cash retainer for his or her Board service of $80,000, (ii) an incremental annual cash retainer of $17,500, $15,000, $12,500 or $12,500 for service as Chairperson of the Audit Committee, Compensation Committee, Finance Committee or Nominating Committee, respectively, (iii) an incremental annual cash retainer of $12,500 to the extent he or she otherwise serves as a member of the Audit Committee, or $10,000 to the extent he or she otherwise serves as a member of the Compensation Committee, Finance Committee and/or Nominating Committee, and (iv) $110,000 in annual equity awards. For information regarding Compensation Committee Interlocks and Insider Participation, see Other Board Information above. In addition to compensation paid for general membership on the Board and its various committees, the Chairman of the Board is entitled to receive an annual, incremental cash retainer. During 2017, the annual cash retainer for the Chairman of the Board was $100,000 until October 2017, at which time it was increased to $110,000.

Table of Contents

The annual cash retainers paid to our non-employee directors under the Director Compensation Policy are generally paid in four equal quarterly installments every March, June, September and December.

We also maintain a deferred compensation plan under which our non-employee directors may elect to defer all or a portion of their cash fees or restricted stock retainers until the earliest of separation from the Board, death, a specified future date or a change in control of the Company. Annual stock retainers are deferred in the form of RSUs with identical vesting schedules to the shares of restricted stock. No deferral elections were made for the 2017 grants.

Director Stock Ownership Guidelines. We believe that, to align the interests of our non-employee directors with our stockholders, our directors should hold a financial stake in the Company. The Board adopted a policy in December 2011 requiring each of our non-employee directors to own stock in the Company equal to a minimum of five times such director’s annual cash retainer for service on the Board (the “Director Stock Ownership Guidelines”). Any newly elected directors have five years from the date of their election to comply with the Director Stock Ownership Guidelines, and should retain at least 50% of all after-tax shares owned by or underlying equity awards granted to them (other than those granted on or prior to December 11, 2012) until the ownership thresholds are met. The Nominating Committee will evaluate whether exceptions should be made for any director on whom this requirement would impose a financial hardship or for other appropriate reasons as determined by the Nominating Committee. For the purposes of the Director Stock Ownership Guidelines, stock includes (i) directly held shares of our Common Stock, (ii) shares of unvested restricted stock and unvested RSUs (other than unvested shares of performance-vested restricted stock or unvested performance-vested restricted stock units) and (iii) vested shares of Common Stock allocated to the account of a non-employee director who was formerly an employee of the Company under any plan qualified under Section 401(a) of the Internal Revenue Code of 1986, as amended.

Table of Contents

Code of Ethics

We have adopted a Code of Ethics applicable to our Chief Executive Officer and senior financial officers and a Code of Business Conduct and Ethics that is applicable to all employees. Each document is available on the Corporate Governance page of the Investor Relations section of our website located at www.gnc.com and will be provided to any stockholder free of charge upon request. Any amendments to or waivers from our Code of Ethics with respect to our Chief Executive Officer and senior financial officers will also be disclosed on our website. Employees generally receive annual training with respect to the expectations specified in the Code of Business Conduct and Ethics, and acknowledge that they understand their responsibilities and will comply with all aspects of the Code of Business Conduct and Ethics.

Certain Relationships and Related Transactions

We recognize that transactions between the Company and related persons present a potential for actual or perceived conflicts of interest. Our general policies with respect to such transactions are included in our Code of Business Conduct and Ethics. All employees are required to follow the Code of Business Conduct and Ethics, and the Audit Committee of the Board, along with Corporate Compliance staff led by our Chief Legal Officer, oversee our Code of Business Conduct and Ethics, which provides that any actual or potential conflict of interest is to be disclosed.

Although we have not adopted formal written procedures for the review, approval or ratification of transactions with related persons, the Board reviews potential transactions with those parties we have identified as related parties prior to the consummation of the transaction, and we adhere to the general policy that such transactions should only be entered into if they are approved by the Board, in accordance with applicable law, and on terms that, on the whole, are no more or less favorable than those available from unaffiliated third parties.

In 2017, we did not participate in any transactions involving an amount in excess of $120,000 in which any related person (as defined in Instruction 1 to Item 404(a) of Regulation S-K) has or will have a direct or indirect material interest. In the ordinary course of business, the Company began to sell certain products through TJX’s retail stores in 2017. Mr. Hines and Ms. Lane serve on the board of directors of TJX. Consistent with SEC rules, neither Mr. Hines nor Ms. Lane are considered to have an interest in these transactions.

Communications from Stockholders and Other Interested Parties

The Board welcomes communications from our stockholders and other interested parties. Stockholders and other interested parties wishing to communicate with the Board, our non-management directors or any particular director may send such communications to the following address: GNC Holdings, Inc., 300 Sixth Avenue, Pittsburgh, Pennsylvania, 15222, Attention: Secretary. Such communications should indicate clearly the director or directors to whom the communication is being sent so that each communication may be forwarded directly to the appropriate director(s).

Table of Contents

EXECUTIVE OFFICERS

Set forth below is information concerning our current executive officers.

Name	Age	Position
Kenneth A. Martindale	58	Chief Executive Officer
Tricia K. Tolivar	49	Executive Vice President, Chief Financial Officer and Interim Chief Marketing Officer
Guru Ramanathan	55	Senior Vice President and Chief Innovation Officer
Joseph C. Gorman	47	Executive Vice President, Operations
Kevin G. Nowe	65	Senior Vice President, Chief Legal Officer and Secretary
Steven Piano	52	Senior Vice President and Chief Human Resources Officer
Gene E. Burt	52	Executive Vice President, Chief Merchandising Officer and Chief Supply Chain Officer

The biography for Mr. Martindale is set forth above under “Election of Directors (Proposal 1).”

Tricia K. Tolivar became our Executive Vice President and Chief Financial Officer in March 2015 and our Interim Chief Marketing Officer in June 2017, having previously served in leadership positions with Ernst & Young, LLP from October 2007 to February 2015, including most recently as Americas Director of Finance, Advisory, with responsibility for the leadership of finance, accounting and operations of a $3 billion client service organization in North and South America. Ms. Tolivar previously served as Chief Financial Officer of the Greater Memphis Arts Council from January 2006 to December 2008 and in a series of executive leadership positions with AutoZone, Inc. from 1996 to 2005. She is a graduate of Emory University.

Guru Ramanathan, Ph.D. joined our Company in 1998 and became our Senior Vice President and Chief Innovation Officer in December 2009 having previously served as Senior Vice President of Product and Package Innovation since February 2008 and Senior Vice President of Scientific Affairs since April 2007. He served as Vice President of Scientific Affairs from December 2003 to April 2007. Prior to joining the Company, Dr. Ramanathan worked as Medical Director and Secretary for the Efamol subsidiary of Scotia Pharmaceuticals in Boston and, in his capacity as a pediatric dentist and dental surgeon, held various industry consulting and management roles, as well as clinical, research and teaching appointments in Madras, India, and Tufts University and New England Medical Center in Boston, Massachusetts. Dr. Ramanathan earned his Ph.D. in Innovation Management from Tufts University and his MBA from Duke University’s Fuqua School of Business.

Joseph C. Gorman was appointed, effective as of March 5, 2017, as Executive Vice President, Operations. Prior to his appointment, Mr. Gorman served as Senior Vice President, Store Operations from January to March 2017 and Vice President, Western Division, from December 2015 to January 2017. Prior to joining the Company in 2015, Mr. Gorman was President of Anomaly Republic, a clothing retailer headquartered in Southern California from 2014 to 2015, with responsibility for the executive management and operational leadership of the company’s business. Prior to that, Mr. Gorman spent approximately six years at GameStop, an omni-channel video game and electronics retailer, where he held various field leadership positions from 2009 to 2014, and approximately 16 years before that at The Home Depot, a home improvement retailer, where he held various operational roles in the field and headquarters.

Table of Contents

Kevin G. Nowe became our Senior Vice President, Chief Legal Officer and Secretary in March 2018. Previously he served as our Senior Vice President and Chief Legal Officer from April 2017 to October 2017 and as our Senior Vice President, Chief Legal Officer and Chief Compliance Officer from October 2017 to March 2018. Mr. Nowe previously served in leadership positions at Kennametal, Inc., most recently as Vice President, Secretary and General Counsel from 2009 to 2016, with responsibility for management of the company’s legal and general corporate governance matters, and as Assistant Secretary and Assistant General Counsel from 1992 to 2009. Mr. Nowe is a graduate of the University of Pittsburgh and the Case Western University School of Law.

Steven Piano became our Senior Vice President and Chief Human Resources Officer in January 2018. Mr. Piano previously served in leadership positions with MoneyGram International, Inc. from 2009 to 2017, most recently as Executive Vice President, Human Resources, Real Estate and Communications with responsibility for MoneyGram International’s global human resources and facilities management. Mr. Piano previously served in a variety of human resources leadership positions for National Grid USA, First Data Corporation and Lehman Brothers, Inc. Mr. Piano is a graduate of Hofstra University.

Gene Eddie Burt II became our Executive Vice President, Chief Merchandising Officer and Chief Supply Chain Officer in January 2018. He previously served as our Senior Vice President and Chief Supply Chain Officer from January 2017 to January 2018. He previously served as Senior Vice President, Supply Chain for Tuesday Morning Corporation from February through September 2016, with responsibility for the oversight of the company’s product distribution network, and prior to that in a variety of executive roles with PetsMart, Inc. from 2007 to 2015, most recently as Senior Vice President, Real Estate and Development with responsibility for the company’s facilities and development initiatives. Mr. Burt is a graduate of Morehouse College.

Table of Contents

ADVISORY VOTE ON EXECUTIVE COMPENSATION

(PROPOSAL 2)

In accordance with Section 14A of the Exchange Act, we are providing our stockholders the opportunity to cast a non-binding advisory vote to approve the 2017 compensation of our Named Executive Officers (defined below) as described in the Compensation Discussion and Analysis section of this proxy statement, the compensation tables that follow and narrative discussions set forth in these proxy materials. This proposal, commonly known as a “say-on-pay” proposal, gives our stockholders the opportunity to express their views on the compensation of our Named Executive Officers. Our Board recommended, and the stockholders approved at our 2017 annual meeting of stockholders, that such advisory vote would be conducted on an annual basis.

As described in the Compensation Discussion and Analysis section of this proxy statement, the primary objectives of our executive compensation program are to (i) align cash and stock-based rewards with individual performance that creates stockholder value, (ii) attract and retain high performing employees, (iii) build an ownership mentality among our key employees and (iv) provide cost effective cash and stock-based rewards that are competitive with other organizations and fair to our stockholders and employees. The foregoing objectives are applicable to the compensation of our Named Executive Officers.

We believe that our executive compensation program achieves these objectives by emphasizing long-term stock-based incentive awards and performance-based compensation, is appropriate in light of our overall compensation philosophy and objectives, and will play an essential role in our future success.

Therefore, the Board recommends a vote in favor of the following resolution:

“RESOLVED, that the compensation paid to the Company’s Named Executive Officers for fiscal year ended December 31, 2017, as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables and narrative discussion, is hereby APPROVED.”

As an advisory vote, this proposal is not binding upon us. Notwithstanding the advisory nature of this vote, the Compensation Committee values the opinions expressed by stockholders in their vote on this proposal, and will consider the outcome of the vote when making future compensation decisions for our Named Executive Officers. Currently, we expect to hold an advisory vote on the compensation paid to the Company’s Named Executive Officers each year and expect that the next such vote will occur at our 2019 Annual Meeting.

The affirmative vote of the holders of a majority of the votes cast by our stockholders in person or represented by proxy and entitled to vote is required to approve this Proposal 2.

Recommendation

THE BOARD RECOMMENDS THAT THE STOCKHOLDERS VOTE FOR THE APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION OF THE NAMED EXECUTIVE OFFICERS FOR THE COMPANY’S FISCAL YEAR ENDED DECEMBER 31, 2017, AS DISCLOSED IN THESE PROXY MATERIALS.

Table of Contents

COMPENSATION DISCUSSION AND ANALYSIS

This section discusses the material elements of compensation awarded to, earned by or paid to our principal executive officer, our principal financial officer, our three other most highly compensated executive officers who were serving as such on December 31, 2017, our former principal executive officer who served as such for a portion of 2017, and two individuals who would have been included in our three other most highly compensated executive officers but for the fact that the individuals were not serving as executive officers as of December 31, 2017. These individuals are referred to collectively as the “Named Executive Officers.”

For 2017, the Named Executive Officers were:

Name	Title

Kenneth A. Martindale	Chief Executive Officer

Tricia K. Tolivar	Executive Vice President, Chief Financial Officer and Interim Chief Marketing Officer

Timothy A. Mantel	Executive Vice President and Chief Merchandising Officer

Guru Ramanathan	Senior Vice President and Chief Innovation Officer

Gene E. Burt	Executive Vice President, Chief Merchandising Officer and Chief Supply Chain Officer

Robert F. Moran	Former Interim Chief Executive Officer

Michael D. Dzura	Former Executive Vice President, Operations

Jeffrey R. Hennion	Former Executive Vice President, Chief Marketing and e-Commerce Officer

The Company had a change in its Named Executive Officers from 2016 to 2017. Mr. Moran ceased to serve as our Interim Chief Executive Officer effective on September 11, 2017. We have included information concerning Mr. Moran in the Summary Compensation Table and other related tables in accordance with SEC rules and regulations, and we discuss matters relating to his compensation in this Compensation Discussion and Analysis where relevant. Mr. Dzura, the former Executive Vice President, Operations, resigned from employment with the Company as of March 24, 2017. Mr. Hennion, the former Executive Vice President, Chief Marketing and e-Commerce Officer, resigned from his position with the Company, effective June 1, 2017. In addition, Mr. Mantel, Executive Vice President and Chief Merchandising Officer, resigned from employment with the Company as of February 9, 2018. For purposes of the stockholder advisory vote relating to 2017 compensation of our Named Executive Officers and, unless otherwise indicated, for purposes of this Compensation Discussion and Analysis, Messrs. Moran, Dzura and Hennion, together with the other officers named in the table above, are our Named Executive Officers. However, unless otherwise indicated, references to the Named Executive Officers in this Compensation Discussion and Analysis exclude (i) Mr. Martindale when the term is used in discussing periods of time prior to September 11, 2017, the date Mr. Martindale joined our Company, and (ii) Messrs. Moran, Dzura, and Hennion when the term is used in discussing periods of time after September 11, 2017, March 24, 2017, and June 1, 2017, respectively.

Table of Contents

Executive Summary

Our business remains profitable, and we have continued to address the ongoing and significant challenges to our strategy and our business during 2017. Following extensive consumer research and market/competitive analysis we developed and launched the One New GNC in December 2016 and we have now marked four consecutive quarters of growth in the number of sale transactions. Customers responded to our simplified pricing model, enhanced loyalty programs and product innovation during 2017, as indicated by positive comparable same store transactions of 11.6% in 2017 for company-owned stores and GNC.com. Also, we achieved same store sales growth of 0.2% in 2017 for domestic company-owned stores and GNC.com.

In September 2017, the Board of Directors appointed Kenneth A. Martindale to be our Chief Executive Officer. In addition to addressing traffic trends in our retail stores, our management team is seeking other substantial opportunities to drive profitable growth, including expansion of our business internationally, increased brand penetration, leveraging our strength in product innovation and delivering a compelling omnichannel experience. As our key efforts take time to produce results, the Company’s operational results in 2017 were challenged, impacting our year-over-year share price, down from approximately $11 per share at the beginning of 2017 to less than $4 per share by the end of the year.

In light of this transforming and challenging business environment, the Compensation Committee made the following pay determinations in 2017 for our Named Executive Officers:

Our Named Executive Officers did not receive routine salary increases in 2017, with the exceptions of benchmarking adjustments for Ms. Tolivar and Messrs. Moran and Hennion.

No annual cash incentive compensation payments were made to our Named Executive Officers for 2017, with the exception of discretionary incentive bonus payments made to Mr. Moran for his performance as Interim Chief Executive Officer through September 11, 2017.

Performance share units for the performance period ending in 2017 were forfeited.

Mr. Martindale received long-term equity awards as an inducement in connection with the commencement of his employment in 2017 and make-whole awards as replacement equity for awards forfeited by Mr. Martindale from his prior employer. Other Named Executive Officers received a mix of stock options, performance-vested restricted stock units (“PSUs”) and time-vested restricted stock units (“RSUs”) in 2017.

Our executive compensation program has been structured to generate and reward superior company performance by establishing compensation packages under which variable, or incentive, compensation is weighted more heavily than base salary. We have established compensation programs to motivate our executives to focus on both our short-term and long-term performance by providing a mix of short-term and long-term incentive compensation in the form of annual cash incentive compensation and long-term equity-based incentive compensation. We believe that our approach allocates more compensation toward non-cash equity compensation on average, and aligns the incentives of our executives with the interests of our stockholders.

Annual Cash Incentive Compensation. For 2017, we approved an annual cash incentive compensation program for our executives based upon certain performance metrics. Also, Mr. Martindale became eligible to earn a bonus under the terms of his employment agreement. The applicable performance metrics for the following Named Executive Officers were earnings before interest and tax (“EBIT”) and retail and web sales comparables, and, for certain Named Executive Officers, if the retail and web sales

Table of Contents

metric was achieved, then gross margin return on inventory (“GMROI”) was also an applicable performance metric. GMROI is defined as gross profit excluding sublease revenue and warehousing, distribution and occupancy costs divided by the average of inventory at the beginning and ending of the period excluding obsolescence and shrinkage reserves. The applicable performance metrics, and their weighting for the following Named Executive Officers were as follows:

Name	EBIT			Retail and Web Sales Comparables			GMROI

Kenneth A. Martindale		50	%		50	%		-

Tricia K. Tolivar		50	%		50	%		-

Timothy A. Mantel		40	%		40	%		20	%

Guru Ramanathan		50	%		50	%		-

Gene E. Burt		40	%		40	%		20	%

Michael D. Dzura		50	%		50	%		-

Jeffrey R. Hennion		50	%		50	%		-

We believed that these criteria would incentivize our Named Executive Officers to focus on multiple performance drivers throughout our business. The Company’s performance for 2017 resulted in no payment of bonuses to the Named Executive Officers listed above under the annual cash incentive compensation program or, in the case of Mr. Martindale, under his employment agreement. In addition to the above Named Executive Officers, Mr. Moran was eligible for and received incentive bonus payments as determined by and at the discretion of the Board. For more information, see “ – Elements of Compensation – Annual Cash Incentive Compensation” below.

Long-term Incentive Compensation. We maintain a long-term incentive program that principally utilizes “full-value” awards, such as restricted stock awards (“RSAs”), RSUs and PSUs, in combination with stock options. Our program aligns with the market trend in favor of grants of PSUs and RSUs and a reduced reliance on stock options. We believe that our long-term incentive program cultivates an ownership mentality among our executives that serves to focus management on achieving our strategic and financial objectives, thereby more closely aligning the interests of our executives with the long-term interests of our stockholders.

In February 2017, our executives, including certain Named Executive Officers, specifically Ms. Tolivar, Dr. Ramanathan, and Messrs. Moran, Mantel, Burt, and Hennion, received long-term incentive grants for 2017. The long-term incentive award grants in February 2017 to these Named Executive Officers were received in the form of PSUs, RSUs, and stock options. The specific proportions of total awards granted in the forms of PSUs, RSUs and stock options are provided in detail below and ranged from 37%-40% for PSUs, 27%-30% for RSUs and 30%-36% for stock options, except for Mr. Moran who received all of his award in the form of stock options.

In connection with Mr. Martindale’s appointment as our Chief Executive Officer on September 11, 2017, he received make-whole and inducement grants including 519,126 stock options and 519,556 RSAs. For more information about Mr. Martindale’s grants, see “Appointment of Mr. Martindale as Chief Executive Officer and Related Grants” below.

Table of Contents

Other 2017 Compensation Highlights

•

At our 2017 annual meeting, our stockholders approved, on a non-binding, advisory basis, the “say-on-pay” proposal with respect to our 2016 executive compensation program by more than 95% of the shares voted. We considered the results of this vote, the Company’s business results and our share price performance in determining our 2017 executive compensation program.

•

In February 2018, the Compensation Committee reviewed our executive compensation program with management from a risk perspective and determined that there are no risks created by our compensation policies and practices that are reasonably likely to have a material adverse effect on the Company. In reaching this conclusion, the Compensation Committee considered various factors, including the balance between annual and long-term compensation and between fixed and variable compensation, the use of multiple types of long-term incentive awards, the use of multiple performance criteria (including both short-term and long-term criteria) for payment of incentive compensation, the use of performance measures that are intended to increase stockholder value if goals are achieved, and various compensation policies and practices that mitigate excessive risk (including substantial stock ownership requirements for key executives, the clawback feature of the Company’s equity awards, the Compensation Committee’s negative discretion to reduce the amount of incentive awards, and the prohibition on hedging or pledging of Company stock by executives).

Compensation Policies and Objectives

The primary objectives of our executive compensation program, and the accordant Committee responsibilities, are to:

•

review and approve the Company’s compensation philosophy, policies and objectives;

•

align cash and stock-based awards with individual and corporate performance that creates stockholder value;

•

build an ownership mentality among our key employees;

•

attract and retain high performing employees;

•

review and determine the compensation for the Company’s executive officers, including the Named Executive Officers;

•

review and approve annually the corporate goals and objectives applicable to the compensation of the Company’s executive officers, including the Named Executive Officers;

•

review the potential risk to the Company from its compensation policies and program;

•

develop succession plans and implement development initiatives for the Company’s senior management; and

•

provide cost effective cash and stock-based rewards that are competitive with other organizations and fair to our stockholders and employees.

Table of Contents

To facilitate the objectives, the Company provides base salary and related benefit plans, annual cash incentive compensation and long-term incentive compensation. The objectives apply to the compensation of the Named Executive Officers and to the elements of their respective executive compensation packages as follows:

Base Salary. The objective in determining base salaries for the Named Executive Officers is to set base salaries at levels that are (i) sufficient to attract and retain high performing, qualified employees and (ii) considered fair to our stockholders and employees. The Compensation Committee seeks to set base salaries at levels that are competitive with a peer group of companies and benchmarks salaries at the median of the peer group. In addition, base salaries are influenced by the complexity and level of the applicable position.

Our Named Executive Officers did not receive routine salary increases in 2017, with exceptions for benchmarking adjustments. There were benchmarking increases to the salaries of Ms. Tolivar, and Mr. Moran and Mr. Hennion.

Annual Cash Incentive Compensation. We use annual cash incentive compensation to incentivize the Named Executive Officers to contribute to our growth and financial performance and to provide rewards based on achievement of predetermined goals that are intended to drive increases in stockholder value. As additional cash compensation that is contingent on our financial performance, annual cash incentive compensation augments the base salary component while being tied to our financial performance.

The Company’s performance in 2017 resulted in no payment of bonuses to the Named Executive Officers except for discretionary incentive bonus payments made to Mr. Moran for his service as our Interim Chief Executive Officer.

Long-term Incentive Compensation. We believe that stock-based awards are important in building an ownership mentality among our executives and aligning the long-term financial interests of our executives with those of our stockholders. Time- and performance-vested awards provide incentives to drive performance, and have long-term horizons because value to our executives is dependent on continued employment, the achievement of pre-established performance goals (in the case of PSUs) and, ultimately, increases in the market value of our common stock.

Our 2017 equity awards consisted of a significant portion of PSUs as noted above, and stock options, which we believe focuses attention on building stockholder value.

Benefits and Perquisites. The Named Executive Officers are entitled to participate in, and to receive benefits under, the benefit plans, arrangements and policies available to our employees or executives generally. Other than the perquisites provided to Mr. Moran during his tenure as Interim Chief Executive Officer of the Company, certain relocation benefits provided to Messrs. Martindale, Burt and Mantel, and certain other minimal perquisite amounts identified in the Summary Compensation Table, the Company does not provide perquisites or make payment of perquisite allowances to any of its executives.

Executive Compensation Process

Role of the Compensation Committee

The Compensation Committee oversees the development and implementation of our executive compensation policies and objectives, determines the structure of our executive compensation packages generally, determines the actual compensation paid to each of our senior executives and evaluates the performance of our Chief Executive Officer. In addition, the Compensation Committee has the authority

Table of Contents

to (i) review our incentive compensation plans, recommend changes to such plans to the Board and exercise all the authority of the Board with respect to the administration of such plans, and (ii) retain, terminate and set the terms of our and the Compensation Committee’s relationship with any consultants and other outside advisors who assist the Compensation Committee in carrying out its duties.

Role of Management

The Compensation Committee considers the recommendations of management, principally our Chief Executive Officer or Interim Chief Executive Officer, as applicable, when determining the structure of our executive compensation packages generally and the actual compensation paid to each of our senior executives. The Compensation Committee does not delegate any of its functions to others in setting compensation, no Named Executive Officer is a member of the Compensation Committee and our Chief Executive Officer or Interim Chief Executive Officer, as applicable, does not provide recommendations with respect to his own compensation.

Role of Outside Advisors

The Compensation Committee has retained Korn Ferry Hay Group as an independent consultant to provide information, advice and recommendations regarding our executive compensation policies and design. In 2017, Korn Ferry Hay Group was engaged to review and provide information, advice and recommendations regarding our executive compensation program generally, as well as the individual compensation packages of each of our senior executives, including the Named Executive Officers. Korn Ferry Hay Group was directed to benchmark executive salaries and other short-term and long-term compensation, including the mix of performance-based compensation. As discussed below under “–Use of Peer Group Data,” at the direction of the Compensation Committee, Korn Ferry Hay Group worked with our Interim Chief Executive Officer and our Human Resources personnel to compare our executive compensation packages to those of a group of comparable companies.

Korn Ferry Hay Group provides advice and recommendations to the Compensation Committee and reports to the Compensation Committee. Prior to its original engagement in 2011, Korn Ferry Hay Group, except for executive search services performed by Korn Ferry prior to its acquisition of Hay Group and as set forth below, had not previously worked with the Company in any capacity, nor has it served us in any capacity, other than as a consultant to the Compensation Committee. The Compensation Committee has reviewed and considered information provided to it by Korn Ferry Hay Group, the Compensation Committee members and our executive officers, and based on its review and the factors described in the NYSE listing standards and such other factors as it deemed relevant, the Compensation Committee has concluded that Korn Ferry Hay Group is independent, that the advice it receives from Korn Ferry Hay Group is objective and that Korn Ferry Hay Group’s work has not raised any conflict of interest. In December 2015, Korn Ferry acquired Hay Group, which became a wholly owned subsidiary of Korn Ferry. The Company has engaged Korn Ferry Hay Group to provide executive search services in the past and may do so from time to time in the future.

Use of Peer Group Data

The Compensation Committee seeks to determine how our compensation programs compare to other publicly traded companies similar to us. The Compensation Committee seeks to set compensation for the Named Executive Officers at levels that are competitive with similar companies in our industry but consistent with our growth strategy and with an emphasis on variable compensation, rather than fixed compensation.

Table of Contents

With the assistance of Korn Ferry Hay Group, the Compensation Committee updated its peer group in September 2016 in order to appropriately reflect companies with revenue sizes, sectors and business models similar to our own, as well as those with which we compete for talent. The updated peer group (the “2017 Peer Group”), which was used for comparative purposes in setting the levels of the 2017 long-term equity awards and cash compensation levels for our Named Executive Officers (other than Mr. Moran and Mr. Martindale, whose 2017 compensation levels were determined in connection with their respective appointments), was comprised of the following 18 companies:

American Eagle Outfitters, Inc.	Lululemon Athletica, Inc.	The Finish Line, Inc.

Cabela’s, Inc.	Mead Johnson Nutrition Co.	Ulta Beauty, Inc.

Dick’s Sporting Goods, Inc.	Panera Bread Co.	Village Super Market

Deckers Outdoor Corporation	Pier 1 Imports, Inc.	Vitamin Shoppe, Inc.

Hain Celestial Group, Inc.	Sally Beauty Holdings, Inc.	Weight Watchers International, Inc.

Herbalife Ltd.	Sprouts Farmers Markets, Inc.	Williams Sonoma, Inc.

Based upon consultation with Korn Ferry Hay Group in July 2017, the Compensation Committee further updated the peer group by removing Cabela’s, Inc., Dick’s Sporting Goods, Inc., Lululemon Athletica, Inc., and Panera Bread Co. from the 2017 Peer Group, and adding Big 5 Sporting Goods Corp. and Nu Skin Enterprises, Inc. (the updated peer group, the “2018 Peer Group”).

In February 2018, we used the 2018 Peer Group for comparative purposes in setting our most recent long-term equity awards and 2018 cash compensation levels for our executives, including the Named Executive Officers, other than Mr. Martindale, for whom 2018 compensation levels, including long-term equity awards, were determined under his employment agreement.

Elements of Compensation

Base Salary

We pay base salaries to the Named Executive Officers. With respect to 2017, the Compensation Committee established the annual base salaries of the Named Executive Officers as follows:

Name	2016 Base Salary ($)		2017 Base Salary ($)		Percentage Increase (%)

Kenneth A Martindale (1)		N/A		975,000		N/A

Tricia K. Tolivar (2)		460,000		510,000		10.9

Timothy A. Mantel (3)		500,000		500,000		0.0

Guru Ramanathan		430,000		430,000		0.0

Gene E. Burt (4)		N/A		385,000		N/A

Robert F. Moran (5)	996,000	1,016,000	2.0

Michael D. Dzura (6)	510,000	510,000	0.0

Jeffrey R. Hennion (7)	500,000	510,000	2.0

Table of Contents

(1)	Mr. Martindale was appointed as the Chief Executive Officer of the Company effective on September 11, 2017 and base salary was paid commencing on his appointment. Mr. Martindale received a pro rata portion of his base salary for service as our Chief Executive Officer during 2017.

(2)

Ms. Tolivar received a $50,000 (10.9%) increase in base salary on March 26, 2017 primarily as an adjustment to attain benchmark salary levels to $510,000 (“Benchmark Salary”). Additionally, Ms. Tolivar received a stipend of $2,500 per month beginning in June 2017 as compensation for her expanded role as the Interim Chief Marketing Officer.

(3)	Mr. Mantel resigned from employment with the Company as of February 9, 2018.

(4)

Mr. Burt was appointed as the Senior Vice President, Chief Supply Chain Officer of the Company effective on January 30, 2017. In addition to his base salary, Mr. Burt received a stipend of $2,500 per month beginning in July 2017 as compensation for his expanded role as the Interim Chief Human Resource Officer.

(5)	Mr. Moran ceased to serve as the Interim Chief Executive Officer of the Company effective on September 11, 2017. Mr. Moran received a pro rata portion of his base salary for service as our Interim Chief Executive Officer during 2017.

(6)

On March 13, 2017, the Company announced the resignation of Mr. Dzura as Executive Vice President, Operations of the Company, effective as of March 24, 2017. Mr. Dzura received a pro rata portion of his base salary during 2017. Additional information regarding Mr. Dzura’s separation is discussed below under “- Mr. Dzura Separation Agreement.”

(7)

On June 1, 2017, the Company announced the resignation of Mr. Hennion as Chief Marketing and e-Commerce Officer, effective as of June 1, 2017. Mr. Hennion received a pro rata portion of his base salary during 2017. Additional information regarding Mr. Hennion’s separation is discussed below under “- Mr. Hennion Consulting Agreement.”

Annual Cash Incentive Compensation

Annual cash incentive compensation is documented in an annual plan that is adopted by the Compensation Committee under the Company’s stock and incentive plan prior to or during the first quarter of the applicable year. The annual performance bonus for each Named Executive Officer has a threshold, target and maximum bonus amount expressed as a percentage of his or her annual base salary, which percentage is determined by the respective position and level of responsibility of such Named Executive Officer.

The annual cash incentive plan for 2017 performance (the “2017 Incentive Plan”) was adopted by the Compensation Committee in February 2017 and provided the following threshold, target and maximum bonus amounts, expressed as a percentage of base salary:

Table of Contents

	2017 Incentive Plan
Level	Threshold Amount			Target Amount			Maximum Amount

Chief Financial Officer		20	%		60	%		120	%

Executive Vice President		20	%		60	%		120	%

Senior Vice President		15	%		45	%		90	%

Mr. Moran’s annual cash incentive compensation was not established under the 2017 Incentive Plan and the incentive bonus payments that he received were determined by and at the discretion of the Board. Mr. Martindale’s annual cash incentive compensation was not established under the 2017 Incentive Plan, as he was appointed as Chief Executive Officer in September 2017, and, in connection with his appointment and employment agreement, the threshold, target, and maximum amounts were set at 50%, 150% and 300%, respectively. In connection with his appointment to Chief Executive Officer, Mr. Martindale was entitled to an annual bonus opportunity of at least 150% of base salary, pro-rated with respect to the 2017 calendar year, which could be earned based on the Compensation Committee’s evaluation of performance objectives established for the applicable year, which were the same incentives established under the 2017 Incentive Plan.

The targets under the 2017 Incentive Plan for Ms. Tolivar, Dr. Ramanathan and Messrs. Hennion and Dzura, which were based on our achievement of (i) a predetermined level of EBIT, which is calculated at the end of the year including certain specified adjustments disclosed in our quarterly earnings reports and (ii) year-over-year comparables for retail and web sales. With respect to these Named Executive Officers, the targets were based on our achievement of the EBIT level and retail and web sales comparables targets set forth in the table below. They were entitled to receive 50% of the target bonus amount if we achieved EBIT equal to or exceeding the target and 50% if we achieved retail and web sales comparables equal to or exceeding the target.

The following thresholds and related goals were established (i) for Ms. Tolivar, Dr. Ramanathan, and Messrs. Hennion and Dzura under the 2017 Incentive Plan and (ii) for Mr. Martindale in connection with his appointment and employment agreement:

Performance Measure	Threshold	Target	Maximum	Relative Weight

EBIT (1)	$216,000,000	$240,000,000	$264,000,000	50%

Retail and Web Sales Comparables	1.50%	4.40%	6.40%	50%

(1)	As this performance measure is a non-GAAP financial metric, please see Annex A for a presentation of the reconciliation between EBIT, as adjusted, and our GAAP financial metric based on the Company’s audited financial statements.

Table of Contents

The objectives under the 2017 Incentive Plan for Messrs. Mantel and Burt were based on our achievement of (i) a predetermined level of EBIT, which is calculated at the end of the year including certain specified adjustments disclosed in our quarterly earnings reports, (ii) year-over-year comparables for retail and web sales and (iii) GMROI. With respect to these Named Executive Officers, the targets were based on our achievement of the EBIT level, retail and web sales comparables targets, and GMROI set forth in the table below. They were entitled to receive 40% of the target bonus amount if we achieved EBIT equal to or exceeding the target, 40% if we achieved retail and web sales comparables equal to or exceeding the target and, if the retail and web sales metric was achieved, then 20% if we also achieved GMROI equal to or exceeding the target.

The thresholds and related goals for Messrs. Mantel and Burt under the 2017 Incentive Plan were as follows:

Performance Measure	Threshold	Target	Maximum	Relative Weight

EBIT	$216,000,000	$240,000,000	$264,000,000	40%

Retail and Web Sales Comparables	1.50%	4.40%	6.40%	40%

GMROI (1)	2.18	2.23	2.30	20%

(1)	If the threshold for Retail and Web Sales was achieved, then Messrs. Mantel and Burt would have been eligible for the threshold and goal related to GMROI.

Results of the 2017 Incentive Plan. The Company’s performance for 2017 resulted in no awards of bonuses during the fiscal year to the Named Executive Officers for whom threshold, target and maximum levels were established under the terms of the 2017 Incentive Plan or, in the case of Mr. Martindale, his appointment and employment agreement. The threshold levels were not met for the EBIT, Retail and Web Sales Comparables or GMROI metrics. Specifically, our results achieved for purposes of the 2017 Incentive Plan and the bonus eligibility under Mr. Martindale’s employment agreement were as follows:

Performance Measure		Achieved Results

EBIT		$206,423,000

Retail and Web Sales Comparables		0.2%

GMROI		2.12

Based on these results, under the terms of the 2017 Incentive Plan or Mr. Martindale’s employment agreement, as applicable, our Named Executive Officers did not receive cash incentive compensation payments for 2017.

As indicated above, Mr. Moran was not subject to the 2017 Incentive Plan and, for his performance as Interim Chief Executive Officer, received two discretionary incentive bonus payments of $498,000 and $110,967 for the periods of February 2017 through July 2017 and August 2017 through September 11, 2017, respectively, in recognition of his leadership.

Table of Contents

Long-term Incentive Compensation

2017 Annual Long-Term Incentive Awards. Substantially all of our employees, and the employees of our direct and indirect subsidiaries and other affiliates, including the Named Executive Officers, are eligible for consideration of awards of stock options, restricted stock, RSUs (including PSUs) and other stock-based awards under the terms of the 2015 Stock and Incentive Plan (the “2015 Stock Plan”), which was adopted in 2015. The Compensation Committee is responsible for administering, selecting the individuals who are eligible to participate in and determining the types and amounts of stock-based awards granted under the 2015 Stock Plan. The Compensation Committee has discretion to delegate all or a portion of its authority under the 2015 Stock Plan. In 2007, we adopted the GNC Acquisition Holdings Inc. 2007 Stock Incentive Plan (the “2007 Stock Plan”) and in 2011, we adopted the GNC Holdings, Inc. 2011 Stock and Incentive Plan (the “2011 Stock Plan”), under which plans awards are outstanding. Following the adoption of the 2015 Stock Plan, we have not granted and will not grant any additional awards under the 2007 Stock Plan or the 2011 Stock Plan.

Stock options granted under the various plans generally are subject to vesting in annual installments and have terms of seven to ten years. The Compensation Committee determines the size of stock-based awards for each Named Executive Officer in accordance with the Named Executive Officer’s position versus the market benchmark, performance and level of position. Options and other stock-based awards under the 2011 Stock Plan and the 2015 Stock Plan are subject to clawback by the Company if the participant engages in any “detrimental activity” during the participant’s service or for one year after the participant’s service ends, which is generally defined to include disclosing confidential information about the Company, engaging in activities that result (or would result if known) in the termination of the participant’s service for cause, soliciting the Company’s employees on behalf of a competing employer, or materially breaching any agreement between the participant and the Company.

The Compensation Committee generally considers grants of long-term incentive compensation awards on an annual basis, except for certain new hires. The Compensation Committee grants equity-based awards to our executives on both an annual and as-desired basis. We do not have any program, plan or practice to time annual or ad hoc grants of equity-based awards in coordination with the release of material non-public information or otherwise.

In February 2017, we granted long-term incentive awards to certain Named Executive Officers, Mr. Moran, Ms. Tolivar, Dr. Ramanathan, and Messrs. Mantel, Burt, and Hennion, under the 2015 Stock Plan. Base award values for these long-term incentive grants were determined based in part on the results of Korn Ferry Hay Group’s analysis of the compensation packages of top executives at companies in the 2017 Peer Group, and were intended to be competitive compared to long-term incentive awards granted to executives with comparable titles and responsibilities within the 2017 Peer Group. The long-term incentive award grant values to these Named Executive Officers were in the following proportions:

Name	Stock Options			Time-Vested RSUs			PSUs

Tricia K. Tolivar		35	%		28	%		37	%

Timothy A. Mantel		30	%		30	%		40	%

Guru Ramanathan		30	%		30	%		40	%

Gene E. Burt		36	%		27	%		37	%

Robert F. Moran		100	%		-			-

Jeffrey R. Hennion

Table of Contents

Mr. Dzura did not receive an award in 2017.

In addition to the long-term incentive compensation awards granted to Ms. Tolivar in February 2017, she also received 150,000 RSUs as a retention award in May 2017. For more information, see “ – Elements of Compensation – Long-Term Incentive Compensation” below. Mr. Burt’s 2017 grant values vary slightly from the program due to contractual terms that were agreed upon in connection with the commencement of his employment with the Company.

In all cases the stock options vest in annual installments over four years from the grant date, the RSUs vest in annual installments over three years from the grant date and the PSUs can be earned based on the achievement of the performance criteria over the period commencing on January 1, 2017 and ending on December 31, 2019 (the “Performance Period”) and subject to the grantees continuous employment with the Company during the Performance Period.

For the February 2017 awards, the portions of the total award value attributable to the RSUs and PSUs were determined by multiplying the number of RSUs and PSUs in the award by $7.99, which was the closing price per share of our common stock on February 22, 2017, the date of grant. For the February 2017 awards, the performance metric for grants of the PSUs is relative total shareholder return (“TSR”). The total number of PSUs that will be earned by a grantee is based upon the Company’s TSR relative to the TSR of other companies reported on the S&P Retail Select Industry Index (the “Index”) for the Performance Period. At the conclusion of the Performance Period, the Compensation Committee will determine whether and the extent to which the performance criteria have been achieved for the purpose of determining the percentage of the target amount of PSUs that have vested for the Performance Period. Any PSUs that have not vested as of the end of the Performance Period, based upon the Compensation Committee’s determination, will be forfeited. The Compensation Committee may, in its sole discretion, reduce the amount to less than the amount that is determined to be vested in accordance with the agreements providing for the PSUs.

The Company’s TSR is measured, using a 31-day average stock price, as a percentile ranking in comparison with the TSR of the Index for the Performance Period. The PSU starting stock price is based upon the average adjusted closing stock price for the month preceding the start of the Performance Period (i.e., beginning on December 1, 2016 and ending on December 31, 2016). If the Company’s TSR for the Performance Period is less than the 30^th percentile TSR of the Index for the Performance Period, no PSUs will be earned by the grantee on December 31, 2019. If the Company’s TSR for the Performance Period is achieved between the 30^th and 40^th percentile TSR of the Index for the Performance Period, then 35% of the total PSUs awarded may be earned by the grantee on December 31, 2019 at the 30^th percentile achievement, with an additional amount earned based on interpolation in relation to the cumulative performance condition. If the Company’s TSR for the Performance Period is achieved between the 40^th and 50^th percentile TSR of the Index for the Performance Period, then 75% of the total PSUs awarded may be earned by the grantee on December 31, 2019 at the 40^th percentile achievement, with an additional amount earned based on interpolation in relation to the cumulative performance condition. If the Company’s TSR for the Performance Period is achieved between the 50^th and 75^th percentile TSR of the Index for the Performance Period, then 100% of the total PSUs awarded may be earned by the grantee on December 31, 2019 at the 50^th percentile achievement, with an additional amount earned based on interpolation in relation to the cumulative performance condition. If the Company’s TSR for the Performance Period is achieved at or above the 75^th percentile TSR of the Index for the Performance Period, then 200% of the total PSUs awarded may be earned by the grantee on December 31, 2019.

Table of Contents

In the event that the Company’s TSR for the Performance Period is at or above the 30^th percentile TSR of the Index for the Performance Period but is a negative amount, then the maximum number of awarded PSUs that may be earned for the Performance Period is limited to 100% of the total number of PSUs awarded. In all events the grantee must remain continuously employed through December 31, 2019 in order to earn the PSUs.

RSUs granted to Ms. Tolivar. Ms. Tolivar was granted a special retention award of 150,000 RSUs in May 2017 with a total award value of $1,020,000. These RSUs vest beginning on the second anniversary of the date of grant based upon the following vesting schedule: 20% in May 2019, 30% in May 2020 and 50% in May 2021.

Appointment of Mr. Martindale as Chief Executive Officer and Related Grants. Effective on September 11, 2017, the Company appointed Mr. Martindale as the Chief Executive Officer. In setting Mr. Martindale’s base compensation and making the inducement grants described below, the Company took into account a number of factors, including: a review of data for the chief executive officer position in the industry; the competitive marketplace; the Company’s current position in the market; and Mr. Martindale’s previous employment at a significantly larger US retail company (in terms of revenue, scope, and employees), overall prior experience, and his then current compensation package which reflected his leadership role at Rite Aid. At the time of his appointment, it was evident that a continued repositioning and turnaround of the Company’s current marketplace position was required. For this reason, the Company made grants to induce Mr. Martindale to join the Company and to make him whole on the value of awards he would be forfeiting, described below. Such grant amounts were larger than the Company typically considers as a recurring equity grant for our Chief Executive Officer. Prior to approving the terms of Mr. Martindale’s compensation, the Compensation Committee had discussions with Korn Ferry Hay Group and reviewed the proposed terms with the independent directors. The Compensation Committee believes that these inducement grants, including the make-whole awards, align Mr. Martindale’s long-term interests with the interests of the Company’s stockholders and provide appropriate incentives to work toward achieving operational growth and stock price appreciation, as a significant portion of Mr. Martindale’s compensation is tied to the performance of the Company. In connection with his appointment as Chief Executive Officer, on September 11, 2017, Mr. Martindale received make-whole and inducement grants of (i) restricted stock in the amount of $600,000, which is fully vested with transfer restrictions that lapse on the earliest to occur of a change in control of the Company, the third anniversary of the date of grant or Mr. Martindale’s death, disability or other separation from service for any reason; (ii) restricted stock in the amount of $950,000, which became fully vested on the last trading day of December 2017 and was subject to acceleration to the extent necessary to cover any applicable income and payroll tax withholding resulting from the recognition of ordinary income pursuant to a Section 83(b) election; (iii) restricted stock in the amount of $1,200,000, which are unvested restricted shares scheduled to vest in three equal installments on each of the first three anniversaries of the date of grant subject to acceleration to the extent necessary to cover any applicable Section 83(b) tax liability; (iv) time-vested restricted stock in the amount of $1,900,000, which are unvested restricted shares scheduled to vest in three equal installments on each of the first three anniversaries of the date of grant; and (v) stock options in the amount of $1,900,000, which are scheduled to vest in three equal installments on each of the first three anniversaries of the date of grant. The structure and base value for the initial long-term incentive grant to Mr. Martindale was determined in connection with his appointment as Chief Executive Officer, and the first three make-whole awards of restricted stock, comprised of the $600,000, $950,000 and $1,200,000 amounts, were awarded as replacement equity for awards forfeited by Mr. Martindale from his prior employer. As inducement awards, Mr. Martindale’s stock and option awards were not granted pursuant to the 2015 Stock Incentive Plan. Mr. Martindale did not receive any additional equity grants in 2017, although he participated in the regular 2018 equity grant process, and received a mix of awards similar to those as were granted to other Named Executive Officers in February 2018.

Table of Contents

For 2018, our Named Executive Officers will receive base salary, an annual bonus opportunity and long-term incentive compensation consisting of time- and performance-based awards. Performance-based awards are based upon an internal financial metric.

Summary of 2017 Named Executive Officer Awards. The total award values for the 2017 awards for our Named Executive Officers, together with the corresponding number of (a) stock options, (b) RSUs or RSAs and (c) target PSUs awarded to each of our Named Executive Officers, is set forth below:

Name	Total Award Value ($)		Number of Stock Options (#)		Number of RSUs or RSAs (#)(1)		Target Number of PSUs (#)

Kenneth A. Martindale (2)		6,550,027		519,126		519,556		—
Tricia K. Tolivar		1,960,288		100,000		182,802		43,736
Timothy A. Mantel		710,438		64,770		26,670		35,560
Guru Ramanathan		291,448		26,571		10,941		14,588
Gene E. Burt		319,011		35,000		10,941		14,588
Robert F. Moran		2,807,998		753,773		—		—
Michael D. Dzura		—		—		—		—
Jeffrey R. Hennion		710,438		64,770		26,670		35,560

(1)	Mr. Martindale received only RSAs, all other individuals received RSUs.

(2)	Of Mr. Martindale’s total award value, $2,750,000 represents make-whole awards, which were awarded as replacement equity for awards forfeited by Mr. Martindale from his prior employer.

As described earlier, the performance metric for the PSU component of these long-term incentive awards is TSR. The Compensation Committee established threshold, intermediate, target and maximum levels of achievement with respect to TSR. Performance is measured as of the end of the three-year Performance Period on December 31, 2019. At the threshold level of performance, 35% of the PSUs vest; at the intermediate level, 75% of the PSUs vest; at the target level, 100% of the PSUs vest; and at or above the maximum level, 200% of the PSUs vest, provided, in each case, that the executive has remained employed until the end of the Performance Period. The applicable portion of the PSUs is forfeited if performance is below the threshold level.

The threshold, target and maximum levels of TSR performance for the February 2017 PSU grants are as follows:

Metric	Threshold (35% payout)	Intermediate (75% payout)	Target (100% payout)	Maximum (200% payout)

Total Shareholder Return (1)	30^th Percentile	40^th Percentile	50^th Percentile	75^th Percentile

(1)

The Company’s TSR is measured, using a 31-day average stock price, as a percentile ranking in comparison with the Index TSR for the Performance Period.

Performance and related payments are interpolated between the various performance goals.

Table of Contents

Benefits and Perquisites

The Company does not have a practice of providing perquisites or make payment of perquisite allowances to any of its executives, other than the perquisites provided to Mr. Moran during his tenure as Interim Chief Executive Officer, for whom the Company provided reasonable use of the Company’s corporate aircraft for purposes of commuting to and from Pittsburgh, Pennsylvania to conduct Company business and temporary housing benefits, certain relocation benefits provided to Messrs. Martindale, Burt and Mantel, and certain other minimal perquisite amounts each as identified in the Summary Compensation Table.

Non-qualified Deferred Compensation Plan

We maintain the GNC Live Well^® Later Non-Qualified Deferred Compensation Plan for the benefit of a select group of our highly compensated employees. Under this plan, certain eligible employees may elect to defer a portion of their future compensation under the deferred compensation plan by electing such deferral prior to the beginning of the calendar year during which the deferral amount would be earned. Mr. Martindale, Ms. Tolivar and Messrs. Burt and Hennion made contributions to the deferred compensation plan in 2017. For 2017, a dollar-for-dollar match with respect to the first three percent of a participant’s compensation deferred under the non-qualified deferred compensation plan was provided. For more information regarding the deferred compensation plan, please see “2017 Non-Qualified Deferred Compensation Table” below.

Executive Severance Pay Policy

The Company maintains an Executive Severance Pay Policy (the “Executive Severance Policy”) for executive officers who are involuntarily terminated from employment and otherwise meet the requirements for benefits. Upon an involuntary termination other than for Cause, as defined in the Executive Severance Policy, eligible executives are entitled to receive cash severance benefits of six months of base salary, in the case of Vice Presidents, or one year base salary, in the case of positions senior to Vice President. The severance is increased to one year and two years for such positions, respectively, in the case of a termination of employment without Cause, or resignation for Good Reason, as defined in the Executive Severance Policy, occurring within 24 months following a Change in Control of Company, also as defined in the Executive Severance Policy. Payments and benefits under the Executive Severance Policy are contingent upon the executive’s execution and non-revocation of a release of claims against the Company and compliance with covenants set forth in the Executive Severance Policy, which include confidentiality, non-competition and non-solicitation of the Company’s employees. In addition, if such executive obtains subsequent employment that is considered comparable to his or her previous employment with the Company, then the amount remaining to be paid to such executive, under the Executive Severance Policy, is offset by the annual gross base salary payable to such executive pursuant to such subsequent employment.

Dr. Ramanathan Employment Agreement

In February 2012, we entered into an amended and restated employment agreement with Dr. Ramanathan for an initial two-year term ending in February 2014, with automatic annual one-year renewals thereafter unless either party provided at least 30 days’ advance notice of non-renewal. In early 2018, the Company and Dr. Ramanathan mutually agreed to not renew his employment agreement and that he would remain employed on an at-will basis; accordingly, his employment agreement expired in February 2018.

Table of Contents

The employment agreement provided that any incentive compensation payable to Dr. Ramanathan will be subject to the clawback policies adopted or implemented by us, including in respect of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 and any rules promulgated thereunder. Please see “Potential Payments Upon Termination or Change in Control” below for more information regarding such employment agreement and termination and payments made in connection with a change in control.

Mr. Martindale Employment Agreement

In connection with his appointment as Chief Executive Officer, we entered into a three-year employment agreement with Mr. Martindale in September 2017.

The employment agreement provides that any incentive compensation payable to Mr. Martindale will be subject to the clawback policies adopted or implemented by us, including in respect of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 and any rules promulgated thereunder. Please see “Potential Payments Upon Termination or Change in Control” below for more information regarding such employment agreement and termination and payments made in connection with a change in control.

Ms. Tolivar and Messrs. Mantel and Burt currently do not have employment agreements with the Company, and Messrs. Moran, Dzura and Hennion did not have employment agreements with the Company.

Mr. Moran’s Cessation as Interim Chief Executive Officer

Mr. Moran ceased to serve as Interim Chief Executive Officer and was elected as Non-Executive Chairman of the Board in September 2017. In connection with his ceasing to serve as Interim Chief Executive Officer, Mr. Moran’s equity awards will continue to vest based upon his service as a non-employee director.

Separation and Consulting Arrangement with Messrs. Dzura and Hennion

Mr. Dzura Separation Agreement. In connection with Mr. Dzura’s resignation, he received severance equal to his annual base salary of $510,000 payable in installments over the one-year period following his resignation. In addition, the Company provided Mr. Dzura with a portion of his health benefits for March 2017, after which the Company provided a COBRA reimbursement for the severance period, which items totaled $12,572. Mr. Dzura was also entitled to certain outplacement services through 2017, which resulted in an expense to the Company of $5,500.

Mr. Hennion Consulting Agreement. In connection with Mr. Hennion’s resignation, he agreed to provide us with consulting services for a period not to exceed one year, unless extended, for an amount not to exceed his annual base salary of $510,000. In addition, the Company provided Mr. Hennion with a COBRA reimbursement of $18,743, and Mr. Hennion remained eligible for a pro-rata bonus for 2017 contingent upon the Company’s performance, which was not earned.

Impact of Accounting and Tax Considerations

As a general matter, the Compensation Committee reviews and considers the various tax and accounting implications of the compensation vehicles we utilize.

Prior to the enactment of the Tax Cuts and Jobs Act, Section 162(m) of the Internal Revenue Code generally disallowed public companies a tax deduction for compensation in excess of $1,000,000 paid to their chief executive officer and their three other most highly compensated executive officers (excluding the chief financial officer) unless certain performance and other requirements are met. As part of the Tax

Table of Contents

Cuts and Jobs Act, the exemption from the deduction limitation for performance-based compensation provided by Section 162(m) has been repealed. This change will be effective for taxable years beginning after December 31, 2017. As a result, compensation paid to certain executive officers which exceeds $1,000,000 will not be deductible unless it qualifies for transition relief applicable to certain arrangements in place as of November 2, 2017.

For 2017, the Compensation Committee factored in the potential loss of deductibility during the pay setting approval process. Our intent generally is to design and administer executive compensation programs in a manner that will preserve deductibility of compensation paid to our executives, and, prior to the enactment of the Tax Cuts and Jobs Act, we believed that a substantial portion of our current executive compensation program (including the annual incentive program and the long-term incentive awards that may be granted under the 2015 Stock Plan) would satisfy the requirements for exemption from the $1,000,000 deduction limitation. However, certain awards, such as the inducement awards granted to our Chief Executive Officer in connection with his appointment were not granted under a stockholder-approved plan as required for a deduction under Section 162(m). Also, because of ambiguities and uncertainties as to the application and interpretation of Section 162(m) and the regulations issued thereunder, including the uncertain scope of the transition relief for the exemption from the deduction limitation for performance based compensation provided by Section 162(m), there can be no assurance that any amounts paid under such compensation programs, even prior to the effectiveness of the legislative changes, will be deductible under Section 162(m), including, without limitation, in special circumstances related to other hirings and separations.

Additionally, we reserve the right to design programs and to structure other compensation arrangements that recognize a full range of performance criteria important to our success or that contain different terms, even where the compensation paid under such programs may not be deductible. The Compensation Committee will, in the exercise of its business judgment, continue to monitor our executive compensation program as part of its primary objective of ensuring that compensation paid to our executives is reasonable, performance-based and consistent with our goals and the goals of our stockholders.

Executive Stock Ownership Guidelines

We believe that, to align the long-term financial interests of our executive officers with those of our stockholders, our executives should hold a financial stake in the Company. The Board adopted a policy in December 2011 (revised most recently in February 2015) requiring our Chief Executive Officer and other executive officers to own stock in the Company (our “Executive Stock Ownership Guidelines”). Specifically, our Executive Stock Ownership Guidelines specify that our (i) Chief Executive Officer should own Company stock with an aggregate value at least equal to six times his or her annual base salary, (ii) Executive Vice Presidents should own Company stock with an aggregate value at least equal to two times their base salaries and (iii) Senior Executive Officers subject to the Executive Stock Ownership Guidelines should own Company stock with an aggregate value at least equal to their annual base salaries. The Executive Stock Ownership Guidelines provide that our newly appointed executive officers have five years from the date of their appointment to comply with the Executive Stock Ownership Guidelines, and should retain at least 50% of all after-tax shares owned by or underlying equity awards granted to them after December 11, 2012 until the ownership thresholds are met. The Compensation Committee will evaluate whether exceptions should be made for any executive officer on whom this requirement would impose a financial hardship or for other appropriate reasons as determined by the Compensation Committee. For the purposes of the Executive Stock Ownership Guidelines, Company stock includes (i) directly held shares of our common stock, (ii) shares of unvested restricted stock or RSUs (other than unvested shares of performance-vested restricted stock or unvested PSUs) and

Table of Contents

(iii) vested shares of our common stock held in any plan qualified under Section 401(a) of the Internal Revenue Code of 1986, as amended.

Policy on Hedging and Pledging of Company Stock

We have a policy applicable to our directors and all of our employees, including our Named Executive Officers, that prohibits such persons from (i) within six months after purchasing any Company securities, selling any Company securities of the same class, (ii) selling the Company’s securities short, (iii) buying or selling puts or calls or other derivative securities on the Company’s securities, (iv) holding Company securities in a margin account or pledging Company securities as collateral for a loan or (v) entering into hedging or monetization transactions or similar arrangements with respect to Company securities.

Table of Contents

COMPENSATION COMMITTEE REPORT

The Compensation Committee has reviewed and discussed with management the Compensation Discussion and Analysis contained in these proxy materials. Based on the Compensation Committee’s review of and the discussions with management with respect to the Compensation Discussion and Analysis, the Compensation Committee recommended to the Board that the Compensation Discussion and Analysis be included in these proxy materials and incorporated by reference in the Annual Report for filing with the SEC.

The foregoing report is provided by the following directors, who constitute the Compensation Committee:

	COMPENSATION AND ORGANIZATIONAL DEVELOPMENT COMMITTEE
	Richard J. Wallace (Chairperson)
	Amy B. Lane
	Philip E. Mallott

Table of Contents

NAMED EXECUTIVE OFFICER COMPENSATION

Summary Compensation Table

The following table sets forth information concerning the compensation we paid to the Named Executive Officers for services rendered in all capacities as employees to us during our last three fiscal years. In accordance with SEC rules, the compensation described in this table does not include the value of medical or group life insurance received by the Named Executive Officers that is available generally to all of our salaried employees. Only 2017 compensation is presented for Mr. Martindale, because 2017 was his first year as an employee of the Company. Only 2017 and 2016 compensation is presented for Mr. Moran and Mr. Mantel, because neither was employed with the Company during 2015. A “Change in Pension Value and Nonqualified Deferred Compensation Earnings” column is not presented because none of our Named Executive Officers participate in a pension plan or receive above-market or preferential earnings on nonqualified deferred compensation.

Name and Principal Position	Year	Salary ($)		Bonus ($) (1)		Stock Awards ($) (2)		Option Awards ($) (3)		Non-Equity Incentive Plan Compensation ($) (4)		All Other Compensation ($) (5)		Total ($)

Kenneth Martindale Chief Executive Officer	2017		262,500		—		4,650,026		1,900,001		—		105,625		6,918,152
Kenneth Martindale Chief Executive Officer

Tricia Tolivar Executive Vice President, Chief Financial Officer and Interim Chief Marketing Officer	2017		514,033		—		1,633,288		327,000		—		15,446		2,489,767
	2016		450,571		—		802,271		300,000		—		16,436		1,569,278
	2015		343,269		75,000		750,000		—		46,753		85,608		1,300,630

Tim Mantel Former Executive Vice President, Chief Merchandising Officer	2017		499,990		—		498,640		211,798		—		5,031		1,215,459



Guru Ramanathan Senior Vice President and Chief Innovation Officer	2017		429,998		—		204,561		86,887		—		1,002		722,448
	2016		397,471		—		240,661		90,000		—		1,022		729,154
	2015		372,618		—		350,000		—		37,806		11,650		772,074

Gene Burt Executive Vice President, Chief Merchandising Officer and Chief Supply Chain Officer	2017		354,616		75,000		204,561		114,450		—		31,595		780,222




Robert Moran Former Interim Chief Executive Officer (6)	2017		697,000		608,967		—		2,807,998		—		410,283		4,524,248
Robert Moran Former Interim Chief Executive Officer (6)	2016		415,000		450,000		1,000,000		—		—		290,455		2,155,455

Michael Dzura (7) Former Executive Vice President, Operations	2017		137,306		—		—		—		—		417,645		554,951
	2016		507,304		—		561,576		210,000		—		17,223		1,296,103
	2015		442,307		30,000		625,000		375,000		60,242		40,797		1,573,346

Jeffrey Hennion (7) Former Executive Vice President, Chief Marketing and e-Commerce Officer	2017		232,689		—		498,640		211,798		—		303,124		1,246,251
	2016		495,713		—		681,923		255,000		—		15,843		1,448,479
	2015		480,304		—		600,000		—		65,417		14,758		1,160,479

Table of Contents

(1)

For 2017, reflects (i) two discretionary incentive bonus payments of $498,000 and $110,967 for the periods of February 2017 through July 2017 and August 2017 through September 11, 2017, respectively, paid to Mr. Moran for his performance as Interim Chief Executive Officer, which were not subject to the 2017 Incentive Plan, and (ii) a $75,000 sign-on bonus paid to Mr. Burt in February 2017 in order to incentivize him to accept his position with the Company. For 2016, reflects a $450,000 bonus paid in February 2017, based on the Compensation Committee’s assessment of Mr. Moran’s extraordinary efforts, contributions and leadership. For 2015, reflects signing bonuses paid to Ms. Tolivar and Mr. Dzura.

(2)

For 2017, reflects the aggregate grant date fair value of the RSUs and PSUs granted to Ms. Tolivar, Dr. Ramanathan and Messrs. Mantel, Burt and Hennion in February 2017, which have been computed in accordance with FASB ASC Topic 718. Additionally, this reflects RSUs granted to Ms. Tolivar in May 2017 and includes RSAs granted to Mr. Martindale in September 2017, each of which has been computed in accordance with FASB ASC Topic 718. For 2016, reflects the aggregate grant date fair value of the PSUs and the RSUs included as part of

Table of Contents

incentive awards granted to Ms. Tolivar, Dr. Ramanathan, and Messrs. Dzura and Hennion in February 2016 and the RSUs to Mr. Moran in connection with his appointment as Interim Chief Executive Officer, which has been computed in accordance with FASB ASC Topic 718. For 2015, reflects (i) the aggregate grant date fair value of time-vested restricted stock and the RSUs granted, which have been computed in accordance with FASB ASC Topic 718 and (ii) the aggregate grant date fair value of PSAs granted to Messrs. Dzura and Hennion and Dr. Ramanathan in February 2015 and included as part of incentive awards granted to Ms. Tolivar in March 2015. The grant date values for the PSAs and the PSUs have been determined assuming 100% of target performance is achieved. If maximum share payouts were achieved for the PSUs, the aggregate grant date fair value for these units would be twice the amount disclosed in each year in the table related to the PSAs and the PSUs. If we assume the maximum 200% of target performance would be achieved, the grant date values of (a) the PSUs granted to Ms. Tolivar, Dr. Ramanathan and Messrs. Mantel, Burt and Hennion in 2017 would be $702,400, $234,283, $571,094, $234,283, and $571,094, respectively, (b) the PSUs granted to Ms. Tolivar, Dr. Ramanathan, Mr. Dzura and Mr. Hennion in 2016 would be $1,004,541, $301,321, $703,151, $853,846, respectively, and (c) the PSAs granted to Ms. Tolivar, Dr. Ramanathan, Mr. Dzura and Mr. Hennion in 2015 would be $750,000, $350,000, $500,000 and $600,000, respectively. For the assumptions underlying the calculation of the aggregate grant date fair value, see Note 14, “Stock-Based Compensation,” to our audited consolidated financial statements included in the Annual Report. The amounts shown in the table may not correspond to the actual value that may be realized by such persons with respect to these awards.

(3)

Reflects the aggregate grant date fair value of options granted during each fiscal year, which has been computed in accordance with FASB ASC Topic 718. For the assumptions underlying the calculation of the aggregate grant date fair value, see Note 14, “Stock-Based Compensation,” to our audited consolidated financial statements included in the Annual Report. The amounts may not correspond to the actual value that may be realized by such persons with respect to these awards.

(4)	Reflects the non-discretionary component of cash incentive compensation.

(5)	The components of “All Other Compensation” for our fiscal year ended December 31, 2017 are set forth in the following table:

Named Executive Officer	Perquisites ($) (a)		Imputed Value for Life Insurance Premiums ($)		Company Contributions to Deferred Compensation Plan ($) (b)		Severance ($) (c)		Consulting Fees ($) (d)		Total ($)

Kenneth Martindale		100,000		—		5,625		—		—		105,625
Tricia Tolivar		190		360		14,896		—		—		15,446
Tim Mantel		4,671		360		—		—		—		5,031
Guru Ramanathan		450		552		—		—		—		1,002
Gene Burt		22,805		349		8,441		—		—		31,595
Robert Moran		408,173		2,110		—		—		—		410,283
Michael Dzura		175		426		—		417,044		—		417,645
Jeffrey Hennion		175		255		6,981		—		295,713		303,124

Table of Contents

(a)

For Messrs. Martindale, Mantel and Burt, this column includes $100,000, $4,491 and $22,425, respectively, of relocation expenses. For Messrs. Mantel and Burt, this amount reflects the actual cost incurred by such NEOs in relocating. For Mr. Martindale, this amount reflects a contractually agreed relocation amount. For the individuals other than Messrs. Martindale, Mantel, Burt and Moran, the column only includes taxable parking benefits. For Messrs. Mantel and Burt, this column also includes $180 and $380 in taxable parking benefits, respectively. For Mr. Moran, this column reflects: (i) $279,663 of incremental cost to the Company associated with personal use of corporate aircraft, (ii) $88,379 in temporary corporate housing and parking in Pittsburgh, and (iii) $40,131 of gross-up amounts reimbursed for the payment of taxes. The amounts disclosed represent aggregate incremental costs, including the incremental cost of Mr. Moran’s personal use of a corporate aircraft calculated in the following manner. Personal use of corporate aircraft is calculated by using an incremental cost method that multiplies the hours flown on a personal flight by the hourly direct operating charge for the aircraft used. In addition, incremental costs for landing fees, crew hotels and meals, on-board catering and taxes for personal flights are also included. Since the Company aircraft is used primarily for business travel, this calculation methodology excludes the fixed costs which do not change based on usage, such as pilots’ salaries, the lease costs of Company aircraft, and the costs of maintenance. During 2017, Messrs. Martindale and Moran were each provided with access to a parking space to use at our corporate headquarters in Pittsburgh, which was provided as a perquisite at no incremental cost to the Company.

(b)

Reflects matching contributions by the Company with respect to compensation deferred by each executive pursuant to the Company’s Non-Qualified Deferred Compensation Plan. For more information, see the “2017 Non-Qualified Deferred Compensation Table” below.

(c)

For Mr. Dzura, reflects severance equal to $402,115 representing base salary, $9,429 representing the COBRA continuation coverage paid during 2017, and $5,500 representing outplacement services through 2017.

(d)

For Mr. Hennion, reflects consulting fees of $286,413 and $9,300 representing the COBRA continuation coverage paid during 2017 in connection with the consulting services provided by Mr. Hennion.

(6)

Mr. Moran ceased to serve as Interim Chief Executive Officer and was elected as Non-Executive Chairman of the Board in September 2017. Fees received for his service as an outside Director beginning in September 2017 are not reflected in the table above but are disclosed under the “Director Compensation” section above.

(7)	Upon their separation from service, Messrs. Dzura’s and Hennion’s equity awards were treated in accordance with the terms of the underlying plans and award agreements, pursuant to which unvested awards were forfeited.

Table of Contents

2017 Grants of Plan Based Awards Table

The following table sets forth information concerning awards under the 2015 Stock Plan and the 2017 Incentive Plan granted to each of the Named Executive Officers during our fiscal year ended December 31, 2017 and, for Mr. Martindale, equity awards granted in September 2017 as make-whole and inducement awards in connection with the commencement of his employment, which were not issued under any stockholder approved plan. Assumptions used in the calculation of certain dollar amounts are included in Note 14 “Stock-Based Compensation,” to our audited consolidated financial statements included in the Annual Report.

		Estimated Future Payouts Under Non-Equity Incentive Plan Awards (1)						Estimated Future Payouts Under Equity Incentive Plan Awards (2)						All Other Stock Awards: Number of		All Other Option Awards: Number of		Exercise Price of		Grant Date Fair Value of Stock and Option
Name	Grant Date	Threshold ($)		Target ($)		Maximum ($)		Threshold (#)		Target (#)		Maximum (#)		Shares (#)		Shares (#)		Options ($)		Awards ($) (3)

Kenneth Martindale	9/11/2017		482,625		1,462,500		2,925,000		—		—		—		519,556		519,126		8.95		6,550,027

Tricia Tolivar	2/22/2017 5/11/2017		100,980 —		306,000 —		612,000 —		15,308 —		43,736 —		87,472 —		32,802 150,000		100,000 —		7.99 —		940,288 1,020,000

Tim Mantel	2/22/2017		99,000		300,000		600,000		12,446		35,560		71,120		26,670		64,770		7.99		710,438

Guru Ramanathan	2/22/2017		63,855		193,500		387,000		5,106		14,588		29,176		10,941		26,571		7.99		291,448

Gene Burt	2/22/2017		57,173		173,250		346,500		5,106		14,588		29,176		10,941		35,000		7.99		319,011


Robert Moran (4)	2/22/2017 7/28/2017		— —		498,000 —		— —		— —		— —		— —		— —		400,000 353,773		7.99 10.17		1,308,000 1,499,998

Michael Dzura	2/22/2017		100,980		306,000		612,000		—		—		—		—		—		—		—

Jeffrey Hennion	2/22/2017		100,980		306,000		612,000		12,446		35,560		71,120		26,670		64,770		7.99		710,438

Table of Contents

(1)

The amounts for Mr. Martindale represent threshold, target and maximum payout amounts under the terms of his employment agreement. The amount for Mr. Moran represents the payment amount determined by the Board. There were no threshold or maximum amounts established for Mr. Moran. The amounts for the other Named Executive Officers represent the threshold, target and maximum payout amounts under the 2017 Incentive Plan. See “Compensation Discussion and Analysis – Elements of Compensation – Annual Cash Incentive Compensation” above for more information regarding the thresholds under the 2017 Incentive Plan.

(2)

The amounts represent the threshold, target and maximum number of shares of our common stock that may be earned under the PSU awards. The PSU awards also provide for an intermediate number of shares of our common stock that may be earned, which falls between the threshold and target. The intermediate number of shares, under the 2017 grants, is 32,802, 26,670, 10,941, 10,941 and 26,670 for Ms. Tolivar, Mr. Mantel, Dr. Ramanathan, Mr. Burt and Mr. Hennion, respectively. The PSUs are scheduled to vest on December 31, 2019 subject to company performance and each officer’s continued employment. See “Compensation Discussion and Analysis – Elements of Compensation – Long Term Incentive Compensation” above for more information regarding the PSUs.

(3)

For Mr. Martindale, reflects the grant date fair value of the stock options and restricted stock awarded to him on September 11, 2017, computed in accordance with FASB ASC Topic 718. For our other Named Executive Officers, reflects the aggregate grant date fair value of the stock options, the RSUs and the target PSUs granted to them in February 2017, computed in accordance with FASB ASC Topic 718. For Ms. Tolivar, this column also reflects the amount of the restricted stock award granted in May 2017 and, for Mr. Moran, this column also reflects the amount of the option award granted in July 2017, each computed in accordance with FASB ASC Topic 718. For the assumptions underlying the calculation of the aggregate grant date fair value, see Note 14, “Stock-Based Compensation,” to our audited consolidated financial statements included in the Annual Report. The amounts shown in the table may not correspond to the actual value that may be realized by such persons with respect to these awards.

(4)	Option amounts represents two option awards granted to Mr. Moran in 2017 in his capacity as Interim Chief Executive Officer of the Company. Mr. Moran did not receive any stock awards during 2017 in his capacity as a director of the Company.

Table of Contents

Outstanding Equity Awards as of December 31, 2017

The following table sets forth information regarding outstanding equity awards held by the Named Executive Officers under the 2007 Stock Plan, the 2011 Stock Plan and the 2015 Stock Plan as of December 31, 2017 and, for Mr. Martindale, equity awards granted in September 2017 as make-whole and inducement awards in connection with the commencement of his employment which were not issued under any stockholder approved plan.

	Option Awards (1)									Stock Awards
Name	Date of Grant	Exercisable		Unexercisable		Option Exercise Price($)		Option Expiration Date		Number of Restricted Shares and RSUs That Have Not Yet Vested (#) (2)		Market Value of Restricted Shares and RSUs That Have Not Yet Vested ($) (3)		Equity Incentive Plan Awards: Number of Unearned PSUs (#) (4)		Equity Incentive Plan Awards: Market or Payout Value of Unearned PSUs ($) (3)

Kenneth Martindale	9/11/2017		—		519,126		8.95	9/11/2027			281,815		1,039,897		—		—

Tricia Tolivar	3/2/2015		—		—		—		—		2,571		9,487		—		—
	2/16/2016		12,437		37,314		27.30	2/16/2026			7,326		27,033		5,128		18,923
	2/22/2017		—		100,000		7.99	2/22/2027			32,802		121,039		15,308		56,487
	5/11/2017		—		—		—		—		150,000		553,500		—		—

Tim Mantel	2/8/2016		16,652		49,955		26.11	2/8/2026			9,574		35,328		—		—
	2/16/2016		—		—		—		—		—		—		3,205		11,826
	2/22/2017		—		64,770		7.99	2/22/2027			26,670		98,412		12,446		45,926

Guru Ramanathan	2/4/2010		15,000		—		13.18	2/4/2020			—		—		—		—
	2/4/2010		15,000		—		8.79	2/4/2020			—		—		—		—
	4/21/2011		30,000		—		18.82	4/21/2018			—		—		—		—
	12/12/2011		18,238		—		27.70	12/12/2018			—		—		—		—
	11/5/2012		6,679		—		36.16	11/5/2019			—		—		—		—
	2/18/2015		—		—		—		—		1,187		4,380		—		—
	2/16/2016		3,731		11,194		27.30	2/16/2026			2,197		8,107		1,538		5,676
	2/22/2017		—		26,571		7.99	2/22/2027			10,941		40,372		5,106		18,841

Gene Burt	2/22/2017		—		35,000		7.99	2/22/2027			10,941		40,372		5,106		18,841

Robert Moran	8/1/2016		—		—		—		—		33,383		123,183		—		—
	2/22/2017		—		400,000		7.99	2/22/2027			—		—		—		—
	7/28/2017		—		353,773		10.17	7/28/2027			—		—		—		—

Michael Dzura			—		—		—		—		—		—		—		—

Jeffrey Hennion			—		—		—		—		—		—		—		—

Table of Contents

(1)

Time-vested stock option awards made under the 2007 Stock Plan,the 2011 Stock Plan and the 2015 Stock Plan vest in four equal annual installments commencing on the first anniversary of the date of grant, subject to continuing employment. Time-vested stock options granted to Mr. Martindale pursuant to his inducement awards vest in three equal installments commencing on the first anniversary of the date of grant, subject to continuing employment.

(2)

Includes time-vested restricted stock and RSUs awarded under the 2007 Stock Plan,the 2011 Stock Plan and the 2015 Stock Plan, which generally vest in three equal annual installments commencing on the first anniversary of the date of grant, subject to continuing employment. Also includes RSAs awarded to Mr. Martindale as make-whole and inducement awards, not under any stockholder approved plan, a portion of which were fully vested on grant, a portion of which vested on the last trading day in 2017 and a portion of which vest in three equal annual installments commencing on the first anniversary of the date of grant.

(3)	Market value is based on the closing price of our Common Stock of $3.69 per share on December 29, 2017.

(4)

Represents the threshold number of the PSUs granted in 2017 and 2016 under the 2015 Stock Plan. The PSAs granted in 2015, under the 2011 Stock Plan, were scheduled to vest on December 31, 2017 (threshold performance was not achieved and no portion of this award vested). The PSUs granted in 2016 are scheduled to vest on December 31, 2018 and the PSUs granted in 2017 are scheduled to vest on December 31, 2019, in each case subject to Company performance and the Named Executive Officer’s continued employment. The threshold award shown above represents 35% of the target award for the 2017 and 2016 awards; the actual number of PSUs that may be earned may range from 0% to 200% of the target number, as described under “Compensation Discussion and Analysis – Long-Term Incentive Compensation” above.

Table of Contents

2017 Option Exercises and Stock Vested Table

The following table sets forth information regarding the vesting of RSUs and restricted stock and exercise of options by the Named Executive Officers during our fiscal year ended December 31, 2017.

	Option Awards				Stock Awards
Name	Number of Shares Acquired on Exercise (#)		Value Realized on Exercise ($)		Number of Shares Acquired Upon Vesting (#) (1)		Value Realized Upon Vesting ($) (2)

Kenneth Martindale		—		—		237,741		2,127,782
Tricia Tolivar		—		—		6,234		48,744
Tim Mantel		—		—		4,788		38,639
Guru Ramanathan		—		—		3,217		24,666
Gene Burt		—		—		—		—
Robert Moran		—		—		21,140		194,238
Michael Dzura		—		—		5,412		44,372
Jeffrey Hennion		—		—		5,149		39,587

(1)

For Mr. Martindale, reflects the gross number of shares acquired upon vesting of his September 2017 restricted stock award. For Ms. Tolivar, reflects the gross number of shares acquired upon vesting of (i) the second tranche of her March 2015 restricted stock award and (ii) the first tranche of her February 2016 RSU award. For Mr. Mantel, reflects the gross number of shares acquired upon vesting of the first tranche of his February 2016 RSU award. For Dr. Ramanathan, reflects the gross number of shares acquired upon the vesting of (i) the third tranche of his February 2014 RSU award, (ii) the second tranche of his February 2015 restricted stock award, and (iii) the first tranche of his February 2016 RSU award. For Mr. Moran, reflects the gross number of shares acquired upon the vesting of the first tranche of his August 2016 RSU award and the gross number of restricted shares granted to Mr. Moran, prior to his appointment as Interim Chief Executive Officer, in his capacity as a non-employee director on May 23, 2016, which vested on May 23, 2017, 4,448 shares valued at $32,159, which were deferred until separation from service. For Mr. Dzura, reflects the gross number of shares acquired upon the vesting of (i) the second tranche of his February 2015 restricted stock award and (ii) the first tranche of his February 2016 RSU award. For Mr. Hennion, reflects the gross number of shares acquired upon the vesting of (i) the second tranche of his February 2015 restricted stock award and (ii) the first tranche of his February 2016 RSU award.

(2)	Market value is based on the average of the high and low trading prices for our Common Stock on the NYSE on the date of vesting.

Table of Contents

2017 Non-Qualified Deferred Compensation Table

We maintain the GNC Live Well^® Later Non-Qualified Deferred Compensation Plan for the benefit of a select group of our highly compensated executives. Under this plan, certain eligible employees may elect to defer a portion of their future salary and bonus compensation up to a maximum of 80% of salary and 100% of bonus, or such other specified limit established by the Company, until a specified future year, or until retirement. We may in our discretion elect to make a matching contribution to the plan for a calendar year, based on amounts deferred by participants for that year. Participants may select the investment fund or funds in which such deferred amounts are deemed to be invested for the purpose of crediting deferrals with earnings, and investment gains and losses. The Company’s contributions to the Non-Qualified Deferred Compensation Plan become fully vested after three years from the start of the year of deferral. Participants receive vested distributions on elected scheduled withdrawal dates or upon separation from service.

Mr. Martindale, Ms. Tolivar, and Messrs. Burt and Hennion each elected to make contributions to the deferred compensation plan in 2017. The following table identifies, for each Named Executive Officer, his or her contributions, our contributions, the aggregate earnings and withdrawals in 2017 and the aggregate balance as of December 31, 2017:

Name	Executive Contributions in Last Fiscal Year (1)		Registrant Contributions in Last Fiscal Year (2)			Aggregate Earnings in Last Fiscal Year (3)		Aggregate Withdrawals/ Distributions		Aggregate Balance at Last Fiscal Year End (4)
Kenneth Martindale	$	11,250	$	5,625		$	211	$	0	$	17,086
Tricia Tolivar	$	29,792	$	14,896		$	13,058	$	0	$	127,573
Tim Mantel	$	0	$	0		$	0	$	0	$	0
Guru Ramanathan	$	0	$	0		$	53,298	$	0	$	309,036
Gene Burt	$	16,881	$	8,441		$	61	$	0	$	25,383
Robert Moran	$	0	$	0		$	0	$	0	$	0
Michael Dzura (5)	$	0	$	(31,532	)	$	8,454	$	63,063	$	0
Jeffrey Hennion	$	13,961	$	6,981		$	13,647	$	0	$	111,584

(1)	Amounts reflected are included in the “Salary” column of the Summary Compensation Table above.

(2)	Amounts reflected are included in the “All Other Compensation” column of the Summary Compensation Table above.

(3)	Amounts reflected are not included as compensation for the relevant Named Executive Officers in the Summary Compensation Table above.

(4)

For Ms. Tolivar, Mr. Dzura, and Mr. Hennion the amount reported includes $40,551, $45,657, and $44,614, respectively, previously earned, but deferred, salary and matching contributions reported in our Summary Compensation Table for 2016 and $26,154, $34,615, and $28,818, respectively, for 2015. For Dr. Ramanathan, the amount reported includes $48,091 previously earned, but deferred, salary and matching contributions reported in our Summary Compensation Table for 2015 and $58,704 for 2014 and $58,925 for 2013.

(5)

Upon Mr. Dzura’s resignation, he forfeited $31,532 of unvested employer contributions. This amount had been previously reflected in the “All Other Compensation” column of the Summary Compensation Table in prior years, but the forfeiture of this amount is not deducted from the “All Other Compensation” column of the Summary Compensation Table above.

Table of Contents

Potential Payments Upon Termination or a Change in Control

The termination and change in control arrangements for the Named Executive Officers (other than Mr. Martindale and Dr. Ramanathan who had employment agreements with the Company during 2017) are generally governed by Company policy. As such, these arrangements generally are uniform and not highly negotiated. The Compensation Committee does not generally consider the amounts payable in connection with termination and change in control events when establishing the compensation of the Named Executive Officers. The Compensation Committee, together with the Board, established the termination and change of control arrangements described herein to address and conform to our: overall compensation objectives in attracting and retaining the caliber of executives that are integral to our growth; market competitiveness; maintaining management continuity, particularly through periods of uncertainty related to change in control events; providing our key personnel with the assurance of equitable treatment following a change in control and other events; and ensuring that our management is held to high standards of integrity and performance.

In general, such policies and arrangements are evidenced by the Company’s Executive Severance Policy, as described in the Compensation Discussion and Analysis section of this proxy statement. Under the Executive Severance Policy, a “Change in Control” occurs if or upon: (i) any person or entity becomes the beneficial owner of securities representing thirty percent (30%) or more of the combined voting power of the Company’s then outstanding securities; (ii) the majority of the Board is no longer made up of continuing directors as described in the Executive Severance Policy; (iii) the consummation of certain mergers or consolidations of the Company; or (iv) stockholder approval of certain plans of complete liquidation or dissolution or the consummation of agreements for the sale or disposition of all or substantially all of the Company’s assets.

The following is a summary of the termination and change of control provisions in the employment agreements for each of Mr. Martindale and Dr. Ramanathan and the policies and arrangements otherwise applicable to the Named Executive Officers as of December 31, 2017. Dr. Ramanathan continues to be employed by the Company, although his employment agreement with the Company expired as of February 2018.

Mr. Martindale

Mr. Martindale’s employment agreement provides for certain benefits upon termination of employment. Upon Mr. Martindale’s death or disability, he (or his estate) is entitled to any unpaid salary, accrued but unpaid vacation, accrued and vested welfare and retirement benefits and all reimbursable business expenses through the date of termination (“accrued obligations”), any unpaid annual bonus for the year prior to the year of termination, and a prorated annual bonus for the year of termination, based on the actual period of employment and actual level of achievement of the performance objectives for the year of termination. Also, in such cases, Mr. Martindale’s time-vesting equity awards would immediately vest; and any performance-vesting awards would become vested at a prorated actual amount, based on the actual period of employment and actual level of achievement of the performance objectives.

Upon termination of employment by us without cause, including a non-renewal of the employment term, or voluntarily by Mr. Martindale for good reason, subject to the execution of a written release, he is also entitled to:

•

two years’ base salary;

•

two times the average actual bonus paid in respect of each of the two fiscal years immediately preceding the date of termination, or in the case of a termination within 24 months of a Change in Control, two times the target bonus;

Table of Contents

•

any unpaid annual bonus for the year prior to the year of termination, and a prorated annual bonus for the year of termination, based on the actual period of employment and actual level of achievement of the performance objectives for the year of termination; and

•

reimbursement for any portion of the monthly cost of COBRA coverage that exceeds the amount of monthly health insurance premium (with respect to Mr. Martindale’s coverage and any eligible dependent coverage) payable by Mr. Martindale immediately prior to such termination, such reimbursements to continue for up to 18 months.

Also, in such cases, Mr. Martindale’s “sign-on” equity awards would immediately vest; any time-vesting equity awards (other than sign-on awards) that would have vested within 24 months following the date of termination shall immediately vest; and any performance-vesting awards shall become vested at a prorated actual amount, based on the actual period of employment and actual level of achievement of the performance objectives. The total amount payable may be subject to reduction to the extent Mr. Martindale would be subject to an excise tax as an excess parachute amount.

For purposes of Mr. Martindale’s employment agreement, “cause” generally means his:

•

failure to comply with any material obligation imposed by his employment agreement;

•

being convicted (including a plea of nolo contendere) to a misdemeanor that causes substantial economic harm to us, or a felony;

•

intentional theft or embezzlement or fraud in connection with the performance of his duties;

•

engaging in any activity that gives rise to a material conflict of interest with us;

•

intentional misappropriation of any of our material business opportunities;

•

willful or reckless material failure to comply with, observe or carry out our rules, regulations, policies or codes of ethics or conduct;

•

substance abuse or illegal use of drugs that impairs his performance or causes or is likely to cause substantial harm to us; or

•

intentional or reckless engagement in conduct that he knows or should know is materially injurious to us.

For purposes of Mr. Martindale’s employment agreement, “good reason” generally means, without Mr. Martindale’s prior written consent and unless we timely cure the good reason:

•

our material failure to comply with material obligations under his employment agreement;

•

a reduction by us of his titles, positions, status or authority or a material reduction by us of his responsibilities and duties other than due to a temporary period of incapacity;

•

our removal of him from the position of Chief Executive Officer, or failure to elect (or nominate) him to, or removal other than for cause, from the Company or the General Nutrition Centers, Inc. boards of directors; or

•

a material reduction in his base salary or target bonus.

For purposes of Mr. Martindale’s employment agreement, “change in control” is as defined in the Company’s 2015 Stock and Incentive Plan, which is generally the same as the definition provided in the Executive Severance Policy.

Table of Contents

Dr. Ramanathan

Dr. Ramanathan’s employment agreement was effective during 2017. Dr. Ramanathan continues to be employed by the Company, although his employment agreement expired as of February 2018. During 2017, his employment agreement provided for certain benefits upon termination of employment. Upon Dr. Ramanathan’s death or disability, he (or his estate) would have been entitled to his then-current base salary for the remainder of the employment period, and, subject to the discretion of the Board or the Compensation Committee, a pro rata share of his current year annual bonus, based on actual employment, provided bonus targets are met. The employment period was the two-year period from the initial effective date of the employment agreement and for one-year periods thereafter. Upon termination of employment by us without cause or voluntarily by Dr. Ramanathan for good reason, subject to the execution of a written release, he was also entitled to:

•

salary continuation generally for one year or two years if the termination occurred upon or within six months following a change in control;

•

subject to the discretion of the Board or the Compensation Committee, a pro rata share of the annual bonus based on actual employment and achievement of performance objectives; and

•

reimbursement for any portion of the monthly cost of COBRA coverage that exceeded the amount of monthly health insurance premium (with respect to Dr. Ramanathan’s coverage and any eligible dependent coverage) payable by Dr. Ramanathan immediately prior to such termination, such reimbursements to continue through the expiration of the agreement term or the severance period, if earlier.

For purposes of Dr. Ramanathan’s employment agreement, “cause” generally meant his:

•

failure to comply with any material obligation imposed by his employment agreement;

•

being indicted for any felony or any misdemeanor that caused or was likely to cause harm or embarrassment to us, in the reasonable judgment of the Board;

•

theft, embezzlement or fraud in connection with the performance of his duties;

•

engaging in any activity that gave rise to a material conflict of interest with us;

•

misappropriation of any of our material business opportunities;

•

any failure to comply with, observe or carry out our or the Board’s rules, regulations, policies or codes of ethics or conduct;

•

substance abuse or illegal use of drugs that, in the reasonable judgment of the Board, impaired his performance or caused or was likely to cause harm or embarrassment to us; or

•

engagement in conduct that he knew or should have known was injurious to us.

For purposes of Dr. Ramanathan’s employment agreement, “good reason” generally means, without Dr. Ramanathan’s prior written consent and unless we timely cured the good reason:

•

our failure to comply with material obligations under his employment agreement; or

•

a material reduction in his base salary.

For purposes of Dr. Ramanathan’s employment agreement, “change in control” generally meant:

•

an acquisition representing 50% or more of either our Common Stock or the combined voting power of our securities entitled to vote generally in the election of the Board; or

•

the approval by our stockholders of (i) a complete liquidation or dissolution of the Company or (ii) the sale or other disposition (other than a merger or consolidation) of all or substantially all of our or our subsidiaries’ assets.

Table of Contents

Under all circumstances, Dr. Ramanathan’s unvested equity awards would have been forfeited as of the date of his termination unless otherwise provided in the award agreement. The employment agreement with Dr. Ramanathan provided that if any payment or benefit was subject to or result in the imposition of the excise tax imposed by Code Section 4999, then the amount of such payment or payments would have been reduced to the highest amount that may be paid by us without subjecting such payment to the excise tax.

Tabular Presentation. The following table quantifies the estimated payments and benefits that the Named Executive Officers would have received if their employment had terminated on December 31, 2017 under the circumstances shown or if we had undergone a change in control on such date. The tables exclude (i) compensation amounts accrued through December 31, 2017 that would be paid in the normal course of continued employment, such as accrued but unpaid salary and bonus, and (ii) vested account balances under our 401(k) plan that are generally available to all of our salaried employees.

Where applicable, the information in the table uses a fair market value per share of $3.69 for our Common Stock, which is equal to the closing price of our Common Stock on December 29, 2017.

Table of Contents

Named Executive Officer	Resignation for Good Reason (1)		Retirement		By Company Without Cause		Termination Without Cause or for Good Reason Following a Change of Control		Death

Kenneth A. Martindale (2)
Cash Severance (3)	$	1,950,000	$	1,950,000	$	1,950,000	$	1,950,000		—
Pro-rated Bonus (3)	$	2,925,000	$	2,925,000	$	2,925,000	$	2,925,000		—
Health and Welfare Benefits (4)	$	23,572		—	$	23,572	$	23,572	$	250,000
Additional Stock Award Vesting (5)	$	1,039,897	$	1,039,897	$	1,039,897	$	1,039,897	$	1,039,897
Total	$	5,938,469	$	5,914,897	$	5,938,469	$	5,938,469	$	1,289,897

Tricia Tolivar
Cash Severance (3)		—		—	$	510,000	$	1,020,000		—
Pro-rated Bonus (3)		—		—		—		—		—
Health and Welfare Benefits		—		—		—		—	$	250,000
Additional Stock Award Vesting (5)		—		—		—	$	829,363		—
Total		—		—	$	510,000	$	1,849,363	$	250,000

Tim Mantel
Cash Severance (3)		—		—	$	500,000	$	1,000,000		—
Pro-rated Bonus (3)		—		—		—		—		—
Health and Welfare Benefits		—		—		—		—	$	250,000
Additional Stock Award Vesting (5)		—		—		—	$	200,005		—
Total		—		—	$	500,000	$	1,200,005	$	250,000

Guru Ramanathan
Cash Severance (3)		—		—	$	430,000	$	860,000	$	72,111
Pro-rated Bonus (3)		—		—		—		—		—
Health and Welfare Benefits (4)	$	1,430		—	$	1,430	$	36,894	$	250,000
Additional Stock Award Vesting (5)		—		—		—	$	94,754		—
Total	$	1,430		—	$	431,430	$	991,649	$	322,111

Gene Burt
Cash Severance (3)		—		—	$	385,000	$	770,000		—
Pro-rated Bonus (3)		—		—		—		—		—
Health and Welfare Benefits		—		—		—		—	$	250,000
Additional Stock Award Vesting (5)		—		—		—	$	58,315		—
Total		—		—	$	385,000	$	828,315	$	250,000

Table of Contents

(1)	No amount is payable to any Named Executive Officer upon any voluntary resignation from service to the Company other than in the case of a resignation for good reason.

(2)	For Mr. Martindale, termination by the Company without cause includes termination by nonrenewal of his employment agreement.

(3)

Amounts shown assume that each Named Executive Officer received payment only from the applicable agreement or plan. Amounts have been calculated in accordance with the terms of the applicable agreements or plan. For terminations by the Company without cause, amounts will be paid in installments over a period not exceeding two years following termination. For terminations in connection with a change of control, amounts will be paid in a lump sum upon termination. We have assumed that none of the payments or benefits provided to any Named Executive Officer would have been subject to or resulted in the imposition of the excise tax imposed by Code Section 4999. Accordingly, no reductions in such payments and benefits have been applied in the table above.

(4)

For Mr. Martindale, payment includes an eighteen month COBRA payment in the following circumstances: Resignation for Good Reason, Termination by Company Without Cause, and Termination Without Cause or for Good Reason Following a Change of Control. For Dr. Ramanathan, payment includes a two month COBRA payment less the cost of the premium payments in the following circumstances: Resignation for Good Reason and Termination by Company Without Cause and an eighteen month COBRA payment in the case of a Termination Without Cause or for Good Reason Following a Change of Control.

(5)

The value of Additional Stock Award Vesting represents the value at December 29, 2017 of all shares of restricted stock, restricted stock units (along with any dividend equivalents accrued on the restricted stock units), and earned PSUs (along with dividend equivalents on the PSUs) that on that date were subject to service-based restrictions, which restrictions lapse on or after certain terminations of employment, including following a change in control, to the extent such restrictions would not lapse on retirement alone.

The 2007 Stock Plan, the 2011 Stock Plan and the 2015 Stock Plan provide that, in the event of a change in control, unvested stock-based awards generally may be fully vested, cancelled for fair value or substituted for awards that substantially preserve the applicable terms of such stock-based awards, and with respect to the 2015 Stock Plan may provide for a limited time period for awards to be exercised. We have assumed for purposes of the above tables that upon a change in control, equity-based awards would not be accelerated, and instead would be substituted for awards that substantially preserve the applicable terms of the stock-based awards.

We have not included Messrs. Moran, Dzura or Hennion in the table above because none of these Named Executive Officers were employed by us on December 31, 2017, and the amounts paid or payable in 2017 to Messrs. Moran, Dzura and Hennion in connection with their separation from employment with the Company are included in the Summary Compensation Table and the 2017 Option Exercises and Stock Vested Table and the related discussion above, including the Compensation Discussion and Analysis section of this proxy statement. For additional detail, see “Compensation Discussion and Analysis – Mr. Moran's Cessation as Interim Chief Executive Officer and Separation and Consulting Arrangement with Messrs. Dzura and Hennion.”

Pay-Ratio Disclosure

For 2017, the median of the annual total compensation for all our employees, within the United States and Canada, other than Mr. Martindale, was $16,901. Since we had more than one non-concurrent Chief Executive Officers serving during 2017, we chose to annualize the compensation paid to Mr. Martindale, as he was serving as Chief Executive Officer on the date used for determining the median employee.

Table of Contents

Mr. Martindale’s annualized Annual Total Compensation for 2017 was $7,654,277 (see Paragraph 3 below for additional detail). The ratio of the Annual Total Compensation of our Chief Executive Officer to the median of the annual total compensation of the other employees included in this calculation is 453 to 1, which is a reasonable estimate calculated consistent with applicable rules.

In order to (1) identify the total number of the Company’s employees, (2) determine the annual total compensation of our median employee, and (3) determine the Annual Total Compensation of our Chief Executive Officer, we did the following:

We selected November 1, 2017 as the date we would use to identify our median employee. As of that date, the Company’s employee population consisted of approximately 15,986 individuals with 14,889 employees located within the United States and 1,097 employees located in jurisdictions outside of the United States, of which 86, 36, and 975 were located in Ireland, China, and Canada, respectively. We excluded the employees in Ireland and China for this calculation. The total number of employees of the Company utilized for the purposes of the pay-ratio calculation was 15,864.

To determine the median of the annual total compensation of all of these employees, excluding Mr. Martindale, we used the amount of wages, salary, bonuses, and other taxable compensation from the payroll records for 2017, for United States Employees, as reported on Form W-2, and for Canadian employees, as reported on Form T4. We identified our median employee using this compensation measure, which was consistently applied to all our employees included in the calculation.

In order to most accurately reflect the pay-ratio, the Company annualized the compensation of approximately 1,123 full-time employees and 3,989 part-time employees who were hired in 2017 and employed on November 1, 2017. In order to convert the total annual compensation of the employees located in Canada, who are paid in Canadian dollars, to U.S. dollars, we used the conversion rate of 0.79534 as of December 31, 2017 provided by xe.com.

Next, we ranked the compensation for the applicable employees from highest to lowest. The median employee was a part-time sales associate located in the United States with taxable compensation of $16,901 for 2017 (the “Median Employee”).

With respect to our Median Employee, we added together all of the elements of such employee’s compensation for 2017 consistent with Item 402(c)(2)(x), resulting in annual total compensation of $16,901. The Median Employee was not paid, and did not otherwise earn or receive any of the compensation elements that are reported in the “Stock Awards”, “Option Awards”, “Changes in Pension Value and Nonqualified Deferred Compensation Earnings”, and “Other Compensation” columns of the Summary Compensation Table.

Table of Contents

In calculating the “Annual Total Compensation” of Mr. Martindale, we annualized his salary and all other recurring compensation, each as presented in the Summary Compensation Table. We did not annualize the equity awards, which were either make-whole awards or annual grants, in calculating Mr. Martindale’s Annual Total Compensation.

Additional Information. The required ratio was affected by Mr. Martindale’s sign-on make-whole awards, which represent grants intended to make him whole from the equity awards that he forfeited from his prior employer. In addition, the required ratio was affected by the larger number, approximately 9,742 as of November 1, 2017, of part-time associates whose total compensation is limited to amounts paid for part-time work.

Table of Contents

APPROVAL OF THE ADOPTION OF THE GNC HOLDINGS, INC.

2018 STOCK AND INCENTIVE PLAN

(PROPOSAL 3)

The Company’s 2015 Stock and Incentive Plan (the “2015 Plan”) was originally established under the name GNC Holding, Inc. 2011 Stock and Incentive Plan and most recently adopted by the Company’s Board of Directors, and approved by the Company’s stockholders on May 21, 2015. The 2015 Plan was renamed the 2018 Stock and Incentive Plan (the “2018 Plan”) and amended to reflect current best practices and subsequently adopted by the Board of Directors, upon recommendation by the Compensation Committee, on March 30, 2018, subject to stockholder approval.

The principal features of the 2018 Plan are summarized below. The summary is qualified in its entirety by the full text of the 2018 Plan, which is set forth as Exhibit A to this Proxy Statement. The principal amendment was to increase by 8,720,000 the total number of shares of the Company’s common stock reserved for issuance as awards under the 2015 Plan. To further align compensation with performance, the 2018 Plan also requires a minimum one-year vesting requirement for awards, prohibits the payment of dividends on unvested awards and adds individual employee and non‑employee director annual award limitations.

The Board of Directors recommends that stockholders vote “FOR” approval of the 2018 Stock and Incentive Plan, as amended. Such approval will ensure the Company’s continuing ability to provide a flexible range of compensation awards, including awards based upon performance criteria, under the 2018 Plan. Unless otherwise specified thereon, proxies received in the accompanying form will be voted in favor of approval of the 2018 Plan.

General

Purpose of the Plan. The purpose of the 2018 Plan is to enhance the profitability and value of the Company for the benefit of its stockholders by enabling the Company to offer eligible employees, consultants and non-employee directors incentive awards to attract, retain and reward such individuals and strengthen the mutuality of interests between such individuals and the Company’s stockholders. Employees, consultants and non-employee directors of the Company or any affiliate, are eligible to receive awards under the 2018 Plan. The Committee (as described in “Administration,” below) will select which employees, consultants and non-employee directors will be participants, the types of awards to be made to participants and the terms, conditions and limitations applicable to the awards. All non-employee directors are expected to be participants. It is currently expected that approximately 150 employees and seven non-employee directors will be eligible to participate in the 2018 Plan.

Shares Available for Grant. The maximum aggregate number of shares of the Company’s common stock, $.001 par value (the “Common Stock”) for which awards may be granted under the 2018 Plan is limited to the sum of (i) the number of shares available under the 2015 Plan immediately prior to stockholder approval of the 2015 Plan (as of February 28, 2018, 1,602,543 shares were available subject to the counting, substitution and adjustment provisions of the 2015 Plan), which shares shall remain available for the grant of awards under the 2018 Plan and (ii) 8,720,000 shares, all subject to adjustment as provided in the 2018 Plan for stock splits, dividends and similar events. The 2018 Plan provides that the number of shares represented by “full value” awards, which are awards for which a participant is not required to pay the fair market value, as measured on the grant date, are counted at a 1.8:1 premium against the remaining shares available. Common Stock which is subject to any unexercised or undistributed portion of any terminated, expired, exchanged or forfeited award (or awards settled in cash in lieu of Common Stock) will become available for grant pursuant to new awards. However, shares delivered or withheld in satisfaction of the exercise price of an award or any tax

Table of Contents

withholding will not become available for grant pursuant to new awards. Stock options and stock appreciation rights to be settled in shares of Common Stock are counted in full against the number of shares available for award under the 2018 Plan regardless of the number of shares issued upon exercise of the stock option or appreciation right as the result of a net settlement. The Common Stock which may be issued pursuant to an award under the 2018 Plan may be treasury shares or authorized but unissued shares or Common Stock acquired, subsequently or in anticipation of the transaction, in the open market or otherwise to satisfy the requirements of the 2018 Plan, or any combination of such shares.

In order to determine the number of shares of the Common Stock to be authorized under the 2018 Plan, the Compensation Committee and the Board considered the needs of the Company for shares and the potential dilution that awarding the requested shares may have on our existing stockholders. The Compensation Committee consulted with an independent compensation advisor, Pay Governance, in this regard. The Compensation Committee recommended that the Board authorize an additional 8,720,000 shares for issuance under the 2018 Plan. Because Proposal 3 does not contemplate the amount or timing of specific equity awards in the future, and because our historical usage may not be indicative of future requirements as our stock price has decreased, it is not possible to calculate with certainty the number of years of equity awards that will be available or the amount of subsequent dilution that may ultimately result from such awards. Based on historical usage, the equity requested under this proposal may last for up to five years. The rationale and practices of the Compensation Committee with respect to equity awards is set forth in “Compensation Discussion and Analysis” above.

The Compensation Committee and the Board also considered the burn rate with respect to the Company’s equity awards. The burn rate is the total equity awards granted by the Company in a fiscal year (sum of stock options granted, time-based shares and units granted, and performance-based shares and units vested based on actual performance), divided by the total common stock outstanding at the beginning of the year. In fiscal 2015, 2016 and 2017, the Company made equity awards representing a total of 192,516 shares, 921,508 shares and 3,592,408 shares, respectively. In 2017, our burn rate includes the inducement awards granted in connection with the appointment of our new Chief Executive Officer. Using the ISS Proxy Advisor Services methodology for calculating burn rate, the Company’s three-year average (ISS adjusted) burn rate for equity grants made in fiscal 2015, 2016 and 2017 was 2.67%. The Compensation Committee and the Board were satisfied that the Company’s burn rate and share usage over the past three years was at an acceptable level and reflective of the fluctuations in the stock price.

An additional metric that the Compensation Committee and the Board used to measure the cumulative dilutive impact of the 2018 Plan is overhang. Overhang is defined as the sum of outstanding stock options and full value awards and the number of shares available for future grant, divided by the total number of outstanding shares. As of February 28, 2018, the Company had 4,899,346 shares subject to outstanding stock options and full value awards, plus 1,602,543 shares available for future issuance under the 2015 Plan and 800,941 shares subject to outstanding stock options and full-value awards under outstanding inducement awards. As of that date, the Company had 83,663,403 outstanding shares of the Common Stock, resulting in an overhang of 8.7%. The following table illustrates the dilutive impact of the 2018 Plan as of February 28, 2018. As illustrated in the table, the proposed request for 8,720,000 additional shares would increase the overhang by 10.4% of outstanding shares of Common Stock.

Table of Contents

Dilution:	# Shares as of 2/28/18	% of CSO as of 2/28/18
New Share Reserve Proposal	8,720,000	10.4%
Shares Remaining Available for Future Issuance Under Prior Plans	1,602,543	1.9%
Stock Options/SARs Outstanding⁽¹⁾	3,003,264	3.6%
Full-Value Awards Outstanding	2,697,023	3.2%
Total Dilution⁽²⁾	16,022,830	19.2%
Common Shares Outstanding (CSO) as of February 28, 2018	83,663,403	-

(1)

The weighted average exercise price of outstanding stock options is $11.17 and the weighted average remaining term of outstanding stock options is 8.4 years.

(2)

This number includes the 519,126 option and 281,815 full value inducement awards granted in connection with the commencement of our Chief Executive Officer’s employment, which were not issued under any stockholder approved plan.

Awards. The 2018 Plan provides for the grant of incentive stock options (“ISOs”), as defined in Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”), and options which do not qualify as ISOs, known as nonqualified stock options (“NSOs,” and, together with ISOs, “options”), but not in tandem. Options granted under the 2018 Plan may be accompanied by stock appreciation rights (“Tandem SARs”), and stock appreciation rights may be granted alone (“Stand Alone SARs,” and, together with Tandem SARs, “SARs”). Performance shares, performance share units and performance-based cash awards (collectively, “Performance Awards”) may also be granted under the 2018 Plan, which Performance Awards may be contingent on the performance of the Company, a subsidiary, affiliate, any division, operational unit, department, business segment or portion thereof or a participant, or any combination thereof. The 2018 Plan also provides for the granting of restricted stock, restricted stock units and other stock-based awards. All of the foregoing grants are sometimes referred to herein as “awards,” and the recipient of any award or grant is sometimes referred to herein as a “grantee.” The participants in the 2018 Plan will consist of those employees, consultants and non-employee directors of the Company and its affiliates who are designated as grantees by the Committee administering the 2018 Plan, as described below.

The minimum vesting schedule applicable to awards provides for vesting over a service period of no less than one year, with ratable vesting only permitted following the one year anniversary of grant, except in the case of a participant’s death or disability and except that this limitation does not apply to awards granted for up to an aggregate of five percent of the maximum number of shares of Common Stock that may be issued under the 2018 Plan, which may be issued without minimum vesting requirements. No dividend equivalents may be paid with respect to options, SARs, or any purchase rights. For other awards that provide for or include a right to dividends or dividend equivalents, if dividends are declared during the period that the award is outstanding, such dividends (or dividend equivalents) may be accumulated subject to the vesting requirements applicable to the award, but may not be paid until the time the vesting requirements are satisfied.

The number of shares available under the 2018 Plan, any outstanding awards and individual per-employee share limits are automatically adjusted in the event of stock dividends and similar events. In the event the shares of Common Stock have been affected in such a way that an adjustment of outstanding awards is appropriate in order to prevent the dilution or enlargement of rights under the awards (including, without limitation, any extraordinary dividend or other distribution (whether in cash or in kind), recapitalization, stock split, reverse split, reorganization, merger, consolidation, spin-off,

Table of Contents

combination, repurchase, or share exchange, or other similar corporate transaction or event), the Committee will make appropriate equitable adjustments, which may include, without limitation, adjustments to any or all of the number and kind of shares of stock (or other securities) which may thereafter be issued in connection with such outstanding awards and adjustments to any exercise price specified in the outstanding awards and will also make appropriate equitable adjustments to the number and kind of shares of stock (or other securities) authorized by, or to be granted under, the 2018 Plan.

Awards are subject to forfeiture and recoupment pursuant to the Company’s recoupment policy or if a 2018 Plan participant engages in misconduct or violation of any Company policy, and incentive-based compensation otherwise payable or paid to current or former executive officers is forfeited and/or repaid to the Company as may be required pursuant to applicable regulatory requirements.

No awards may be granted under the 2018 Plan, as amended, after March 29, 2028.

Administration

The 2018 Plan will be administered by the Compensation Committee (for purposes of Proposal 3, the “Committee”), consisting of not less than two members of the Board. Each member of the committee must be a “non-employee director” as defined in Rule 16b-3 under the Securities Exchange Act of 1934 (the “Exchange Act”), an independent director under the rules of any stock exchange on which the Common Stock may be listed and under any other applicable regulatory requirements and, to the extent required for purposes of compliance with transitional rules under Section 162(m) of the Code, an “outside director” as defined in Section 162(m) of the Code prior to its amendment effective on January 1, 2018. However the Board will administer the 2018 Plan and otherwise exercise the same authority as the Committee, with respect to grants to non-employee directors. As used herein with respect to awards granted to non-employee directors, the term Committee refers to the Board.

A majority of the members of the Committee will constitute a quorum. The vote of a majority of a quorum (or the unanimous written consent of the Committee members) will constitute action by the Committee. The Committee will periodically determine the participants in the 2018 Plan and the nature, amount, pricing, timing, and other terms of awards to be made to such individuals. The Committee has the power to interpret and administer the 2018 Plan. All questions of interpretation with respect to the 2018 Plan, the number of shares of Common Stock or other securities, stock options, stock appreciation rights, or units granted, and the terms of any agreements evidencing such awards will be determined by the Committee, and its determination will be final and conclusive upon all parties in interest. In the event of any conflict between an award agreement and the 2018 Plan, the terms of the 2018 Plan govern. The Committee may delegate to the officers or employees of the Company the authority to execute and deliver such instruments and documents, to do all such ministerial acts and things, and to take all such other ministerial steps deemed necessary, advisable or convenient for the effective administration of the 2018 Plan in accordance with its terms and purpose.

Stock Options

Options which may be granted by the Committee represent a right to purchase a specified number of shares of Common Stock at a specified price during such period of time as the Committee determines. The exercise price per share of Common Stock of any option will be no less than the fair market value per share of the Common Stock subject to the option on the date the option is granted. Fair market value, for purposes of the 2018 Plan, is the closing price per share of the Company’s Common Stock on the New York Stock Exchange for the date as of which fair market value is to be determined. On March 26, 2018 the fair market value of a share of the Company’s Common Stock was $4.00. The maximum number of shares of Common Stock for which options, SARs and other purchase rights constituting

Table of Contents

appreciation awards under the 2018 Plan can be granted to any one employee under the 2018 Plan may not exceed 1,500,000 shares per fiscal year of the Company.

An option may be exercised, in whole or in part, by giving written notice of exercise to the Company, specifying the number of shares to be purchased. At the discretion of the Committee, the exercise price of the option may be paid in cash, by cash forwarded through a broker or other agent sponsored exercise or financing program, through a combination of the foregoing, or through such other means as the Committee determines are consistent with the 2018 Plan’s purpose and applicable law, including the net withholding of shares to be issued upon exercise or by payment of the exercise price with previously‑owned shares.

For ISOs, the aggregate fair market value (determined on the date of grant) of the shares with respect to which ISOs are exercisable for the first time by an employee during any calendar year under all plans of the corporation employing such employee, any parent or subsidiary corporation of such corporation and any predecessor corporation of any such corporation will not exceed $100,000.

Subject to the foregoing and the other provisions of the 2018 Plan, stock options granted under the 2018 Plan may be exercised at such times and in such amounts and be subject to such restrictions and other terms and conditions, if any, as determined in its discretion by the Committee.

Stock Appreciation Rights

A SAR is a right to receive, upon surrender of the right, an amount payable in cash and/or shares of Common Stock under such terms and conditions as the Committee determines. A SAR may be granted in tandem with part or all of (or in addition to, or completely independent of) an option or any other award under the 2018 Plan. A SAR issued in tandem with a stock option may only be granted at the time of grant of the related option. A SAR issued in tandem with an ISO is not exercisable unless the then fair market value of the Common Stock exceeds the exercise price of the ISO. The amount payable in cash and/or shares of Common Stock with respect to each SAR will be equal in value to a percentage (including up to a maximum of 100%) of the amount by which the fair market value per share of Common Stock on the exercise date exceeds the fair market value per share of Common Stock on the date of grant of the SAR. The applicable percentage will be established by the Committee. The exercise price of any SAR will be no less than the fair market value per share of the Common Stock subject to the SAR on the date the SAR is granted. The agreement evidencing the award may state whether the amount payable is to be paid wholly in cash, wholly in shares of Common Stock or partly in each. If the award agreement does not state the manner of payment, the Committee will determine the manner of payment at the time of payment. The amount payable in shares of Common Stock, if any, is determined with reference to the fair market value per share of Common Stock on the date of exercise. Tandem SARs are exercisable only to the extent that the options to which they relate are exercisable. Upon exercise of the Tandem SAR, and to the extent of such exercise, the participant’s underlying option will automatically terminate. Similarly, upon the exercise of the tandem option, and to the extent of such exercise, the participant’s related SAR will automatically terminate.

Repricing Prohibited

The 2018 Plan prohibits repricing of options, SARs or other purchase rights without further stockholder approval. Repricing includes the grant of a new option, SAR or purchase right in return for the cancellation, exchange or forfeiture of an award that has a higher grant price than the new award, the amendment of an outstanding award to reduce the grant price, the cancellation or repurchase of an option, SAR or purchase right at a time when the grant price is greater than the fair market value of the Common Stock or any action that would be treated, for accounting purposes, as a repricing and excepting

Table of Contents

only share adjustments or substitutions under the anti-dilution and adjustment provisions of the 2018 Plan explained under “General,” above.

Other Terms of Options and SARs

No dividend equivalents may be paid or advanced in connection with any option, SAR or other purchase right. The term of any option, SAR or other purchase right may not exceed ten years from the date of grant.

Unless otherwise provided in a grantee’s award agreement, the following provisions of this paragraph will apply in the case of a grantee whose employment is terminated. If the employment of a grantee is terminated for reasons other than (i) voluntary termination after the occurrence of an event that would be grounds for a termination for cause, (ii) termination for cause, (iii) disability or (iv) death, all outstanding options, SARs and other appreciation awards held by the grantee immediately prior to termination of employment will be exercisable by the grantee (but only to the extent exercisable immediately prior to termination of employment) at any time prior to the expiration date of the option, SARs and other appreciation awards or within sixty days following the date of termination, whichever is the shorter period.

Following the death of a grantee during employment or termination due to disability, all outstanding options, SARs and other appreciation awards held by the grantee immediately prior to termination (but only to the extent exercisable immediately prior to the death of the grantee or termination due to disability) will be exercisable by the grantee or by the person entitled to do so under the Will of the grantee, at any time prior to the expiration date of the option, SAR or other appreciation award or within one year after the date of death of the grantee or termination due to disability, whichever is the shorter period.

Following the termination of a grantee’s employment for cause, or voluntary termination after an event that would constitute grounds for termination for cause, all outstanding options held by the grantee immediately prior to termination (whether or not exercisable) will be immediately forfeited.

Restricted Stock and Restricted Stock Units

Restricted stock is Common Stock that is issued to a participant and is subject to such terms, conditions and restrictions as the Committee deems appropriate, which may include, but are not limited to, restrictions upon the sale, assignment, transfer or other disposition of the restricted stock and the requirement of forfeiture of the restricted stock upon termination of employment or service under certain specified conditions, including the failure to achieve performance conditions. Restricted stock units are units representing shares of Common Stock that are issued to a participant and are subject to such terms and conditions as the Committee deems appropriate, which may include, but are not limited to, restrictions upon sale, assignment, transfer or other disposition of the restricted stock units and the requirement of forfeiture of the restricted stock units upon termination of employment or service under certain specified conditions, including the failure to achieve performance conditions. The Committee may provide for the lapse of any such term or condition or waive any term or condition based on such factors or criteria as the Committee may determine, provided that the Committee will not accelerate the vesting of, or waive the restrictions with respect to, restricted stock except in the case of death, disability, retirement, involuntary termination other than for cause, or change in control. Subject to such restrictions as the Committee may impose, the participant will have, with respect to awards of restricted stock, all of the rights of a stockholder of the Company, including the right to vote the restricted stock and the right to receive any dividends on such stock, provided that no dividends may be paid, and are conditioned upon, the vesting of the restricted stock dividend. With respect to awards of restricted stock

Table of Contents

units, the participant will have no rights of stockholders until shares of Common Stock are issued in satisfaction thereof, but may have dividend equivalent rights, as determined by the Committee, except that no dividends equivalent rights may be paid until, and are conditioned upon, the vesting of the restricted stock unit award.

If the grantee of restricted stock or restricted stock units ceases to be an employee for any reason, any outstanding shares of restricted stock or restricted stock units held by the grantee will vest or be forfeited according to the terms of the award agreements.

Performance Shares, Performance Share Units and Performance-Based Cash Awards

Performance Shares, Performance Share Units, and Performance-Based Cash Awards may be granted under the 2018 Plan from time to time based on such terms and conditions as the Committee deems appropriate, consistent with the terms and purposes of the 2018 Plan. Performance Shares, Performance Share Units and Performance-Based Cash Awards are awards the payment or vesting of which is contingent upon the achievement of specified levels of performance under specified performance criteria during a performance period by the Company, an affiliate, subsidiary, division, other operational unit, business segment, administrative department of the Company or the participant individually.

The performance criteria to be used in determining whether a Performance Award has been earned, the level of achievement of such performance criteria necessary for the Performance Award to be earned in whole or in part, and the performance period over which such performance will be measured will be determined by the Committee at the time a Performance Award is granted. Such performance criteria will be one or more preestablished objective measures of performance during the performance period by the Company, an affiliate, a subsidiary or subsidiaries, division, business segment, any branch, department, business unit or other portion thereof or the participant individually. Performance goals may be based on the following performance criteria:

enterprise value or value creation targets;

after-tax or pre-tax profits, including without limitation as attributable to continuing and/or other operations of the Company;

operational cash flow or economic value added;

specified objectives with regard to limiting the level of increase in all or a portion of, the Company’s bank debt or other long-term or short-term public or private debt or other similar financial obligations of the Company, or other capital structure improvements, which may be calculated net of cash balances and/or other offsets and adjustments as may be established by the Committee;

earnings per share or earnings per share from continuing operations;

sales (domestic and/or international), operating performance and revenues, net income, gross margin, operating income or earnings before income tax or other exclusions;

return on capital employed, return on invested capital, gross margin return on inventory, or return on assets;

total shareholder return, including after-tax or pre-tax return on stockholder equity;

Table of Contents

the fair market value or book value of the shares of the Company’s Common Stock;

the growth in the value of an investment in the Company’s Common Stock assuming the reinvestment of dividends, dividend growth or market capitalization;

a transaction that results in the sale of stock or assets of the Company;

earnings before interest, taxes plus amortization and depreciation;

earnings before interest and taxes (EBIT);

reduction in expenses or cost savings;

strategic objectives including management development, new product development and introduction;

individual Participant goals and objectives, including management development, new product development and introduction; or

any financial metric set forth in the 2018 Plan or in the Company’s financial statements as a percentage of another financial metric.

The Committee may in its discretion also determine to use other objective performance measures as performance criteria for awards.

If a grantee ceases to be employed for any reason during the performance period of any Performance Award, any shares or amounts will vest or be forfeited according to the terms of the Performance Award agreement.

Other Stock‑Based Awards

The Committee is authorized to grant such other stock-based awards, either alone or in addition to other awards granted under the 2018 Plan to eligible participants.

The Committee shall determine the terms and conditions of other stock-based awards, subject to the same one-year minimum vesting requirements applicable to other awards. Any shares of common stock or securities delivered pursuant to a purchase right granted under the 2018 Plan shall be purchased for such consideration, paid for by such methods and in such forms, including, without limitation, cash, shares of common stock, or other property or any combination thereof, as the committee shall determine. However, for purchase rights the value of such consideration shall not be less than the fair market value of such shares of common stock or other securities represented by the purchase right on the date of grant. Dividends or dividend equivalents may be granted with respect to other stock-based awards except for purchase rights, provided that no dividends or dividend equivalents may be paid until, and are conditioned upon, the vesting of other stock-based awards.

Individual Limitations

The 2018 Plan provides that the maximum amount of awards that may be granted to a non-employee director in any calendar year in respect of the non-employee director’s service as a member of the Board, including service as a member or chair of any committees of the Board, may not exceed $500,000, with the value of any award based on the accounting grant date value of such award. For employees and consultants, the maximum number of shares of Restricted Stock or Performance

Table of Contents

Shares awarded or shares represented under any Restricted Stock Unit or Performance Share Unit during any calendar year is 800,000 shares per award type, subject to adjustment as provided in the 2018 Plan, and the maximum payment under any Performance Based Cash Award payable with respect to any calendar year is $5,000,000.

Effect of Change in Control

Notwithstanding any other provision of the 2018 Plan to the contrary, and unless the award agreement otherwise provides, in the event the employment of a participant is terminated by the Company and its affiliates without “cause” within two years following the occurrence of a Change in Control of the Company (as defined in Section 2.7 of the 2018 Plan), (i) all options, stock appreciation rights and other appreciation awards which are then outstanding will become fully vested and exercisable and (ii) all restrictions with respect to shares of restricted stock and shares represented by restricted stock units or other stock-based awards which are then outstanding will lapse, and such shares will be fully vested and nonforfeitable. Notwithstanding any other provision of the 2018 Plan to the contrary, and unless the award agreement provides otherwise, if a Change in Control of the Company occurs prior to the end of the Performance Period, with respect to all Performance Awards which are then outstanding, all uncompleted Performance Periods will be deemed to have been completed, the target level of performance set forth with respect to each criteria under such Performance Awards will be deemed to have been attained and a pro rata portion (based on the ratio of (a) the number of full and partial months which have elapsed from the beginning of the Performance Period through the Change in Control to (b) the number of months originally contained in the Performance Period) of each such Performance Award will become payable to the participant, with the remainder of the Performance Award being converted into restricted stock (in the case of Performance Shares) or restricted stock units (in the case of other performance awards), subject to the forfeiture unless the participant continues to be actively employed by the Company through the end of the original Performance Period, but subject to an exception in the case of a termination of employment by the Company without “cause” and such other exceptions as may be provided by the Committee.

Non-Transferability

Awards are not transferable under the 2018 Plan. However, in the Committee’s discretion, an award agreement for an NSO and a Tandem SAR may expressly provide for specifically limited transferability to individual family members of the awardee, provided that transfers for value are not permitted and no transfer may be made to third-party financial institutions.

Possible Anti-Takeover Effect

The provisions of the 2018 Plan providing for the potential acceleration of the vesting of awards, or the lapse of restrictions or deemed achievement of performance criteria upon the occurrence of a Change in Control, may be considered as having an anti-takeover effect.

Amendment and Termination

The Board may at any time amend, suspend or terminate the 2018 Plan. The Committee may at any time alter or amend any or all award agreements under the 2018 Plan to the extent permitted by law. However, no such action by the Board or by the Committee may impair the rights of participants under outstanding awards without the consent of the participants affected thereby. Further, the Board may not amend the 2018 Plan without the approval of the Company’s stockholders to the extent such approval is required by law, agreement or the rules of any exchange upon which the Common Stock is listed.

Table of Contents

Payment of Taxes

Award agreements will contain a provision requiring the withholding of applicable taxes required by law from all amounts paid to the participant in satisfaction of an award. In the case of an award paid in cash, the withholding obligation will be satisfied by withholding the applicable amount and paying the net amount in cash to the participant. In the case of awards paid in shares of Common Stock or other securities of the Company, (i) a participant may satisfy the withholding obligation by paying the amount of any taxes in cash, or (ii) with the approval of the Committee (or, in case of deduction, by the unilateral action of the Committee), shares of Common Stock or other securities may be deducted by the Company from the payment or delivered to the Company by the participant to satisfy the obligation in full or in part, as long as such withholding or delivery of shares of Common Stock or other securities does not violate any applicable laws, rules or regulations of federal, state or local authorities or Company policies. The number of shares or other securities to be deducted or delivered will be determined by reference to the fair market value of such shares or securities on the applicable date.

New Plan Benefits

The actual amount of awards to be received by or allocated to participants or groups under the 2018 Plan is not determinable in advance because the selection of participants who receive awards under the 2018 Plan, and the size and type of awards to such individuals and groups are generally determined by the Committee in its discretion. The Grants of Plan Based Awards Table, above, includes information with respect to prior year grants made to our Named Executive Officers under the 2015 Plan and under inducement awards not granted pursuant to the 2015 Plan. The grants provided to (i) all current executive officers as a group, (ii) all current directors who are not executive officers as a group, and (iii) all employees, including current officers who are not executive officers, as a group, during 2017 under the 2015 Plan, the predecessor plan to the 2018 Plan, and under inducement awards not granted pursuant to the 2015 Plan, are set forth in the following table:

	Dollar value ($)		Number of units

Executive Group		9,458,633		1,584,098

Non-Executive Director Group		3,467,993		842,363

Non-Executive Officer Employee Group		8,449,279		1,531,239

Equity Compensation Plans

The following table sets forth information as of December 31, 2017 concerning common stock issuable under the Company’s equity compensation plans.

Table of Contents

Plan Category	Number of securities to be issued upon exercise of outstanding options, warrants and rights (a)		Weighted average exercise price of outstanding options, warrants and rights (b)		Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)) (c)
Equity compensation plans approved by security holders (1)
2007 Stock Plan		107,220	$	12.17		—
2015 Stock Plan		1,978,821	$	12.51		4,627,292	(2)(3)
Subtotal		2,086,041	$	12.50		4,627,292	(2)(3)
Equity compensation plans not approved by security holders (4)		519,126	$	8.95		—	(5)
Total (6)		2,605,167	$	11.79		4,627,292

(1) Effective May 21, 2015, our 2011 Stock Plan was amended and restated as the 2015 Stock Plan. The 2007 Stock Plan and the 2015 Stock Plan are the only equity compensation plans that we have adopted and each has been approved by our stockholders. As of February 28, 2018, for equity compensation plans approved by security holders, the number of securities to be issued upon the exercise of outstanding options, warrants and rights was 2,484,138, the weighted average exercise price was $11.63, and the number of securities remaining available for future issuance was 1,602,543.

(2) Excludes 1,978,821 outstanding stock options as set forth in the first column, 96,969 shares of outstanding time vested restricted stock, zero shares of performance vesting restricted stock, 660,596 shares of outstanding time vesting restricted stock units and 367,150 of market vesting restricted stock units.

(3) Up to 11,500,000 shares of our Common Stock may be issued under the 2015 Stock Plan (subject to adjustment to reflect certain transactions and events specified in the 2015 Stock Plan for any award grant). If any award granted under the 2015 Stock Plan expires, terminates or is canceled without having been exercised in full, the number of shares underlying such unexercised award will again become available for issuance under the 2015 Stock Plan. The total number of shares of our Common Stock available for awards under the 2015 Stock Plan will be reduced by (i) the total number of stock options or stock appreciation rights exercised, regardless of whether any of the shares of our Common Stock underlying such awards are not actually issued to the participant as the result of a net settlement and (ii) any shares of our Common Stock used to pay any exercise price or tax withholding obligation. In addition, the number of shares of our Common Stock that are subject to restricted stock, performance shares or other stock-based awards that are not subject to the appreciation of the value of a share of our Common Stock (“Full Share Awards”) is limited by counting shares granted pursuant to such Full Share Awards against the aggregate share reserve as 1.8 shares for every share granted. If any stock option, stock appreciation right or other stock-based award that is not a Full Share Award is canceled, expires or terminates unexercised for any reason, the shares covered by such awards will again be available for issuance under the 2015 Stock Plan. If any shares of our Common Stock that are subject to Full Share Awards are forfeited for any reason, 1.8 shares of our Common Stock will again be available for issuance under the 2015 Stock Plan. As of February 28, 2018, the number of securities remaining available for future issuance under the 2015 Stock Plan was 1,602,543.

(4) The Company's non-shareholder approved plan is the inducement exception plan pursuant to NYSE rules for awards granted to Mr. Martindale on September 11, 2017 pursuant to his employment agreement (“Inducement Exception Awards”), under which no further grants may be made. The Inducement Exception Awards were made pursuant to the inducement award exception under the NYSE rules to induce an executive officer to join the Company. These awards were granted to Mr. Martindale

Table of Contents

pursuant to his employment agreement and were made in order to attract and retain an executive of his unique caliber and experience. Refer to Item 8, “Financial Statements and Supplementary Data,” Note 14, “Stock-Based Compensation” for details of the non-plan inducement awards.

(5) Excludes 519,126 stock options as set forth in the first column.

(6) As of February 28, 2018, there were a total of 3,003,264 outstanding stock options with a weighted average exercise price of $11.17 and a weighted average remaining term of 8.4 years, reflecting 2,484,138 options outstanding under shareholder-approved plans plus 519,126 options outstanding under the inducement exception plan. As of February 28, 2018, there were a total of 2,697,023 full-value awards outstanding, reflecting 2,415,208 shares outstanding under shareholder-approved plans plus 281,815 shares outstanding under the inducement exception plan.

Federal Income Tax Consequences

The following is a brief summary of the principal Federal income tax consequences of the grant and exercise of awards under present law.

Incentive Stock Options. An optionee will not recognize any taxable income for Federal income tax purposes upon receipt of an ISO or, generally, at the time of exercise of an ISO. The exercise of an ISO generally will result in an increase in an optionee’s taxable income for alternative minimum tax purposes.

If an optionee exercises an ISO and does not dispose of the shares received in a subsequent “disqualifying disposition” (generally, a sale, gift or other transfer within two years after the date of grant of the ISO or within one year after the shares are transferred to the optionee), upon disposition of the shares any amount realized in excess of the optionee’s tax basis in the shares disposed of will be treated as a long-term capital gain, and any loss will be treated as a long-term capital loss. In the event of a “disqualifying disposition,” the difference between the fair market value of the shares received on the date of exercise and the option price (limited, in the case of a taxable sale or exchange, to the excess of the amount realized upon disposition over the optionee’s tax basis in the shares) will be treated as compensation received by the optionee in the year of disposition. Any additional gain will be taxable as a capital gain and any loss as a capital loss, which will be long-term or short-term depending on whether the shares were held for more than one year. Under regulations, special rules apply in determining the compensation income recognized upon a disqualifying disposition if the option price of the ISO is paid with shares of the Company’s Common Stock. If shares of the Company’s Common Stock received upon the prior exercise of an ISO are transferred to the Company in payment of the option price of an ISO within either of the periods referred to above, the transfer will be considered a “disqualifying disposition” of the shares transferred, but, under proposed regulations, only compensation income determined as stated above, and no capital gain or loss, will be recognized.

Neither the Company nor any of its subsidiaries will be entitled to a deduction with respect to shares received by an optionee upon exercise of an ISO and not disposed of in a “disqualifying disposition.” Except as described in “Other Tax Matters” below, if an amount is treated as compensation received by an optionee because of a “disqualifying disposition,” the Company or one of its subsidiaries generally will be entitled to a corresponding deduction in the same amount for compensation paid.

Nonqualified Stock Options. An optionee will not recognize any taxable income for Federal income tax purposes upon receipt of a NSO. Upon the exercise of a NSO the amount by which the fair market value of the shares received, determined as of the date of exercise, exceeds the option price will

Table of Contents

be treated as compensation received by the optionee in the year of exercise. If the option price of a NSO is paid in whole or in part with shares of the Company’s Common Stock, no income, gain or loss will be recognized by the optionee on the receipt of shares equal in value on the date of exercise to the shares delivered in payment of the option price. The fair market value of the remainder of the shares received upon exercise of the NSO, determined as of the date of exercise, less the amount of cash, if any, paid upon exercise will be treated as compensation income received by the optionee on the date of exercise of the stock option.

Except as described in “Other Tax Matters” below, the Company or one of its subsidiaries generally will be entitled to a deduction for compensation paid in the same amount treated as compensation received by the optionee.

Stock Appreciation Rights. An awardee will not recognize any taxable income for Federal income tax purposes upon receipt of SARs. The value of any Common Stock or cash received in payment of SARs will be treated as compensation received by the awardee in the year in which the awardee receives the Common Stock or cash. Except as described in “Other Tax Matters” below, the Company generally will be entitled to a corresponding deduction in the same amount for compensation paid.

Restricted Stock. An awardee of restricted stock will not recognize any taxable income for Federal income tax purposes in the year of the award, provided the shares are subject to restrictions (that is, they are nontransferable and subject to a substantial risk of forfeiture). However, an awardee may elect under Section 83(b) of the Code to recognize compensation income in the year of the award in an amount equal to the fair market value of the shares on the date of the award, determined without regard to the restrictions. If the awardee does not make a Section 83(b) election, the fair market value of the shares on the date the restrictions lapse will be treated as compensation income to the awardee and will be taxable in the year the restrictions lapse. Except as described in “Other Tax Matters” below, the Company or one of its subsidiaries generally will be entitled to a deduction for compensation paid in the same amount treated as compensation income to the awardee.

Restricted Stock Units. An awardee who receives restricted stock units will not recognize any taxable income for federal income tax purposes upon receipt of the award. Any cash or shares of Common Stock received pursuant to the award will be treated as compensation income received by the awardee generally in the year in which the awardee receives such cash or shares of Common Stock. Except as described in “Other Tax Matters” below, the Company or one of its subsidiaries generally will be entitled to a deduction for compensation paid in the same amount treated as compensation income to the awardee.

Performance Awards. An awardee who receives performance shares, performance share units or a performance‑based cash award will not recognize any taxable income for federal income tax purposes upon receipt of the shares, units or award. The fair market value of the shares on the date the performance condition is determined to be achieved will be treated as compensation income to the awardee and will be taxable in the year the performance condition is achieved (if the awardee does not make a Section 83(b) election upon the receipt of the performance shares, in which case the awardee would recognize compensation income on the date of the award). Any cash received pursuant to a performance‑based cash award will be treated as compensation income received by the awardee generally in the year in which the awardee receives such cash. Except as described in “Other Tax Matters” below, the Company or one of its subsidiaries generally will be entitled to a deduction for compensation paid in the same amount treated as compensation income to the awardee.

Other Tax Matters. The exercise by an awardee of a stock option or stock appreciation right, the lapse of restrictions on restricted stock or restricted stock units or the achievement or fulfillment of

Table of Contents

performance shares, performance share units or performance‑based cash awards following the occurrence of a Change in Control, in certain circumstances, may result in (i) a 20% Federal excise tax (in addition to Federal income tax) to the awardee on certain payments of the Company’s Common Stock or cash resulting from such exercise or deemed achievement or fulfillment of performance awards or, in the case of restricted stock or restricted stock units on all or a portion of the fair market value of the shares on the date the restrictions lapse and (ii) the loss of a compensation deduction which would otherwise be allowable to the Company or one of its subsidiaries as explained above. The Company and its subsidiaries may lose a compensation deduction, which would otherwise be allowable, for all or a part of compensation paid in the form of awards under the 2018 Plan, if, the employee is the Chief Executive Officer or Chief Financial Officer of the Company (or acts in such capacity) or is another “covered employee” as defined under the Code or was such an employee beginning in any year after 2017, if the total compensation paid to such employee exceeds $1,000,000.

Vote Required for Approval

Pursuant to the Company’s Bylaws, approval of the adoption of the 2018 Plan requires the affirmative vote of the holders of shares entitled to cast a majority of the votes entitled to be cast by the holders of shares present in person or represented by proxy and entitled to vote on the proposal, with a quorum of a majority of the total votes entitled to be cast by the holders of all outstanding capital stock of the Company being present or represented by proxy at the Annual Meeting.

Recommendation

THE BOARD RECOMMENDS THAT THE STOCKHOLDERS VOTE “FOR” APPROVAL OF THE 2018 STOCK AND INCENTIVE PLAN.

Table of Contents

RATIFICATION OF APPOINTMENT OF AUDITORS

(PROPOSAL 4)

In accordance with the Audit Committee’s charter, the Audit Committee is responsible for the appointment and retention of our independent auditors. In our fiscal years ended December 31, 2017 and 2016, all audit and non-audit services were pre-approved by the Audit Committee in accordance with the Audit Committee’s charter.

The Audit Committee has appointed PricewaterhouseCoopers LLP (“PwC”) to serve as our independent auditors for our fiscal year ending December 31, 2018, subject to ratification by our stockholders. Representatives of PwC will be present at the Annual Meeting to answer questions and will also have the opportunity to make a statement if they desire to do so. If the proposal to ratify PwC’s appointment is not approved, other certified public accountants will be considered by the Audit Committee. Even if the proposal is approved, the Audit Committee, in its discretion, may direct the appointment of new independent auditors at any time during the year if it believes that such a change would be in the best interest of the Company and its stockholders.

Fees Paid to PricewaterhouseCoopers LLP

The fees incurred by us for professional services rendered by PwC for our fiscal years ended December 31, 2017 and 2016 were as follows:

Audit Fees, Audit Related Fees, Tax Fees and All Other Fees
	2017 ($)		2016 ($)

Audit Fees (1)		1,432,100		1,302,300
Audit Related Fees (2)		80,000		5,000
Tax Fees (3)		15,000		110,000
All Other Fees (4)		1,800		1,800

		1,528,900		1,419,100

(1)

Includes services related to the audit of the Company’s financial statements and internal controls over financial reporting, statutory audits of subsidiaries, and various other filings with the SEC.

(2)

Principally includes review of implementation of new accounting pronouncements and franchise disclosure documents.

(3)

Includes services related to Federal tax planning and advice, and certain individual tax compliance services.

(4)

Represents license fees for access to technical accounting information.

The Audit Committee has concluded that the provision of the foregoing services is compatible with maintaining PwC’s independence.

The affirmative vote of the holders of a majority of the votes cast by our stockholders in person or represented by proxy at the Annual Meeting and entitled to vote is required to approve this Proposal 4.

Table of Contents

Pre-Approval Policies and Procedures

All of the services performed for us by PwC during 2017 were pre-approved by the Audit Committee. The Audit Committee’s policy, as reflected in its charter, requires that the Audit Committee pre-approve on an engagement-by-engagement basis all audit and non-audit services to be performed by our independent auditors, provided that the Audit Committee may delegate the authority to pre-approve such services to a subcommittee of the Audit Committee.

Recommendation

THE BOARD RECOMMENDS THAT THE STOCKHOLDERS VOTE FOR THE RATIFICATION OF THE APPOINTMENT OF PWC AS INDEPENDENT AUDITORS FOR OUR FISCAL YEAR ENDING DECEMBER 31, 2018.

Table of Contents

AUDIT COMMITTEE REPORT

The Board has determined that each member of the Audit Committee meets the SEC and the NYSE independence and financial literacy requirements. The Board has also determined that each of Messrs. Berger, Hines and Mallott qualifies as an “audit committee financial expert.”

The Audit Committee has reviewed and discussed our audited financial statements for the year ended December 31, 2017 with both management and the independent auditors. The Audit Committee discussed the auditors’ review of our quarterly financial information with the auditors prior to the release of such information and the filing of our quarterly reports with the SEC.

Further, the Audit Committee discussed with the independent auditors the matters required to be discussed by Public Company Accounting Oversight Board (“PCAOB”) Auditing Standard No. 1301 (Communications with Audit Committees), received the written disclosures and the letter from the independent auditors required by applicable requirements of the PCAOB regarding the independent accountant’s communications with the Audit Committee concerning independence and discussed with the auditors the auditors’ independence. The Audit Committee also discussed with the auditors financial management matters related to our internal control over financial reporting. Based on these discussions, the Audit Committee’s review of our audited financial statements for the year ended December 31, 2017 and the written disclosures received from the independent auditors, the Audit Committee recommended that the Board include the audited financial statements in our Annual Report on Form 10-K for the fiscal year ended December 31, 2017 for filing with the SEC.

This audit committee report is not deemed filed under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, and is not incorporated by reference into any filings that we may make with the SEC.

	AUDIT COMMITTEE
	Philip E. Mallott (Chairperson)
	Jeffrey P. Berger
	Michael F. Hines

Table of Contents

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

The following table below sets forth information regarding the beneficial ownership of our Common Stock as of the Record Date by: (i) each person, or group of affiliated persons, known by us to beneficially own more than five percent of our Common Stock; (ii) the Named Executive Officers; (iii) each of our directors and nominees for director; and (iv) all of our current directors and executive officers as a group, based on information furnished by each person.

Beneficial ownership is determined in accordance with the Exchange Act and includes voting and investment power with respect to our Common Stock. The following table includes Common Stock issuable within 60 days of the Record Date upon the exercise of all options and other rights beneficially owned by the indicated stockholders on that date. Percentage of beneficial ownership is based on 83,661,965 shares of Common Stock outstanding as of March 26, 2018. Except as otherwise noted below, each person or entity named in the following table has sole voting and investment power with respect to all shares of our Common Stock that he, she or it beneficially owns.

Unless otherwise indicated, the address of each beneficial owner listed below is c/o GNC Holdings, Inc., 300 Sixth Avenue, Pittsburgh, PA 15222.

Name of Beneficial Owner	Position	Shares	Percentage

Kenneth A. Martindale	Chief Executive Officer and Director	455,001 (1)	*

Tricia K. Tolivar	Executive Vice President, Chief Financial Officer and Interim Chief Marketing Officer	67,513 (2)	*

Timothy A. Mantel	Former Executive Vice President and Chief Merchandising Officer	110,308 (3)	*

Guru Ramanathan	Senior Vice President and Chief Innovation Officer	156,589 (4)	*

Gene E. Burt	Executive Vice President, Chief Merchandising Officer and Chief Supply Chain Officer	11,091 (5)	*

Michael D. Dzura	Former Executive Vice President, Operations	5,284 (6)	*

Jeffrey R. Hennion	Former Executive Vice President, Chief Marketing and e-Commerce Officer	—	*

Robert F. Moran	Director and Former Interim Chief Executive Officer	1,019,888 (7)	1.22%

Jeffrey P. Berger	Director	96,429 (8)	*

Table of Contents

Alan D. Feldman	Director	62,102 (9)	*

Michael F. Hines	Director	220,674 (10)	*

Amy B. Lane	Director	62,254 (11)	*

Philip E. Mallott	Director	51,837 (12)	*

Richard J. Wallace	Director	63,754 (13)	*

All directors and executive officers as a group (14 persons)		2,298,275	2.75%

*Less than 1% of the outstanding shares of Common Stock.

(1)	Consists of (i) 173,186 shares directly held and (ii) 281,815 shares of time-vested restricted stock.

(2)	Consists of (i) 17,637 shares directly held and (iii) 49,876 shares issuable upon the exercise of options that are currently exercisable or will become exercisable within 60 days following the Record Date.

(3)	Consists of (i) 77,004 shares directly held and (ii) 33,304 shares issuable upon the exercise of options that are currently exercisable or will become exercisable within 60 days following the Record Date.

(4)	Consists of (i) 57,567 shares directly held and (ii) 99,022 shares issuable upon exercise of options that are currently exercisable or will become exercisable within 60 days following the Record Date.

(5)	Consists of (i) 2,341 shares directly held and (ii) 8,750 shares issuable upon the exercise of options that are currently exercisable or will become exercisable within 60 days following the Record Date.

(6)	Consists of 5,284 shares directly held.

(7)	Consists of (i) 919,888 shares directly held and (ii) 100,000 shares issuable upon the exercise of options that are currently exercisable or will become exercisable within 60 days following the Record Date.

(8)	Consists of (i) 67,664 shares directly held, (ii) 14,765 shares of time-vested restricted stock and (iii) 14,000 shares issuable upon the exercise of options that are currently exercisable or will become exercisable within 60 days following the Record Date.

(9)	Consists of (i) 47,337 shares directly held and (ii) 14,765 shares of time-vested restricted stock.

(10)	Consists of (i) 168,989 shares directly held, (ii) 14,765 time-vested restricted stock and (iii) 36,920 shares issuable upon the exercise of options that are currently exercisable or will become exercisable within 60 days following the Record Date.

(11)	Consists of (i) 16,989 shares directly held, (ii) 14,765 time-vested restricted stock and (iii) 30,500 shares issuable upon the exercise of options that are currently exercisable or become exercisable within 60 days following the Record Date.

Table of Contents

(12)	Consists of (i) 37,072 shares directly held and (ii) 14,765 shares of time-vested restricted stock.

(13)	Consists of (i) 13,989 shares directly held, (ii) 14,765 shares of time-vested restricted stock and (iii) 35,000 shares issuable upon the exercise of options that are currently exercisable or will become exercisable within 60 days following the Record Date.

Table of Contents

Based on filings made under Section 13(d) and 13(g) of the Exchange Act reporting ownership of shares and percent of beneficial ownership as of December 31, 2017, as of March 26, 2018 the only persons known by us to be beneficial owners of more than 5% of our Common Stock were as follows:

Beneficial Owners of 5% or More of Our Outstanding Common Stock	Shares	Percentage

FMR LLC and certain affiliated parties 245 Summer Street Boston, MA 02210	7,172,255 (1)	10.394%

BlackRock, Inc. 55 East 52^nd Street New York, NY 10055	4,633,563 (2)	6.7%

The Vanguard Group, Inc. 100 Vanguard Blvd. Malvern, PA 19355	5,590,081 (3)	8.10%

(1)

Based on the Amendment No. 5 to Schedule 13G filed with the SEC on February 13, 2018 by FMR LLC, a parent holding company, Abigail P. Johnson, a Director, the Chairman and Chief Executive Officer of FMR LLC and Fidelity Series Intrinsic Opportunities (the “FSIO”). In the Amendment No. 5 to Schedule 13G, (i) FMR LLC discloses it has sole voting power over 339,158 shares and sole dispositive power over 7,172,255 shares, (ii) Ms. Johnson discloses that she has sole dispositive power over 7,172,255 shares and (iii) FSIO discloses that it has sole voting power over 5,939,600 shares. Members of the Johnson family are the predominant owners, directly or through trusts, of the Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC, and through a shareholders’ voting agreement, members of the Johnson family may be deemed to form a controlling group with respect to FMR LLC.

(2)	Based on the Amendment No. 5 to Schedule 13G filed with the SEC on February 8, 2018 by BlackRock, Inc. (“BlackRock”) in which BlackRock discloses that it has sole voting power over 4,409,328 shares and sole dispositive power over 4,633,563 shares.

(3)

Based on the Amendment No. 5 to Schedule 13G filed with the SEC on February 9, 2018 by The Vanguard Group, Inc. (“Vanguard”). In the Amendment No. 5 to Schedule 13G, Vanguard reports it has sole voting power over 77,664 shares, sole dispositive power over 5,516,126 shares, shared voting power of 4,100 shares and shared dispositive power over 73,955 shares.

SECTION 16(A) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE

Our directors, executive officers and holders of more than 10% of our Common Stock are subject to the reporting requirements of Section 16(a) of the Exchange Act, which requires them to file reports with the SEC on Forms 3, 4 and 5 with respect to their ownership and change of ownership of our Common Stock.

Based solely upon a review of the copies of these forms or written representations, which we have received from such persons or entities for transactions in our Common Stock and their Common Stock holdings for our fiscal year ended December 31, 2017, we believe that all reporting requirements under Section 16(a) for such fiscal year were met in a timely manner by our directors, executive officers and holders of more than 10% of our Common Stock, except that there was a failure to timely file Forms 4 by

Table of Contents

certain of our NEOs in connection with exempt tax withholding transactions occurring upon the vesting of awards in 2017 as follows: Messrs. Mantel, Dzura and Gorman (one tax withholding transaction each); Ms. Tolivar and Mr. Hennion (two tax withholding transactions each); and Dr. Ramanathan (three tax withholding transactions). Additionally, Mr. Mantel failed to timely file one Form 4 during 2017 in connection with an acquisition of shares of the Company’s common stock.

Table of Contents

STOCKHOLDER PROPOSALS FOR 2019 ANNUAL MEETING

Stockholder proposals submitted pursuant to Rule 14a-8 of the Exchange Act for our 2019 Annual Meeting must be received by us no later than December 11, 2018 to be presented at the 2019 Annual Meeting or to be eligible for inclusion in the proxy materials related thereto under the SEC’s proxy rules. Such proposals can be sent to us at GNC Holdings, Inc., 300 Sixth Avenue, Pittsburgh, Pennsylvania 15222, Attention: Secretary.

Our Fifth Amended and Restated Bylaws (the “Bylaws”) prescribe the procedures that a record stockholder must follow to nominate directors for election at an annual meeting or to bring other business before an annual meeting (other than matters submitted pursuant to Rule 14a-8 under the Exchange Act). The following summary of these procedures is qualified by reference to our Bylaws, a copy of which can be obtained, without charge, upon written request to GNC Holdings, Inc., 300 Sixth Avenue, Pittsburgh, Pennsylvania 15222, Attention: Secretary.

Pursuant to Article II, Section 5(b) of our Bylaws, a record stockholder must provide timely notice of any stockholder proposal (including director nomination(s)) other than those submitted pursuant to Rule 14a-8 of the Exchange Act to be properly brought before the 2019 Annual Meeting. To be timely, such notice must be received by our secretary at our principal executive offices at 300 Sixth Avenue, Pittsburgh, Pennsylvania 15222 between the opening of business on January 22, 2019 and the close of business on February 21, 2019. The notice must contain the information specified in our Bylaws regarding the stockholder giving the notice and the business proposed to be brought before the meeting. For director nominations, the notice must also contain the information specified in our Bylaws regarding each person whom the stockholder wishes to nominate for election as director and be accompanied by the written consent of each proposed nominee to serve as director if elected. Such stockholder proposals must also be in compliance with the additional requirements set forth in the Bylaws. However, if the date of the 2019 Annual Meeting is more than 30 days before or more than 70 days after May 22, 2019, to be timely, such notice must be received no earlier than the 120th day prior to the date of the 2019 Annual Meeting and not later than (i) the close of business on the 90th day prior to the date of the 2019 Annual Meeting or (ii) the tenth day following the day on which the public announcement of the date of the 2019 Annual Meeting is first made.

With respect to stockholder proposals not included in our proxy statement for the 2018 Annual Meeting, the persons named in the Board’s proxy for the 2019 Annual Meeting will be entitled to exercise the discretionary voting power conferred by such proxy under the circumstances specified in Rule 14a-4(c) under the Exchange Act.

OTHER INFORMATION

Annual Report on Form 10-K

Copies of our Annual Report on Form 10-K can be obtained free of charge upon request to GNC Holdings, Inc., 300 Sixth Avenue, Pittsburgh, Pennsylvania, 15222, Attention: Secretary.

Table of Contents

ANNEX A

Reconciliation of Non-GAAP to GAAP financial metric

Operating income (EBIT) including certain specified adjustments disclosed in our quarterly earnings reports, was used as a performance metric under the 2017 Incentive Plan. Below we have set forth a reconciliation of the adjusted EBIT to the GAAP financial metric. This reconciliation is based upon the Reported EBIT from the Company’s audited financial statements.

GNC HOLDINGS, INC. AND SUBSIDIARIES

Reconciliation of Operating Loss to Adjusted Operating Income

(in thousands, except per share data)

	Year ended December 31,
	2017

Reported	$	(260,413	)
Gains on refranchising		(384	)
Long-lived asset impairments		457,794
Loss on sale of Lucky Vitamin		1,696
Selling, general and administrative⁽¹⁾		7,730
Adjusted	$	206,423

(1)	Includes $3.3 million of executive placement costs primarily related to make-whole stock-based compensation awards including the impact of accelerated vesting associated with a Section 83(b) tax election and $4.4 million of legal-related charges.

Table of Contents

GNC HOLDINGS, INC.

2018 STOCK AND INCENTIVE PLAN

as amended and restated March 30, 2018

ARTICLE I.

PURPOSE

This 2018 Stock and Incentive Plan was originally established under the name GNC Holdings, Inc. 2011 Stock and Incentive Plan and most recently adopted by the Company’s Board of Directors, and approved by the Company’s stockholders as the GNC Holdings, Inc. 2015 Stock and Incentive Plan (the “2015 Plan”) on May 21, 2015. The 2015 Plan hereby is amended, restated, and renamed as set forth herein, effective upon and subject to the approval of the Company’s stockholders. The purpose of the Plan is to enhance the profitability and value of the Company for the benefit of its stockholders by enabling the Company to offer Eligible Employees, Consultants and Non-Employee Directors incentive awards to attract, retain and reward such individuals and strengthen the mutuality of interests between such individuals and the Company’s stockholders.

ARTICLE II.

DEFINITIONS

For purposes of the Plan, the following terms shall have the following meanings:

2.1 “Affiliate” means each of the following: (a) any Subsidiary; (b) any Parent; (c) any corporation, trade or business (including, without limitation, a partnership or limited liability company) that is directly or indirectly controlled 50% or more (whether by ownership of stock, assets or an equivalent ownership interest or voting interest) by the Company; (d) any corporation, trade or business (including, without limitation, a partnership or limited liability company) that directly or indirectly controls 50% or more (whether by ownership of stock, assets or an equivalent ownership interest or voting interest) of the Company; and (e) any other entity in which the Company or any of its Affiliates has a material equity interest and that is designated as an “Affiliate” by resolution of the Committee; provided, however, that if the Common Stock subject to any Award does not constitute “service recipient stock” for purposes of Section 409A of the Code, the Company intends that such award shall be designed to comply with Section 409A of the Code.

2.2 “Appreciation Award” means any Award under this Plan of any Stock Option, Stock Appreciation Right or Other Stock-Based Award, provided that such Other Stock-Based Award is based on the appreciation in value of a share of Common Stock in excess of an amount equal to at least the Fair Market Value of the Common Stock on the date such Other Stock-Based Award is granted.

2.3 “Award” means any award under the Plan of any Stock Option, Stock Appreciation Right, Restricted Stock, Restricted Stock Unit, Performance Share, Performance Share Unit, Performance-Based Cash Award or Other Stock-Based Award. All Awards shall be subject to the terms of a written or electronic agreement executed by the Company and the Participant. Any reference herein to an agreement in writing shall be deemed to include an electronic writing to the extent permitted by applicable law.

Table of Contents

2.4 “Beneficial Owner” shall have the meaning set forth in Rule 13d-3 under the Exchange Act.

2.5 “Board” means the Board of Directors of the Company.

2.6 “Cause” means, except as provided in Article XIII, with respect to a Participant’s Termination of Employment or Termination of Consultancy from and after the date hereof, the following: (a) in the case where there is no employment agreement, consulting agreement, change in control agreement or similar agreement in effect between the Company or an Affiliate and the Participant at the time of the grant of the Award (or where there is such an agreement but it does not define “cause” (or words of like import)), termination due to a Participant’s commission of acts that constitute a felony under applicable federal or state law, insubordination, dishonesty, fraud, incompetence, moral turpitude, misconduct, refusal to perform his or her duties or responsibilities for any reason other than illness or incapacity, or unsatisfactory performance of his or her duties for the Company or an Affiliate, as determined by the Committee in its sole discretion; or (b) in the case where there is an employment agreement, consulting agreement, change in control agreement or similar agreement in effect between the Company or an Affiliate and the Participant at the time of the grant of the Award or an Award agreement that defines “cause” (or words of like import), “cause” as defined under such agreement; provided, however, that with regard to any agreement under which the definition of “cause” only applies on occurrence of a change in control, such definition of “cause” shall not apply until a change in control actually takes place and then only with regard to a termination thereafter. With respect to a Participant’s Termination of Directorship, “cause” means an act or failure to act that constitutes cause for removal of a director under applicable Delaware law.

2.7 “Change in Control” shall be deemed to have occurred, unless otherwise provided in the applicable Award agreement, if an event set forth in any one of the following paragraphs of this Section 2.7 shall have occurred:

(a) any Person is or becomes the Beneficial Owner, directly or indirectly, of securities of the Company (not including in the securities beneficially owned by such Person any securities acquired directly from the Company or its Affiliates) representing thirty percent (30%) or more of the combined voting power of the Company’s then outstanding securities, excluding any Person who becomes such a Beneficial Owner in connection with a transaction described in clause (i) of paragraph (c) below; or

(b) the following individuals cease for any reason to constitute a majority of the number of directors then serving: individuals who, on the Effective Date, constitute the Board and any new director (other than a director whose initial assumption of office is in connection with an actual or threatened election contest, including but not limited to a consent solicitation, relating to the election of directors of the Company) whose appointment or election by the Board or nomination for election by the Company’s shareholders was approved or recommended by a vote of at least two thirds (⅔) of the directors then still in office who either were directors on the Effective Date or whose appointment, election or nomination for election was previously so approved or recommended; or

(c) there is consummated a merger or consolidation of the Company or any direct or indirect subsidiary of the Company with any other corporation, other than (i) a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior to such merger or consolidation continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or any parent thereof), in combination with the ownership of any trustee or other fiduciary holding securities under an employee benefit plan of the Company or any subsidiary of the Company, at least fifty-one percent (51%) of the combined voting power of the securities of the Company or such

Table of Contents

surviving entity or any parent thereof outstanding immediately after such merger or consolidation, or (ii) a merger or consolidation effected to implement a recapitalization of the Company (or similar transaction) in which no Person is or becomes the Beneficial Owner, directly or indirectly, of securities of the Company representing thirty percent (30%) or more of the combined voting power of the Company’s then outstanding securities; or

(d) the shareholders of the Company approve a plan of complete liquidation or dissolution of the Company or there is consummated an agreement for the sale or disposition by the Company of all or substantially all of the Company’s assets, other than a sale or disposition by the Company of all or substantially all of the Company’s assets to an entity, at least fifty-one percent (51%) of the combined voting power of the voting securities of which are owned by shareholders of the Company in substantially the same proportions as their ownership of the Company immediately prior to such sale.

Notwithstanding the foregoing, a “Change in Control” shall not be deemed to have occurred by virtue of the consummation of any transaction or series of integrated transactions immediately following which the record holders of the Common Stock immediately prior to such transaction or series of transactions continue to have substantially the same proportionate ownership in an entity which owns all or substantially all of the assets of the Company immediately following such transaction or series of transactions.

2.8 “Code” means the Internal Revenue Code of 1986, as amended. Any reference to any section of the Code shall also be a reference to any successor provision and any Treasury Regulation promulgated thereunder.

2.9 “Committee” means a committee or subcommittee of the Board appointed from time to time by the Board, which committee or subcommittee shall consist of two or more non-employee directors, each of whom is intended to be, (i) to the extent required by Rule 16b-3 promulgated under Section 16(b) of the Exchange Act, a “non-employee director” as defined in Rule 16b-3; (ii) an “independent director” as defined under Section 303A.02 of the NYSE Listed Company Manual or such other applicable stock exchange rules; and (iii) to the extent required for purposes of compliance with transitional rules under Section 162(m) of the Code, an “outside director” as defined in Section 162(m) of the Code prior to its amendment effective on January 1, 2018. To the extent that no Committee exists that has the authority to administer this Plan, the functions of the Committee shall be exercised by the Board, or subcommittee thereof, and all references herein to the Committee shall be deemed references to the Board. If for any reason the appointed Committee does not meet the requirements, such noncompliance shall not affect the validity of Awards, grants, interpretations or other actions of the Committee. When used herein with respect to Awards granted to Non-Employee Directors administered by the Board, the term Committee shall refer to the Board.

2.10 “Common Stock” means the Class A Common Stock of the Company, par value $0.001 per share.

2.11 “Company” means GNC Holdings, Inc., a Delaware corporation, and its successors by operation of law.

2.12 “Consultant” means any Person who provides bona fide consulting or advisory services to the Company or its Affiliates, provided that such services are not in connection with the offer or sale of securities in a capital raising transaction, and do not, directly or indirectly, promote or maintain a market for the Company’s or its Affiliates’ securities.

2.13 “Detrimental Activity” means:

Table of Contents

(a) disclosing, divulging, furnishing or making available to anyone at any time, except as necessary in the furtherance of Participant’s responsibilities to the Company or any of its Affiliates, either during or subsequent to Participant’s service relationship with the Company or its Affiliates, any knowledge or information with respect to confidential or proprietary information, methods, processes, plans or materials of the Company or any of its Affiliates, or with respect to any other confidential or proprietary aspects of the business of the Company or any of its Affiliates, acquired by the Participant at any time prior to the Participant’s Termination;

(b) (i) any activity while employed or performing services that results, or if known could reasonably be expected to result, in the Participant’s Termination that is classified by the Company as a termination for Cause; (ii) directly or indirectly engaging in conduct that is materially adverse to the interests of the Company, including fraud or conduct contributing to any financial restatements or irregularities;

(c) (i) directly or indirectly soliciting, enticing or inducing any employee of the Company or of any of its Affiliates to be employed by a person, firm or corporation that is, directly or indirectly, in competition with the business or activities of the Company or any of its Affiliates; (ii) directly or indirectly approaching any such employee for these purposes; (iii) authorizing or knowingly approving the taking of such actions by other persons on behalf of any such person, firm or corporation, or assisting any such person, firm or corporation in taking such action; (iv) directly or indirectly soliciting, raiding, enticing or inducing any person, firm or corporation (other than the U.S. Government or its agencies) who or which is, or at any time from and after the date of grant of the Award was, a customer of the Company or of any of its Affiliates to become a customer for the same or similar products or services that it purchased from the Company or any of its Affiliates, or any other person, firm or corporation, or approaching any such customer for such purpose or authorize or knowingly approving the taking of such actions by any other person; or

(d) a material breach of any agreement between the Participant and the Company or an Affiliate (including, without limitation, any employment agreement or noncompetition or nonsolicitation or confidentiality agreement). Unless otherwise determined by the Committee at grant, Detrimental Activity shall not be deemed to occur after the end of the one-year period following the Participant’s Termination or, if longer, the term of the underlying agreement.

For purposes of subsections (a), (c) and (d) above, the Chief Executive Officer of the Company has the authority to provide the Participant with written authorization to engage in the activities contemplated thereby and no other person shall have authority to provide the Participant with such authorization.

2.14 “Disability” means with respect to a Participant’s Termination, a permanent and total disability as defined in Section 22(e)(3) of the Code. A Disability shall only be deemed to occur at the time of the determination by the Committee of the Disability. Notwithstanding the foregoing, for Awards that are subject to Section 409A of the Code, Disability shall mean that a Participant is disabled under Section 409A(a)(2)(C)(i) or (ii) of the Code.

2.15 “Disparagement” means making comments or statements to the press, the Company’s or its Affiliates’ employees, consultants or any individual or entity with whom the Company or its Affiliates has a business relationship that could reasonably be expected to adversely affect in any manner: (a) the conduct of the business of the Company or its Affiliates (including, without limitation, any products or business plans or prospects); or (b) the business reputation of the Company or its Affiliates, or any of their products, or their past or present officers, directors or employees.

2.16 “Effective Date” means the effective date of the Plan as defined in Article XVII.

Table of Contents

2.17 “Eligible Employee” means each employee of the Company or an Affiliate.

2.18 “Exchange Act” means the Securities Exchange Act of 1934, as amended, and all rules and regulations promulgated thereunder. Any references to any section of the Exchange Act shall also be a reference to any successor provision.

2.19 “Fair Market Value” means, unless otherwise required by any applicable provision of the Code or any regulations issued thereunder, as of any date and except as provided below, the closing price reported for the Common Stock on the applicable date: (a) as reported on the principal national securities exchange in the United States on which it is then traded; or (b) if not traded on any such national securities exchange, as quoted on an automated quotation system sponsored by the Financial Industry Regulatory Authority or if the Common Stock shall not have been reported or quoted on such date, on the first day prior thereto on which the Common Stock was reported or quoted. If the Common Stock is not traded, listed or otherwise reported or quoted, then Fair Market Value means the fair market value of the Common Stock as determined by the Committee in good faith in whatever manner it considers appropriate taking into account the requirements of Section 422 of the Code or Section 409A of the Code, as applicable.

2.20 “Family Member” means “family member”, as defined in Section A.1.(5) of the general instructions of Form S-8, as may be amended from time to time.

2.21 “Incentive Stock Option” means any Stock Option awarded to an Eligible Employee of the Company, its Subsidiaries or its Parent (if any) under the Plan intended to be and designated as an “Incentive Stock Option” within the meaning of Section 422 of the Code.

2.22 “Individual Target Award” has the meaning set forth in Section 11.1.

2.23 “Limited Stock Appreciation Right” has the meaning set forth in Section 7.5.

2.24 “Non-Employee Director” means a director of the Company who is not an active employee of the Company or an Affiliate.

2.25 “Non-Qualified Stock Option” means any Stock Option awarded under the Plan that is not an Incentive Stock Option.

2.26 “Other Stock-Based Award” means an Award of Common Stock and other awards (including awards of cash) made pursuant to Article X that is valued in whole or in part by reference to, or is payable in or otherwise based on, Common Stock, including, without limitation, an Award valued by reference to an Affiliate.

2.27 “Parent” means any parent corporation of the Company within the meaning of Section 424(e) of the Code.

2.28 “Participant” means an Eligible Employee, Consultant or Non-Employee Director to whom an Award has been granted pursuant to the Plan.

2.29 “Performance Award” means an Award of Performance Shares or Performance Share Units representing the right to receive Common Stock or cash of an equivalent value made pursuant to Article IX of this Plan in connection with a specified Performance Period.

2.30 “Performance-Based Cash Award” means a cash Award under Article XI that is payable or otherwise based on the attainment of certain pre-established performance criteria during a Performance Period.

Table of Contents

2.31 “Performance Period” means each fiscal year of the Company or such period (as specified by the Committee) over which the performance of any performance criteria (including, the Performance Goals specified in Exhibit A attached hereto) is to be measured.

2.32 “Permissible Transferee” means any Family Member and excluding any third-party financial institutions.

2.33 “Person” means any individual, corporation, partnership, limited liability company, firm, joint venture, association, joint-stock company, trust, incorporated organization, governmental or regulatory or other entity.

2.34 “Plan” means this GNC Holdings, Inc. 2018 Stock and Incentive Plan, as amended from time to time.

2.35 “Reference Stock Option” has the meaning set forth in Section 7.1.

2.36 “Restricted Stock” means an Award of shares of Common Stock issued under the Plan that is subject to restrictions pursuant to Article VIII.

2.37 “Restricted Stock Unit” means an Award of units issued under the Plan that is subject to restrictions pursuant to Article VIII.

2.38 “Restriction Period” has the meaning set forth in Section 8.3(a).

2.39 “Rule 16b-3” means Rule 16b-3 under Section 16(b) of the Exchange Act as then in effect or any successor provision.

2.40 “Section 4.2 Event” has the meaning set forth in Section 4.2(b).

2.41 “Securities Act” means the Securities Act of 1933, as amended, and all rules and regulations promulgated thereunder. Any reference to any section of the Securities Act shall also be a reference to any successor provision.

2.42 “Section 409A of the Code” means the nonqualified deferred compensation rules under Section 409A of the Code and any applicable Treasury regulations thereunder.

2.43 “Stock Appreciation Right” means the right pursuant to an Award granted under Article VII. A Tandem Stock Appreciation Right shall mean the right to surrender to the Company all (or a portion) of a Stock Option in exchange for a number of shares of Common Stock equal to the difference between (i) the Fair Market Value on the date such Stock Option (or such portion thereof) is surrendered, of the Common Stock covered by such Stock Option (or such portion thereof), and (ii) the aggregate exercise price of such Stock Option (or such portion thereof). A Non-Tandem Stock Appreciation Right shall mean the right to receive a number of shares of Common Stock equal to the difference between (x) the Fair Market Value of a share of Common Stock on the date such right is exercised, and (y) the aggregate exercise price of such right, otherwise than on surrender of a Stock Option.

2.44 “Stock Option” or “Option” means any option to purchase shares of Common Stock granted to Eligible Employees, Non-Employee Directors or Consultants pursuant to Article VI.

2.45 “Subsidiary” means any subsidiary corporation of the Company within the meaning of Section 424(f) of the Code.

Table of Contents

2.46 “Tandem Stock Appreciation Rights” has the meaning set forth in Section 7.1.

2.47 “Ten Percent Stockholder” means a person owning stock possessing more than 10% of the total combined voting power of all classes of stock of the Company, its Subsidiaries or its Parent.

2.48 “Termination” means a Termination of Consultancy, Termination of Directorship or Termination of Employment, as applicable.

2.49 “Termination of Consultancy” means: (a) that the Consultant is no longer acting as a consultant to the Company or an Affiliate; or (b) when an entity that is retaining a Participant as a Consultant ceases to be an Affiliate unless the Participant otherwise is, or thereupon becomes, a Consultant to the Company or another Affiliate at the time the entity ceases to be an Affiliate. In the event that a Consultant becomes an Eligible Employee or a Non-Employee Director upon the termination of his or her consultancy, subject to Section 409A of the Code, no Termination of Consultancy shall be deemed to occur until such time as such Consultant is no longer a Consultant, an Eligible Employee or a Non-Employee Director. Notwithstanding the foregoing, subject to Section 409A of the Code, the Committee may, in its sole discretion, otherwise define Termination of Consultancy in the Award agreement or, if no rights of a Participant are reduced, may otherwise define Termination of Consultancy thereafter.

2.50 “Termination of Directorship” means that, subject to Section 409A of the Code, the Non-Employee Director has ceased to be a director of the Company.

2.51 “Termination of Employment” means: (a) a termination of employment (for reasons other than a military or approved personal leave of absence) of a Participant from the Company and its Affiliates; or (b) when an entity that is employing a Participant ceases to be an Affiliate, unless the Participant otherwise is, or thereupon becomes, employed by the Company or another Affiliate at the time the entity ceases to be an Affiliate. In the event that an Eligible Employee becomes a Consultant upon the termination of his or her employment, subject to Section 409A of the Code, no Termination of Employment shall be deemed to occur until such time as such Eligible Employee is no longer an Eligible Employee or a Consultant. Notwithstanding the foregoing, subject to Section 409A of the Code, the Committee may, in its sole discretion, otherwise define Termination of Employment in the Award agreement or, if no rights of a Participant are reduced, may otherwise define Termination of Employment thereafter.

2.52 “Transfer” means: (a) when used as a noun, any direct or indirect transfer, sale, assignment, pledge, hypothecation, encumbrance or other disposition (including the issuance of equity in a Person), whether for value or no value and whether voluntary or involuntary (including by operation of law), and (b) when used as a verb, to directly or indirectly transfer, sell, assign, pledge, encumber, charge, hypothecate or otherwise dispose of (including the issuance of equity in a Person) whether for value or for no value and whether voluntarily or involuntarily (including by operation of law). “Transferred” and “Transferrable” shall have a correlative meaning.

ARTICLE III.

ADMINISTRATION

3.1 The Committee. The Plan shall be administered and interpreted by the Committee. Notwithstanding the foregoing, unless otherwise determined by the Board, the Board shall administer the Plan and otherwise exercise the same authority as the Committee with respect to grants to Non-Employee Directors.

Table of Contents

3.2 Grants of Awards. The Committee shall have full authority to grant, pursuant to the terms of the Plan, to Eligible Employees, Consultants and Non-Employee Directors: (i) Stock Options, (ii) Stock Appreciation Rights, (iii) Restricted Stock, (iv) Restricted Stock Units, (v) Performance Awards, (vi) Other Stock-Based Awards and (vii) Performance‑Based Cash Awards. In particular, the Committee shall have the authority:

(a) to select the Eligible Employees, Consultants and Non-Employee Directors to whom Awards may from time to time be granted hereunder;

(b) to determine whether and to what extent Awards are to be granted hereunder to one or more Eligible Employees, Consultants or Non-Employee Directors;

(c) to determine, in accordance with the terms of the Plan, the number of shares of Common Stock or cash amount to be covered by each Award granted hereunder;

(d) to determine the terms and conditions, not inconsistent with the terms of the Plan, of any Award granted hereunder (including, but not limited to, the exercise or purchase price (if any), any restriction or limitation, any vesting schedule or acceleration thereof, or any forfeiture restrictions or waiver thereof, regarding any Award and the shares of Common Stock relating thereto, based on such factors, if any, as the Committee shall determine, in its sole discretion);

(e) to determine the method(s) of exercise for a Stock Option under Section 6.3(d) and the method(s) of exercise for other Appreciation Awards;

(f) to determine whether a Stock Option is an Incentive Stock Option or Non-Qualified Stock Option;

(g) to determine whether to require an Eligible Employee, Non-Employee Director or Consultant, as a condition of the granting of any Award, not to sell or otherwise dispose of shares of Common Stock acquired pursuant to an Award for a period of time as determined by the Committee, in its sole discretion, following the date of the Award;

(h) to set the performance criteria and the Performance Period with respect to any Award for which the grant, vesting or payment of such Award is conditioned upon the attainment of specified performance criteria and to certify the attainment of any such performance criteria;

(i) to determine whether, to what extent and under what circumstances grants of Options and other Awards under this Plan are to operate on a tandem basis and/or in conjunction with or apart from other awards made by the Company outside of this Plan;

(j) to determine whether, to what extent and under what circumstances Common Stock and other amounts payable with respect to an Award under this Plan shall be deferred either automatically or at the election of the Participant in any case, in a manner intended to comply with Section 409A of the Code; and

(k) generally, to exercise such powers and to perform such acts as the Committee deems necessary or expedient to promote the best interests of the Company, including without limitation delegation to appropriate officers of the Company, that are not in conflict with the provisions of the Plan.

3.3 Guidelines. Subject to Article XIV, the Committee shall, in its sole discretion, have the authority to adopt, alter and repeal such administrative rules, guidelines and practices governing the Plan

Table of Contents

and perform all acts, including the delegation of its administrative responsibilities (to the extent permitted by applicable law and applicable stock exchange rules), as it shall, from time to time, deem advisable; to construe and interpret the terms and provisions of the Plan and any Award granted under the Plan (and any agreements relating thereto); and to otherwise supervise the administration of the Plan. The Committee may, in its sole discretion, correct any defect, supply any omission or reconcile any inconsistency in the Plan or in any agreement relating thereto in the manner and to the extent it shall deem necessary to effectuate the purpose and intent of the Plan. The Committee may, in its sole discretion, adopt special guidelines and provisions for persons who are residing in or employed in, or subject to, the taxes of, any domestic or foreign jurisdictions to comply with applicable tax and securities laws and may impose any limitations and restrictions that it deems necessary to comply with the applicable tax and securities laws of such domestic or foreign jurisdictions. To the extent applicable, the Plan is intended to comply with the applicable requirements of Rule 16b-3 and this Plan shall be limited, construed and interpreted in a manner so as to comply therewith.

3.4 Decisions Final. Any decision, interpretation or other action made or taken in good faith by or at the direction of the Company, the Board or the Committee (or any of its members) arising out of or in connection with the Plan shall be within the absolute discretion of all and each of them, as the case may be, and shall be final, binding and conclusive on the Company and all employees and Participants and their respective heirs, executors, administrators, successors and assigns.

3.5 Procedures. If the Committee is appointed, the Board shall designate one of the members of the Committee as chairman and the Committee shall hold meetings, subject to the By‑Laws of the Company, at such times and places as it shall deem advisable, including, without limitation, by telephone conference or by written consent to the extent permitted by applicable law. A majority of the Committee members shall constitute a quorum. All determinations of the Committee shall be made by a majority of its members. Any decision or determination reduced to writing and signed by all the Committee members in accordance with the By‑Laws of the Company, shall be as fully effective as if it had been made by a vote at a meeting duly called and held. The Committee shall keep minutes of its meetings and shall make such rules and regulations for the conduct of its business as it shall deem advisable.

3.6 Designation of Consultants/Liability. (a) The Committee may, in its sole discretion and to the extent permitted by applicable law and applicable exchange rules, designate employees of the Company and professional advisors to assist the Committee in the administration of the Plan and may grant authority to officers to execute agreements or other documents on behalf of the Committee.

(b) The Committee may, in its sole discretion, employ such legal counsel, consultants and agents as it may deem desirable for the administration of the Plan and may rely upon any opinion received from any such counsel or consultant and any computation received from any such consultant or agent. Expenses incurred by the Committee or the Board in the engagement of any such counsel, consultant or agent shall be paid by the Company. The Committee, its members and any person designated pursuant to this Section 3.6 shall not be liable for any action or determination made in good faith with respect to the Plan. To the maximum extent permitted by applicable law, no officer of the Company or member or former member of the Committee or of the Board shall be liable for any action or determination made in good faith with respect to the Plan or any Award granted under it.

3.7 Indemnification. To the maximum extent permitted by applicable law and the Certificate of Incorporation and By‑Laws of the Company and to the extent not covered by insurance directly insuring such person, each officer or employee of the Company or any Affiliate and member or former member of the Committee or the Board shall be indemnified and held harmless by the Company against any cost or expense (including reasonable fees of counsel reasonably acceptable to the Committee) or liability (including any sum paid in settlement of a claim with the approval of the Committee), and advanced amounts necessary to pay the foregoing at the earliest time and to the fullest

Table of Contents

extent permitted, arising out of any act or omission to act in connection with the administration of the Plan, except to the extent arising out of such officer’s, employee’s, member’s or former member’s own fraud or bad faith. Such indemnification shall be in addition to any rights of indemnification the employees, officers, directors or members or former officers, directors or members may have under applicable law or under the Certificate of Incorporation or By‑Laws of the Company or any Affiliate. Notwithstanding anything else herein, this indemnification will not apply to the actions or determinations made by an individual with regard to Awards granted to him or her under the Plan.

ARTICLE IV.

SHARE LIMITATIONS

4.1 Shares

(a) General Limitations. The aggregate number of shares of Common Stock that may be issued or used for reference purposes or with respect to which Awards may be granted under this Plan is the sum of (i) the number of shares of Common Stock available under the Plan immediately prior to shareholder approval of this Plan as amended, which shares shall remain available for grants of Awards, and (ii) 8,720,000 shares of Common Stock (subject to any increase or decrease pursuant to Section 4.2), which may be either authorized and unissued Common Stock or Common Stock held in or acquired for the treasury of the Company or both. Any shares of Common Stock that are subject to Restricted Stock, Restricted Stock Units, Performance Awards or Other Stock-Based Awards that are not Appreciation Awards shall be counted against this limit as 1.8 shares for every share granted. If any Option, Stock Appreciation Right or Other Stock-Based Award that is an Appreciation Award granted under this Plan expires, terminates or is canceled for any reason without having been exercised in full, the number of shares of Common Stock underlying any unexercised Award shall again be available for the purpose of Awards under this Plan. If any shares of Restricted Stock, Restricted Stock Units, Performance Awards or Other Stock-Based Awards that are not Appreciation Awards granted under this Plan to a Participant are forfeited for any reason, 1.8 shares of Common Stock shall again be available for the purposes of Awards under this Plan. If a Tandem Stock Appreciation Right or a Limited Stock Appreciation Right is granted in tandem with an Option, such grant shall only apply once against the maximum number of shares of Common Stock which may be issued under this Plan. The number of shares of Common Stock available for the purpose of Awards under this Plan shall be reduced by (i) the total number of Stock Options or Stock Appreciation Rights exercised, regardless of whether any of the shares of Common Stock underlying such Awards are not actually issued to the Participant as the result of a net settlement, and (ii) any shares of Common Stock used to pay any exercise price or tax withholding obligation with respect to any Award. In addition, the Company may not use the cash proceeds it receives from Stock Option exercises to repurchase shares of Common Stock on the open market for reuse under this Plan. Awards that may be settled solely in cash shall not be deemed to use any shares of Common Stock which may be issued under this Plan.

(b) Individual Participation Limitations. The individual limits on Awards that may be granted under the Plan set forth in this Section 4.1(b) shall be effective for all Awards granted following shareholder approval of the Plan, as amended:

(i) The maximum number of shares of Common Stock subject to Stock Options, Stock Appreciation Rights and other purchase rights constituting Appreciation Awards which may be granted under this Plan during any fiscal year of the Company to each Eligible Employee or Consultant shall not exceed 1,500,000 (which shall be subject to any further increase or decrease pursuant to Section 4.2). If a Tandem Stock Appreciation Right is granted or a Limited Stock Appreciation Right is granted in

Table of Contents

tandem with a Stock Option, it shall apply against the Eligible Employee’s or Consultant’s individual share limitations.

(ii) For Eligible Employees and Consultants, the maximum number of shares of Restricted Stock or Performance Shares awarded or shares represented under any Restricted Stock Unit or Performance Share Unit during any calendar year shall be 800,000 shares per award type, subject to adjustment as provided in the Plan. The maximum payment under any Performance‑Based Cash Award payable with respect to any calendar year to each Eligible Employee or Consultant shall be $5,000,000.

(iii) No Non‑Employee Director may be granted in any calendar year Awards in respect of the Non-Employee Director’s service as a member of the Board, including service as a member or chair of any committees of the Board, with a value in excess of $500,000, with the value of any Award based on the accounting grant date value of such Award.

4.2 Changes.

(a) The existence of the Plan and the Awards granted hereunder shall not affect in any way the right or power of the Board or the stockholders of the Company to make or authorize (i) any adjustment, recapitalization, reorganization or other change in the Company’s capital structure or its business, (ii) any merger or consolidation of the Company or any Affiliate, (iii) any issuance of bonds, debentures, preferred or prior preference stock ahead of or affecting the Common Stock, (iv) the dissolution or liquidation of the Company or any Affiliate, (v) any sale or transfer of all or part of the assets or business of the Company or any Affiliate, (vi) any Section 4.2 Event or (vii) any other corporate act or proceeding.

(b) In the event of any change in the capital structure or business of the Company by reason of any stock split, reverse stock split, stock dividend, combination or reclassification of shares, recapitalization, merger, consolidation, spin‑off, reorganization, partial or complete liquidation, issuance of rights or warrants to purchase any Common Stock or securities convertible into Common Stock, any sale or transfer of all or part of the Company’s assets or business, or any other corporate transaction or event having an effect similar to any of the foregoing and effected without receipt of consideration by the Company (a “Section 4.2 Event”) then the Committee shall make such adjustments consistent with such change in such manner as the Committee deems equitable to prevent substantial dilution or enlargement of the rights granted to, or available for, Participants under this Plan, to (i) the aggregate number and kind of shares that thereafter may be issued under the Plan, (ii) the number and kind of shares or other property (including cash) to be issued upon exercise of an outstanding Award or under other Awards granted under the Plan and (iii) the purchase price thereof, and/or the individual Participant limits set forth or referenced in Section 4.1(b) (other than those based on cash limitations). Any such adjustment determined by the Committee in good faith shall be final, binding and conclusive on the Company and all Participants and their respective heirs, executors, administrators, successors and assigns. In connection with any Section 4.2 Event, the Committee may provide, in its sole discretion, for the cancellation of any outstanding Awards and payment in cash or other property in exchange therefor. Except as provided in this Section 4.2 or in the applicable Award agreement, a Participant shall have no rights by reason of any issuance by the Company of any class of securities convertible into stock of any class, any subdivision or consolidation of shares of stock of any class, the payment of any stock dividend, any other increase or decrease in the number of shares of stock of any class, any sale or transfer of all or part of the Company’s assets or business or any other change affecting the Company’s capital structure or business.

Table of Contents

(c) Fractional shares of Common Stock resulting from any adjustment in Awards pursuant to Section 4.2(a) or (b) shall be eliminated at the time of such adjustment by rounding‑down for any fractional shares. No fractional shares of Common Stock shall be issued under the Plan. Notice of any adjustment shall be given by the Committee to each Participant whose Award has been adjusted and such adjustment (whether or not such notice is given) shall be effective and binding for all purposes of the Plan.

4.3 Minimum Purchase Price. Notwithstanding any provision of the Plan to the contrary, if authorized but previously unissued shares of Common Stock are issued under the Plan, such shares shall not be issued for a consideration that is less than as permitted under applicable law.

ARTICLE V.

ELIGIBILITY AND GENERAL REQUIREMENTS FOR AWARDS

5.1 General Eligibility. All Eligible Employees, Non-Employee Directors and Consultants and prospective Eligible Employees, Consultants and Non-Employee Directors are eligible to be granted Awards. Eligibility for the grant of Awards and actual participation in this Plan shall be determined by the Committee in its sole discretion. Notwithstanding anything herein to the contrary, no Award under which a Participant may receive shares of Common Stock may be granted under this Plan to an Eligible Employee, Consultant or Non-Employee Director of any Affiliate if such shares of Common Stock do not constitute “service recipient stock” for purposes of Section 409A of the Code with respect to such Eligible Employee, Consultant or Non-Employee Director.

5.2 Incentive Stock Options. Notwithstanding anything herein to the contrary, only Eligible Employees of the Company, its Subsidiaries and its Parent (if any) are eligible to be granted Incentive Stock Options under the Plan. Eligibility for the grant of an Incentive Stock Option and actual participation in the Plan shall be determined by the Committee in its sole discretion.

5.3 General Requirement. The granting, vesting and exercise of Awards granted to a prospective Eligible Employee, Consultant or Non-Employee Director are conditioned upon such individual actually becoming an Eligible Employee, Consultant or Non-Employee Director, provided that no Award may be granted to a prospective Eligible Employee, Consultant or Non-Employee Director unless the Company determines that the Award will comply with applicable laws, including the securities laws of all relevant jurisdictions.

5.4 Minimum Vesting Period for Awards. Notwithstanding anything to the contrary herein, the minimum vesting schedule applicable to Awards shall provide for vesting over a service period of no less than one year, with ratable vesting only permitted following the one year anniversary of grant, except in the case of a participant’s death or Disability; and provided, however, that this limitation shall not apply to Awards granted for up to an aggregate of five percent of the maximum number of shares of Common Stock that may be issued under this Plan, which may be issued without minimum vesting requirements. The minimum vesting provisions may be satisfied by reference to the vesting or performance period of any such other compensation or incentive plan, program or arrangement the obligations of which are satisfied through the use of Awards under the Plan.

5.5 Treatment of Dividends and Dividend Equivalents on Unvested Awards. Notwithstanding any other provision of the Plan to the contrary, with respect to any Award that provides for or includes a right to dividends or dividend equivalents, if dividends are declared during the period that an equity Award is outstanding, such dividends (or dividend equivalents) shall either (i) not be paid or credited with respect to such Award or (ii) be accumulated but remain subject to vesting requirement(s) to the same extent as the applicable Award and shall only be paid at the time or times such vesting requirement(s) are satisfied.

Table of Contents

ARTICLE VI.

STOCK OPTIONS

6.1 Stock Options. Stock Options may be granted alone or in addition to other Awards granted under the Plan. Each Stock Option granted under the Plan shall be one of two types: (a) an Incentive Stock Option; or (b) a Non-Qualified Stock Option.

6.2 Grants. The Committee shall, in its sole discretion, have the authority to grant to any Eligible Employee (subject to Section 5.2) Incentive Stock Options, Non-Qualified Stock Options or both types of Stock Options, but not in tandem. To the extent that any Stock Option does not qualify as an Incentive Stock Option (whether because of its provisions or the time or manner of its exercise or otherwise), such Stock Option or the portion thereof that does not qualify, shall constitute a separate Non-Qualified Stock Option. The Committee shall, in its sole discretion, have the authority to grant any Consultant or Non-Employee Director one or more Non-Qualified Stock Options.

6.3 Terms of Stock Options. Stock Options granted under the Plan shall be subject to the following terms and conditions, and shall be in such form and contain such additional terms and conditions, not inconsistent with the terms of the Plan, as the Committee, in its sole discretion, shall deem desirable:

(a) Exercise Price. The exercise price per share of Common Stock subject to a Stock Option shall be determined by the Committee at the time of grant, provided that the per share exercise price of a Stock Option shall not be less than 100% (or, in the case of an Incentive Stock Option granted to a Ten Percent Stockholder, 110%) of the Fair Market Value of the Common Stock at the time of grant.

(b) Stock Option Term. The term of each Stock Option shall be fixed by the Committee; provided, that (i) no Stock Option shall be exercisable more than 10 years after the date such Stock Option is granted; and (ii) the term of an Incentive Stock Option granted to a Ten Percent Stockholder shall not exceed five years.

(c) Exercisability. Subject to Section 5.4, Stock Options shall be exercisable at such time or times and subject to such terms and conditions as shall be determined by the Committee at the time of grant. Subject to Section 5.4, if the Committee provides, in its discretion, that any Stock Option is exercisable subject to certain limitations (including, without limitation, that such Stock Option is exercisable only in installments or within certain time periods or upon the attainment of certain financial results or other criteria), the Committee may waive such limitations on the exercisability at any time at or after grant in whole or in part (including, without limitation, waiver of the installment exercise provisions or acceleration of the time at which such Stock Option may be exercised), based on such factors, if any, as the Committee shall determine, in its sole discretion. The Option terms shall provide that (i) in the event the Participant engages in Detrimental Activity prior to any exercise of the Stock Option, all Stock Options held by the Participant shall thereupon terminate and expire, (ii) as a condition of the exercise of a Stock Option, the Participant shall be required to certify (or shall be deemed to have certified) at the time of exercise in a manner acceptable to the Company that the Participant is in compliance with the terms and conditions of the Plan and that the Participant has not engaged in, and does not intend to engage in, any Detrimental Activity, and (iii) in the event the Participant engages in Detrimental Activity during the one-year period commencing on the later of the date the Stock Option is exercised or the date of the Participant’s Termination, the Company shall be entitled to recover from the Participant at any time within one year after such date, and the Participant shall pay over to the Company, an amount equal to any gain realized as a result of the exercise (whether at the time of exercise or thereafter). In the event that a written employment

Table of Contents

agreement between the Company and a Participant provides for a vesting schedule that is more favorable than the vesting schedule provided in the form of Award agreement, the vesting schedule in such employment agreement shall govern, provided that such agreement is in effect on the date of grant and applicable to the specific Award.

(d) Method of Exercise. Subject to whatever installment exercise and waiting period provisions apply under subsection (c) above, to the extent vested, a Stock Option may be exercised in whole or in part at any time and from time to time during the Stock Option term by giving written notice of exercise to the Company specifying the number of shares of Common Stock to be acquired. Such notice shall be accompanied by payment in full of the purchase price as follows: (i) in cash or by check, bank draft or money order payable to the order of the Company; (ii) solely to the extent permitted by applicable law, if the Common Stock is traded on a national securities exchange or quoted on a national quotation system sponsored by the National Association of Securities Dealers, through a procedure whereby the Participant delivers irrevocable instructions to a broker reasonably acceptable to the Committee to deliver promptly to the Company an amount equal to the purchase price, to the extent authorized by the Committee; or (iii) on such other terms and conditions as may be acceptable to the Committee (including, without limitation, the net withholding of shares of Common Stock through relinquishment of Stock Options or by payment in full or in part in the form of Common Stock owned by the Participant and for which the Participant has good title free and clear of any liens and encumbrances) based on the Fair Market Value of the Common Stock on the payment date as determined by the Committee, in its sole discretion. No shares of Common Stock shall be issued until payment therefor, as provided herein, has been made or provided for.

(e) Incentive Stock Option Limitations. To the extent that the aggregate Fair Market Value (determined as of the time of grant) of the Common Stock with respect to which Incentive Stock Options are exercisable for the first time by an Eligible Employee during any calendar year under the Plan and/or any other stock option plan of the Company, any Subsidiary or any Parent exceeds $100,000, such Options shall be treated as Non-Qualified Stock Options. In addition, if an Eligible Employee does not remain employed by the Company, any Subsidiary or any Parent at all times from the time an Incentive Stock Option is granted until three months prior to the date of exercise thereof (or such other period as required by applicable law), such Stock Option shall be treated as a Non-Qualified Stock Option. Should any provision of the Plan not be necessary in order for the Stock Options to qualify as Incentive Stock Options, or should any additional provisions be required, the Committee may, in its sole discretion, amend the Plan accordingly, without the necessity of obtaining the approval of the stockholders of the Company.

(f) Form, Modification, Extension and Renewal of Stock Options. Subject to the terms and conditions and within the limitations of the Plan, Stock Options shall be evidenced by such form of agreement or grant as is approved by the Committee, and the Committee may, in its sole discretion, alter or amend Award Agreements to the extent permitted by law, provided that (i) the rights of a Participant are not reduced or adversely affected without his or her consent and (ii) such action does not subject the Stock Options to Section 409A of the Code. Notwithstanding anything herein to the contrary, an Appreciation Award may not be modified to reduce the exercise price thereof nor may a new Option, Stock Appreciation Right or other purchase right at a lower price be substituted for a surrendered Option, Stock Appreciation Right or other purchase right or any repricing of such awards be accomplished through cancellation or repurchase (other than adjustments or substitutions in accordance with Section 4.2), unless such action is approved by the stockholders of the Company.

(g) Other Terms and Conditions. Stock Options may contain such other provisions, which shall not be inconsistent with any of the terms of the Plan, as the Committee shall, in its sole discretion, deem appropriate.

Table of Contents

(h) No Dividends. No dividend equivalents may be paid or advanced with respect to any Appreciation Award.

ARTICLE VII.

STOCK APPRECIATION RIGHTS

7.1 Tandem Stock Appreciation Rights. Stock Appreciation Rights may be granted in conjunction with all or part of any Stock Option (a “Reference Stock Option”) granted under this Plan (“Tandem Stock Appreciation Rights”). In the case of a Non-Qualified Stock Option, such rights may be granted either at or after the time of the grant of such Reference Stock Option. In the case of an Incentive Stock Option, such rights may be granted only at the time of the grant of such Reference Stock Option.

7.2 Terms and Conditions of Tandem Stock Appreciation Rights. Tandem Stock Appreciation Rights granted hereunder shall be subject to such terms and conditions, not inconsistent with the provisions of this Plan, as shall be determined from time to time by the Committee in its sole discretion, and the following:

(a) Exercise Price. The exercise price per share of Common Stock subject to a Tandem Stock Appreciation Right shall be the exercise price of the Reference Stock Option as determined in accordance with Section 6.3(a).

(b) Term. A Tandem Stock Appreciation Right or applicable portion thereof granted with respect to a Reference Stock Option shall terminate and no longer be exercisable upon the termination or exercise of the Reference Stock Option, except that, unless otherwise determined by the Committee, in its sole discretion, at the time of grant, a Tandem Stock Appreciation Right granted with respect to less than the full number of shares covered by the Reference Stock Option shall not be reduced until and then only to the extent the exercise or termination of the Reference Stock Option causes the number of shares covered by the Tandem Stock Appreciation Right to exceed the number of shares remaining available and unexercised under the Reference Stock Option.

(c) Exercisability. Tandem Stock Appreciation Rights shall be exercisable only at such time or times and to the extent that the Reference Stock Options to which they relate shall be exercisable in accordance with the provisions of Article VI and Section 12.2, and shall be subject to the provisions of Section 6.3(c) and, by reference, Section 5.4. Tandem Stock Appreciation Rights granted in connection with an Incentive Stock Option are not exercisable unless the then fair market value of the Common Stock exceeds the exercise price of the tandem Option.

(d) Method of Exercise. A Tandem Stock Appreciation Right may be exercised by the Participant by surrendering the applicable portion of the Reference Stock Option. Upon such exercise and surrender, the Participant shall be entitled to receive an amount determined in the manner prescribed in this Section 7.2. Stock Options which have been so surrendered, in whole or in part, shall no longer be exercisable to the extent the related Tandem Stock Appreciation Rights have been exercised.

(e) Payment. Upon the exercise of a Tandem Stock Appreciation Right, a Participant shall be entitled to receive up to, but no more than, a number of shares of Common Stock equal in value to the excess of the Fair Market Value of one share of Common Stock over the Option exercise price per share specified in the Reference Stock Option agreement,

Table of Contents

multiplied by the number of shares in respect of which the Tandem Stock Appreciation Right shall have been exercised.

(f) Deemed Exercise of Reference Stock Option. Upon the exercise of a Tandem Stock Appreciation Right, the Reference Stock Option or part thereof to which such Stock Appreciation Right is related shall be deemed to have been exercised for the purpose of the limitation set forth in Article IV of the Plan on the number of shares of Common Stock to be issued under the Plan.

(g) Transferability. Tandem Stock Appreciation Rights shall be Transferable only when and to the extent that the underlying Stock Option would be Transferable under Section 12.1 of the Plan.

7.3 Non-Tandem Stock Appreciation Rights. Non-Tandem Stock Appreciation Rights may also be granted without reference to any Reference Stock Options granted under the Plan.

7.4 Terms and Conditions of Non-Tandem Stock Appreciation Rights. Non-Tandem Stock Appreciation Rights granted hereunder shall be subject to such terms and conditions, not inconsistent with the provisions of this Plan, as shall be determined from time to time by the Committee in its sole discretion, and the following:

(a) Exercise Price. The exercise price per share of Common Stock subject to a Non-Tandem Stock Appreciation Right shall be determined by the Committee at the time of grant, provided that the per share exercise price of a Non-Tandem Stock Appreciation Right shall not be less than 100% of the Fair Market Value of the Common Stock at the time of grant.

(b) Term. The term of each Non-Tandem Stock Appreciation Right shall be fixed by the Committee; provided that no Non-Tandem Stock Appreciation Right shall be exercisable more than ten (10) years after the date the right is granted.

(c) Exercisability. Subject to Section 5.4, Non-Tandem Stock Appreciation Rights shall be exercisable at such time or times and subject to such terms and conditions as shall be determined by the Committee at grant. Subject to Section 5.4, the Committee provides, in its discretion, that any such right is exercisable subject to certain limitations (including, without limitation, that it is exercisable only in installments or within certain time periods), the Committee may waive such limitations on the exercisability at any time at or after grant in whole or in part (including, without limitation, waiver of the installment exercise provisions or acceleration of the time at which such right may be exercised), based on such factors, if any, as the Committee shall determine, in its sole discretion. The Award terms shall provide that (i) in the event the Participant engages in Detrimental Activity prior to any exercise of the Non-Tandem Stock Appreciation Right, all Non-Tandem Stock Appreciation Rights held by the Participant shall thereupon terminate and expire, (ii) as a condition of the exercise of a Non-Tandem Stock Appreciation Right, the Participant shall be required to certify (or shall be deemed to have certified) at the time of exercise in a manner acceptable to the Company that the Participant is in compliance with the terms and conditions of this Plan and that the Participant has not engaged in, and does not intend to engage in, any Detrimental Activity, and (iii) in the event the Participant engages in Detrimental Activity during the one year period commencing on the later of the date the Non-Tandem Stock Appreciation Right is exercised or becomes vested, the Company shall be entitled to recover from the Participant at any time within one year after such exercise or vesting, and the Participant shall pay over to the Company, an amount equal to any gain realized as a result of the exercise (whether at the time of exercise or thereafter).

Table of Contents

(d) Method of Exercise. Subject to whatever installment exercise and waiting period provisions apply under subsection (c) above, Non-Tandem Stock Appreciation Rights may be exercised in whole or in part at any time in accordance with the applicable Award agreement, by giving written notice of exercise to the Company specifying the number of Non-Tandem Stock Appreciation Rights to be exercised.

(e) Payment. Upon the exercise of a Non-Tandem Stock Appreciation Right a Participant shall be entitled to receive, for each right exercised, up to, but no more than, a number of shares of Common Stock equal in value to the excess of the Fair Market Value of one share of Common Stock on the date the right is exercised over the Fair Market Value of one share of Common Stock on the date the right was awarded to the Participant.

(f) Non-Transferability. No Non-Tandem Stock Appreciation Rights shall be Transferable by the Participant otherwise than by Will or by the laws of descent and distribution, and all such rights shall be exercisable, during the Participant’s lifetime, only by the Participant.

(g) Termination. Unless otherwise provided in an Award agreement, upon Termination, Non-Tandem Stock Appreciation Rights shall be exercised in accordance with the provisions of Section 12.2 of this Plan.

7.5 Limited Stock Appreciation Rights. The Committee may, in its sole discretion, grant Tandem and Non-Tandem Stock Appreciation Rights either as a general Stock Appreciation Right or as a limited stock appreciation right (a “Limited Stock Appreciation Right”). Limited Stock Appreciation Rights may be exercised only upon the occurrence of a Change in Control or such other event as the Committee may, in its sole discretion, designate at the time of grant or thereafter. Upon the exercise of Limited Stock Appreciation Rights, except as otherwise provided in an Award agreement, the Participant shall receive a number of shares of Common Stock equal to the amount (a) set forth in Section 7.2(e) with respect to Tandem Stock Appreciation Rights, or (b) set forth in Section 7.4(e) with respect to Non-Tandem Stock Appreciation Rights, as applicable.

ARTICLE VIII.

RESTRICTED STOCK AND RESTRICTED STOCK UNITS

8.1 Awards of Restricted Stock and Restricted Stock Units. Restricted Stock and Restricted Stock Units may be issued either alone or in addition to other Awards granted under the Plan. The Committee shall, in its sole discretion, determine the Eligible Employees, Consultants and Non-Employee Directors to whom, and the time or times within which, grants of Restricted Stock or Restricted Stock Units will be made, the number of shares or units to be awarded, the purchase price (if any) to be paid by the Participant (subject to Section 4.3), the time or times at which such Awards may be subject to forfeiture (if any), the vesting schedule (if any) and rights to acceleration thereof (subject to Section 5.4), and all other terms and conditions of the Awards.

Each Award of Restricted Stock and Restricted Stock Units shall provide that in the event the Participant engages in Detrimental Activity prior to, or during the one-year period after, any vesting of Restricted Stock or Restricted Stock Units, all unvested Restricted Stock and Restricted Stock Units shall be immediately forfeited to the Company and the Company shall be entitled to recover from the Participant an amount equal to the Fair Market Value at the time of vesting of any Restricted Stock and Restricted Stock Units that had vested in the period referred to above.

Table of Contents

The Committee may condition the grant or vesting of Restricted Stock and Restricted Stock Units upon the attainment of specified performance criteria (including, the Performance Goals specified in Exhibit A attached hereto) or such other factors as the Committee may determine, in its sole discretion.

8.2 Awards and Certificates. An Eligible Employee, Consultant and Non-Employee Director selected to receive Restricted Stock or Restricted Stock Units shall not have any rights with respect to such Award, unless and until such Participant has delivered a fully executed copy of the Award agreement evidencing the Award to the Company and has otherwise complied with the applicable terms and conditions of such Award. Further, such Award shall be subject to the following conditions:

(a) Purchase Price. The purchase price (if any) of Restricted Stock or Restricted Stock Units shall be determined by the Committee, but shall not be less than as permitted under applicable law.

(b) Acceptance. Awards of Restricted Stock or Restricted Stock Units must be accepted within a period of 60 days (or such shorter period as the Committee may specify at grant) after the grant date, by executing an Award agreement and by paying whatever price (if any) the Committee has designated thereunder and all applicable withholding taxes due upon the granting and acceptance of the Award (if any) in accordance with the provisions of Section 16.4.

(c) Legend. Each Participant receiving Restricted Stock shall be issued a stock certificate in respect of such shares of Restricted Stock, unless the Committee elects to use another system, such as book entries by the transfer agent, as evidencing ownership of Restricted Stock. Such certificate shall, in addition to such legends required by applicable securities laws, be registered in the name of such Participant, and shall bear an appropriate legend referring to the terms, conditions, and restrictions applicable to such Award, substantially in the following form:

“The anticipation, alienation, attachment, sale, transfer, assignment, pledge, encumbrance or charge of the shares of stock represented hereby are subject to the terms and conditions (including forfeiture) of the GNC Holdings, Inc. (the “Company”) 2018 Stock and Incentive Plan (as the same may be amended or supplemented from time to time), and an Award agreement entered into between the registered owner and the Company dated ____________. Copies of such Plan and Award agreement are on file at the principal office of the Company.”

(d) Custody. The Committee may require that any stock certificates evidencing such shares be held in custody by the Company until the restrictions thereon shall have lapsed, and that, as a condition of any grant of Restricted Stock, the Participant shall have delivered a duly signed stock power, endorsed in blank, relating to the Common Stock covered by such Award.

8.3 Restrictions and Conditions. The shares of Restricted Stock and Restricted Stock Units awarded pursuant to this Plan shall be subject to the following restrictions and conditions:

(a) Restriction Period. (i) The Participant shall not be permitted to Transfer shares of Restricted Stock or Restricted Stock Units awarded under this Plan during the period or periods set by the Committee (the “Restriction Period”) commencing on the date of such Award, as set forth in the Restricted Stock or Restricted Stock Unit Award agreement and such agreement shall set forth a vesting schedule and any events which would accelerate vesting of the shares of Restricted Stock or Restricted Stock Units. Within these limits, based on service, attainment of performance criteria pursuant to Section 8.3(b) below and/or such other factors or criteria as the Committee may determine in its sole discretion, the Committee may condition the grant or provide for the lapse of such restrictions in installments in whole or in part, or may accelerate the vesting of all or any part of any Restricted Stock or Restricted Stock Unit and/or

Table of Contents

waive the deferral limitations for all or any part of any Restricted Stock or Restricted Stock Unit. Notwithstanding the foregoing, the restriction period applicable to Restricted Stock or Restricted Stock Unit shall be subject to Section 5.4; and the Committee may accelerate vesting of, or waive the restrictions with respect to, Restricted Stock or Restricted Stock Units in the case of death, Disability, retirement, involuntary termination other than for Cause, or Change in Control.

(b) Objective Performance Goals, Formulae or Standards. If the grant of shares of Restricted Stock or Restricted Stock Units or the lapse of restrictions is based on the attainment of performance criteria, the Committee shall, in its sole discretion, establish the objective performance criteria and the applicable vesting percentage of the Restricted Stock or Restricted Stock Units applicable to each Participant or class of Participants in writing prior to the beginning of the applicable Performance Period or at such later date while the outcome of the Performance Goals are substantially uncertain as otherwise determined by the Committee in its sole discretion. Such performance criteria may incorporate provisions for disregarding (or adjusting for) changes in accounting methods, corporate transactions (including, without limitation, dispositions and acquisitions) and other similar type events or circumstances. The Committee may in its discretion also determine to use other objective performance measures than those set forth in Exhibit A hereto for Restricted Stock or Restricted Stock Units.

(c) Rights as Stockholder. Except as provided in this subsection and subsection (a) above and as otherwise determined by the Committee, the Participant shall have, with respect to the shares of Restricted Stock, all of the rights of a holder of shares of Common Stock of the Company including, without limitation, the right to vote such shares and, subject to and conditioned upon the full vesting of shares of Restricted Stock, the right to tender such shares and the right to receive any dividends, provided, however, no dividends may be paid until, and are conditioned upon, the vesting of the Restricted Share Award. Holders of Restricted Stock Units shall not have the rights of stockholders until shares of Common Stock are issued in satisfaction thereof, but may have dividend equivalent rights, as determined by the Committee; provided, however, no dividends equivalent rights may be paid until, and are conditioned upon, the vesting of the Restricted Stock Unit Award.

(d) Termination. Unless otherwise determined by the Committee at grant or, if no rights of the Participant are reduced, thereafter, subject to the applicable provisions of the Restricted Stock or Restricted Stock Unit Award agreement and this Plan, upon a Participant’s Termination for any reason during the relevant Restriction Period, all Restricted Stock and Restricted Stock Units still subject to restriction will vest or be forfeited in accordance with the terms and conditions established by the Committee at grant or thereafter.

(e) Lapse of Restrictions. If and when the Restriction Period expires without a prior forfeiture of the Restricted Stock or Restricted Stock Units subject to such Restriction Period, the certificates for such shares or units shall be delivered to the Participant. All legends shall be removed from said certificates at the time of delivery to the Participant except as otherwise required by applicable law. Notwithstanding the foregoing, actual certificates shall not be issued to the extent that book entry recordkeeping is used.

ARTICLE IX.

PERFORMANCE AWARDS

9.1 Award of Performance Shares or Performance Share Units. A Performance Share Award represents an award of shares of Common Stock entitling the recipient to earn the shares based upon the achievement, or level of achievement, of one or more performance goals established by the Committee at the time of grant. A Performance Share Unit represents a right to receive shares of

Table of Contents

Common Stock or cash based upon the achievement, or level of achievement, of one or more performance goals established by the Committee at the time of grant. Performance Shares and Performance Share Units may be awarded either alone or in addition to other Awards granted under this Plan. The Committee shall, in its sole discretion, determine the Eligible Employees, Consultants and Non-Employee Directors, to whom, and the time or times at which, Performance Shares and Performance Share Units shall be awarded, the number of Performance Shares and Performance Share Units to be awarded to any person, the duration of the applicable Performance Period during which, and the conditions under which, receipt of the shares or cash will be deferred, and the other terms and conditions of the Award in addition to those set forth in Section 9.2.

Each Award of Performance Shares and Performance Share Units shall provide that in the event the Participant engages in Detrimental Activity prior to, or during the one year period after, any vesting of Performance Shares or Performance Share Units, all unvested Performance Shares and Performance Share Units shall be immediately forfeited to the Company and the Company shall be entitled to recover from the Participant an amount equal to any gain the Participant realized from any Performance Shares and Performance Share Units which had vested in the period referred to above.

Except as otherwise provided herein, the Committee shall condition the right to payment of any Performance Share or Performance Share Unit upon the attainment of specified objective performance criteria (including, the Performance Goals specified in Exhibit A attached hereto) established pursuant to Section 9.2(c) below and such other factors as the Committee may determine, in its sole discretion.

9.2 Terms and Conditions. Performance Shares and Performance Share Units awarded pursuant to this Article IX shall be subject to the following terms and conditions:

(a) Earning of Performance Award. At the expiration of the applicable Performance Period, and subject to Section 5.4, the Committee shall determine the extent to which the performance criteria established pursuant to Section 9.2(c) are achieved and the percentage of each Performance Share Award or Performance Share Unit that has been earned.

(b) Non-Transferability. Subject to the applicable provisions of the Award agreement and this Plan, Performance Shares and Performance Share Units may not be Transferred during the Performance Period.

(c) Objective Performance Goals, Formulae or Standards. The Committee shall, in its sole discretion, establish the objective performance criteria for the earning of Performance Shares and Performance Share Units based on a Performance Period applicable to each Participant or class of Participants in writing prior to the beginning of the applicable Performance Period or at such later date while the outcome of the Performance Goals are substantially uncertain as otherwise determined by the Committee in its sole discretion. Such performance criteria may incorporate provisions for disregarding (or adjusting for) changes in accounting methods, corporate transactions (including, without limitation, dispositions and acquisitions) and other similar type events or circumstances. The Committee may in its discretion also determine to use other objective performance measures that those set forth in Exhibit A hereto for Performance Shares or Performance Share Units.

(d) Rights as Stockholder. Except as provided in this subsection and subsection (a) and (b) above, and as otherwise determined by the Committee, the Participant shall have, with respect to Performance Share Awards, all of the rights of a holder of shares of Common Stock of the Company including, without limitation, the right to vote such shares and, subject to and conditioned upon the full vesting of the shares, the right to tender such shares and the right to receive any dividends, provided, however, no dividends may be paid until, and are conditioned upon, the vesting of the Performance Share Award. Holders of Performance Share Units shall

Table of Contents

not have the rights of stockholders until shares of Common Stock are issued in satisfaction thereof, but may have dividend equivalent rights, as determined by the Committee; provided, however, no dividends equivalent rights may be paid until, and are conditioned upon, the vesting of the Performance Share Unit.

(e) Payment. Following the Committee’s determination in accordance with subsection (a) above, shares of Common Stock or, as determined by the Committee in its sole discretion, the cash equivalent of such shares shall be delivered to the Eligible Employee, Consultant or Non-Employee Director, or his legal representative, in an amount equal to such individual’s earned Performance Shares or Performance Share Units, as applicable. Notwithstanding the foregoing, the Committee may, in its sole discretion, award an amount less than the earned Performance Share and/or subject the payment of all or part of any Performance Shares or Performance Share Units, as applicable, to additional vesting, forfeiture and deferral conditions as it deems appropriate.

(f) Termination. Subject to the applicable provisions of the Award agreement and this Plan, upon a Participant’s Termination for any reason during the Performance Period for a given Award, the Performance Shares and Performance Share Units in question will vest or be forfeited in accordance with the terms and conditions established by the Committee at grant.

ARTICLE X.

OTHER STOCK-BASED AWARDS

10.1 Other Awards. Other Stock-Based Awards may be granted either alone or in addition to or other Awards granted under the Plan to all eligible Participants pursuant to Article X. Each Other Stock-Based Award shall provide that in the event the Participant engages in Detrimental Activity prior to, or during the one-year period after the later of the date of any vesting of Other-Stock Based Award or the date of the Participant’s Termination, any unvested portion of such Award shall be immediately forfeited to the Company and the Company shall be entitled to recover from the Participant an amount equal to any gain the Participant realized from any such Award that had vested in the period referred to above.

10.2 Committee. Subject to the provisions of the Plan, including Section 5.4, the Committee shall have authority to determine the Eligible Employees, Consultants and Non-Employee Directors to whom, and the time or times at which, Other Stock-Based Awards shall be made, the number of shares of Common Stock to be awarded pursuant to such Awards, and all other conditions of the Awards. The Committee may condition the grant or vesting of Other Stock-Based Awards upon the attainment of specified performance criteria (including, the Performance Goals specified in Exhibit A attached hereto) or such other factors as the Committee may determine, in its sole discretion. If the grant or vesting of an Other Stock-Based Award is based on the attainment of performance criteria, the Committee shall, in its sole discretion, establish the objective performance criteria and the applicable vesting percentage of the Other Stock-Based Award applicable to each Participant or class of Participants in writing prior to the beginning of the applicable Performance Period or at such later date while the outcome of the Performance Goals are substantially uncertain as otherwise determined by the Committee in its sole discretion. Such performance criteria may incorporate provisions for disregarding (or adjusting for) changes in accounting methods, corporate transactions (including, without limitation, dispositions and acquisitions) and other similar type events or circumstances. The Committee may in its discretion also determine to use other objective performance measures than those set forth in Exhibit A hereto for Other Stock-Based Awards.

10.3 Terms and Conditions. Other Stock-Based Awards made pursuant to this Article X shall be subject to the following terms and conditions:

Table of Contents

(a) Non-Transferability. Subject to the applicable provisions of the Award agreement and this Plan, shares of Common Stock subject to Awards made under this Article X may not be Transferred prior to the date on which the shares are issued, or, if later, the date on which any applicable restriction, performance or deferral period lapses.

(b) Dividends. The recipient of an Award under this Article X may be entitled to receive dividends or dividend equivalents with respect to the number of shares of Common Stock covered by the Award, as determined at the time of the Award by the Committee, in its sole discretion, provided, however, no dividends may be paid until, and are conditioned upon, the vesting of the Other Stock-Based Award and no dividend equivalents may be paid or advanced with respect to any purchase right.

(c) Vesting. Subject to Section 5.4, any Award under this Article X and any Common Stock covered by any such Award shall vest or be forfeited to the extent so provided in the Award agreement, as determined by the Committee, in its sole discretion. Subject to Section 5.4, in the event that a written employment agreement between the Company and a Participant provides for a vesting schedule that is more favorable than the vesting schedule provided in the form of Award agreement, the vesting schedule in such employment agreement shall govern, provided that such agreement is in effect on the date of grant and applicable to the specific Award.

(d) Price. The exercise price of any Other Stock-Based Awards constituting an Appreciation Award may not be less than the Fair Market Value of the Common Stock on the date such Other Stock-Based Award is granted. Common Stock or Other Stock-Based Awards issued on a bonus basis under this Article X may be issued for no cash consideration (except for the exercise price of an Appreciation Award); and may be priced as determined by the Committee. Subject to Section 4.3, the purchase price of shares of Common Stock or Other Stock-Based Awards may be zero to the extent permitted by applicable law, and, to the extent not so permitted, such purchase price may not be less than par value.

(e) Payment. The form of payment for the Other Stock-Based Awards shall be specified in the Award agreement.

ARTICLE XI.

PERFORMANCE-BASED CASH AWARDS

11.1 Performance-Based Cash Awards. Performance-Based Cash Awards may be granted either alone or in addition to other Awards granted under this Plan. Subject to the provisions of this Plan, the Committee shall, in its sole discretion, have authority to determine the Eligible Employees and Consultants to whom, and the time or times at which, Performance-Based Cash Awards shall be made, the dollar amount to be awarded pursuant to such Performance-Based Cash Award, and all other conditions for the payment of the Performance-Based Cash Award. The Committee may also provide for the payment of a dollar amount under a Performance-Based Cash Award upon the completion of a specified Performance Period.

Except as otherwise provided herein, the Committee shall condition the right to payment of any Performance-Based Cash Award upon the attainment of specified objective performance criteria (including, the Performance Goals specified in Exhibit A attached hereto) established pursuant to Section 11.2(c) below and such other factors as the Committee may determine, in its sole discretion.

Subject to Section 11.2(c), for any Participant the Committee may, in its sole discretion, specify a targeted Performance-Based Cash Award for a Performance Period (each an “Individual Target

Table of Contents

Award”). An Individual Target Award may be expressed, at the Committee’s sole discretion, as a fixed dollar amount, a percentage of the Participant’s base pay, as a percentage of a bonus pool funded by a formula as determined by the Committee based on achievement of performance criteria, or an amount determined pursuant to an objective formula or standard. The Committee’s establishment of an Individual Target Award for a Participant for a Performance Period shall not imply or require that the same level or any Individual Target Award be established for the Participant for any subsequent Performance Period or for any other Participant for that Performance Period or any subsequent Performance Period. At the time the performance criteria are established (as provided in Section 11.2(c)), the Committee shall prescribe a formula to be used to determine the maximum and minimum percentages (which may be greater or less than one-hundred percent (100%), as applicable) of an Individual Target Award that may be earned or payable based upon the degree of attainment of the performance criteria during the Performance Period. Notwithstanding anything else herein, unless otherwise specified by the Committee with respect to an Individual Target Award, the Committee may, in its sole discretion, elect to pay a Participant an amount that is less than the Participant’s Individual Target Award (or attained percentages thereof) regardless of the degree of attainment of the performance criteria; provided that, except as otherwise specified by the Committee with respect to an Individual Target Award, no discretion to reduce a Performance-Based Cash Award earned based on achievement of the applicable performance criteria shall be permitted for any Performance Period in which a Change of Control occurs, or during such Performance Period with regard to the prior Performance Periods if the Performance-Based Cash Awards for the prior Performance Periods have not been paid by the time of the Change of Control, with regard to individuals who were Participants at the time of the Change of Control.

11.2 Terms and Conditions. Performance-Based Cash Awards made pursuant to this Article XI shall be subject to the following terms and conditions:

(a) Committee Certification. At the expiration of the applicable Performance Period, and subject to Section 5.4, the Committee shall determine and certify in writing the extent to which the performance criteria established pursuant to Section 11.2(c) are achieved and, if applicable, the percentage of the Participant’s Individual Target Award that has been vested and earned.

(b) Waiver of Limitation. In the event of the Participant’s retirement, Disability or death, the Committee may, in its sole discretion, waive in whole or in part any or all of the limitations imposed hereunder (if any) with respect to any or all of an Award under this Article XI.

(c) Objective Performance Goals, Formulae or Standards. The Committee shall, in its sole discretion, establish the objective performance criteria for the earning of Performance-Based Cash Awards based on a Performance Period applicable to each Participant or class of Participants in writing prior to the beginning of the applicable Performance Period or at such later date while the outcome of the Performance Goals are substantially uncertain as otherwise determined by the Committee in its sole discretion. Such performance criteria may incorporate provisions for disregarding (or adjusting for) changes in accounting methods, corporate transactions (including, without limitation, dispositions and acquisitions) and other similar type events or circumstances. The Committee may in its discretion also determine to use other objective performance measures than those set forth in Exhibit A hereto for Performance-Based Cash Awards.

(d) Payment. Following the Committee’s determination and certification in accordance with subsection (a) above, the Performance-Based Cash Award amount shall be paid to the Eligible Employee or his legal representative, in accordance with the terms and conditions

Table of Contents

set forth in Performance-Based Cash Award agreement, but in no event, except as provided in the next sentence, shall such amount be paid by no later than the later of: (i) March 15 of the year following the year in which the applicable Performance Period ends; or (ii) two and one-half (2½) months after the expiration of the fiscal year of the Company in which the applicable Performance Period ends. Notwithstanding the foregoing, the Committee may place such conditions on the payment of all or any portion of any Performance-Based Cash Award as the Committee may determine, and prior to the beginning of a Performance Period the Committee may (x) provide that the payment of all or any portion of any Performance-Based Cash Award shall be deferred and (y) permit a Participant to elect to defer receipt of all or a portion of any Performance-Based Cash Award. To the extent applicable, any deferral under this Section 11.2(d) shall be made in a manner intended to comply with the applicable requirements of Section 409A of the Code.

(e) Termination. Unless otherwise determined by the Committee, in its sole discretion, no Performance-Based Cash Award or pro rata portion thereof shall be payable to any Participant who incurs a Termination prior to the date such Performance-Based Cash Award is paid.

ARTICLE XII.

NON‑TRANSFERABILITY AND TERMINATION OF EMPLOYMENT/ CONSULTANCY/DIRECTORSHIP WITH RESPECT TO APPRECIATION AWARDS

12.1 Non-Transferability.

(a) No Awards shall be Transferable by the Participant otherwise than by Will or by the laws of descent and distribution, except as specifically provided in Section 12.1(b) with respect to Stock Options. All Stock Options shall be exercisable, during the Participant’s lifetime, only by the Participant.

(b) Notwithstanding the foregoing, the Committee may determine, in its sole discretion, at the time of grant or thereafter that a Non-Qualified Stock Option that is otherwise not Transferable pursuant to this Section 12.1 is Transferable to an individual Family Member by gift in whole or in part and in such circumstances, and under such conditions, as specified by the Committee, provided that no transfer may be made to third-party financial institutions without stockholder approval. A Non-Qualified Stock Option that is Transferred to an individual Family Member pursuant to the preceding sentence (i) may not be subsequently Transferred otherwise than by Will or by the laws of descent and distribution and (ii) remains subject to the terms of the Plan and the Stock Option agreement. Any shares of Common Stock acquired upon the exercise of a Stock Option by a Permissible Transferee of a Stock Option or a Permissible Transferee pursuant to a Transfer after the exercise of the Stock Option shall be subject to the terms of the Plan and the Stock Option agreement.

12.2 Termination. The following rules apply with regard to the Termination of a Participant.

(a) Unless otherwise determined by the Committee at grant or, if no rights of the Participant are reduced, thereafter:

(i) Termination by Reason of Death or Disability. If a Participant’s Termination is by reason of death or Disability, all Stock Options and other Appreciation Awards that are held by such Participant that are vested and exercisable at the time of the Participant’s Termination may be exercised by the Participant (or, in the case of death, by the legal representative of the Participant’s estate) at any time within a period of one

Table of Contents

year from the date of such Termination, but in no event beyond the expiration of the stated term of such Stock Options and other Appreciation Awards.

(ii) Involuntary Termination Without Cause. If a Participant’s Termination is by involuntary termination without Cause, all Stock Options and other Appreciation Awards that are held by such Participant that are vested and exercisable at the time of the Participant’s Termination may be exercised by the Participant at any time within a period of 60 days from the date of such Termination, but in no event beyond the expiration of the stated term of such Stock Options and other Appreciation Awards.

(iii) Voluntary Termination. If a Participant’s Termination is voluntary (other than a voluntary termination described in Section 12.2(a)(iv)(2)), all Stock Options and other Appreciation Awards that are held by such Participant that are vested and exercisable at the time of the Participant’s Termination may be exercised by the Participant at any time within a period of 60 days from the date of such Termination, but in no event beyond the expiration of the stated terms of such Stock Options and other Appreciation Awards.

(iv) Termination for Cause. If a Participant’s Termination: (1) is for Cause or (2) is a voluntary Termination (as provided in subsection (iii) above) after the occurrence of an event that would be grounds for a Termination for Cause, all Stock Options and other Appreciation Awards, whether vested or not vested, that are held by such Participant shall thereupon terminate and expire as of the date of such Termination.

(v) Unvested Stock Options and other Appreciation Awards. Stock Options and other Appreciation Awards that are not vested as of the date of a Participant’s Termination for any reason shall terminate and expire as of the date of such Termination.

ARTICLE XIII.

CHANGE IN CONTROL PROVISIONS

13.1 Notwithstanding any other provision of the Plan to the contrary, and unless the applicable Award agreement shall otherwise provide, in the event the employment of a Participant is terminated by the Company and its Affiliates without “Cause”, as defined in this Section 13.1, within two years following the occurrence of a Change in Control of the Company,

(i) all of such Participant’s Stock Options and other Appreciation Awards which are then outstanding hereunder shall become fully vested and exercisable, and

(ii) all restrictions with respect to shares of Restricted Stock or shares represented by Restricted Stock Units or Other Stock-Based Awards of such Participant which are then outstanding hereunder shall lapse, and such Shares shall be fully vested, issued and nonforfeitable; provided, however, that if the Awards are subject to Section 409A of the Code and the Change in Control is not a change in ownership or effective control of the Company or a change in the ownership of a substantial portion of the assets of the Company under Section 409A of the Code (a “409A Change in Control”), any Restricted Stock Units and Other Stock-Based Awards that constitute deferred compensation under Section 409A of the Code shall remain payable on the date(s) provided in the underlying Award agreement and provisions of the Plan.

Notwithstanding any other provision of this Plan to the contrary, and unless the applicable Award agreement shall otherwise provide, if a Change in Control occurs prior to the end of any

Table of Contents

Performance Period, with respect to all Performance‑Based Cash Awards, Performance Shares, Performance Share Units, and other performance-based awards of such Participant which are then outstanding hereunder, all uncompleted Performance Periods shall terminate, the target level of performance set forth with respect to each criteria upon which Performance Goals are based for such Performance‑Based Cash Awards, Performance Shares, Performance Share Units, and other performance‑based awards shall be deemed to have been attained and a pro rata portion (based on the ratio of (i) the number of full and partial months which have elapsed from the beginning of the Performance Period through the Change in Control to (ii) the number of months originally contained in the Performance Period) of each such Performance‑Based Cash Award, Performance Share, Performance Share Unit and other performance‑based award shall become vested and the remainder of each such Performance‑Based Cash Award, Performance Shares, Performance Share Units and other performance‑based awards shall be converted into and remain outstanding as Restricted Stock (in the case of Performance Shares) or Restricted Stock Units (in the case of other performance awards), subject to forfeiture unless the Participant continues to be actively employed by the Company through the end of the original Performance Period, but subject to an exception in the case of a termination of employment by the Company without Cause and such other exceptions as may be provided by the Committee. If the Awards are subject to Section 409A of the Code and the Change in Control is not a 409A Change in Control, such Awards shall remain payable on the date(s) provided in the underlying Award agreement and provisions of the Plan. Solely for purposes of this Section 13.1, following a Change in Control, “Cause” means any termination of employment where it can be shown that the Participant has (i) willfully failed to perform his or her employment duties for the Company or an Affiliate, (ii) willfully engaged in conduct that is materially injurious to the Company or an Affiliate, monetarily or otherwise, or (iii) committed acts that constitute a felony under applicable federal or state law or constitute common law fraud. For purposes of this definition, no act or failure to act on the Participant’s part shall be considered “willful” unless done, or omitted to be done, by him or her not in good faith and without reasonable belief that his or her action or omission was in the best interest of the Company or Affiliate.

Except as otherwise provided by the Committee in an Award agreement, in the event of a Change in Control of the Company after the Effective Date, the Committee may, but shall not be obligated to provide for the cancellation of any Appreciation Awards without payment if the Change in Control Price (as defined below) is less than the exercise price of such Appreciation Awards; and/or provide for a limited time period during which Appreciation Awards may be exercised and/or for the purchase of any Awards by the Company or an Affiliate for an amount of cash equal to the excess of the Change in Control Price of the shares of Common Stock covered by such Awards, over the aggregate exercise price of such Awards; and/or provide for the issuance of substitute Awards that will substantially preserve the otherwise applicable terms of any affected Awards previously granted hereunder as determined by the Committee in its sole discretion. Notwithstanding anything to the contrary herein, for purposes of Incentive Stock Options, any assumed or substituted Stock Option shall comply with the requirements of Treasury Regulation § 1.424-1 (and any amendments thereto). For purposes of this Article XIII, “Change in Control Price” shall mean the highest price per share of Common Stock paid in any transaction related to a Change in Control of the Company; provided, however, that such price shall not exceed the fair market value of the Common Stock at the time of purchase as determined in accordance Section 409A of the Code.

ARTICLE XIV.

TERMINATION OR AMENDMENT OF PLAN

Notwithstanding any other provision of the Plan, the Board or the Committee may at any time, and from time to time, amend, in whole or in part, any or all of the provisions of the Plan (including any amendment deemed necessary to ensure that the Company may comply with any regulatory requirement referred to in Article XIV or Section 409A of the Code as described below), or suspend or terminate it entirely, retroactively or otherwise; provided, however, that if the Committee, in its sole discretion,

Table of Contents

determines that the rights of a Participant with respect to Awards granted prior to such amendment, suspension or termination, may be adversely impaired, the consent of such Participant shall be required; and provided further, without the approval of the stockholders of the Company entitled to vote in accordance with applicable law, no amendment may be made that would:

(a) increase the aggregate number of shares of Common Stock that may be issued under the Plan (other than due to an adjustment under Section 4.2);

(b) increase the maximum individual Participant limitations for a fiscal year under Section 4.1(b) (except by operation of Section 4.2);

(d) other than adjustments or substitutions in accordance with Section 4.2, amend the terms of outstanding Awards to reduce the exercise price of outstanding Stock Options, Stock Appreciation Rights or other Appreciation Awards or to cancel outstanding Stock Options, Stock Appreciation Rights or other Appreciation Awards (where prior to the reduction or cancellation the exercise price equals or exceeds the fair market value of the shares of Common Stock underlying such Awards) in exchange for cash, other Awards or Stock Options, Stock Appreciation Rights or other Appreciation Awards with an exercise price that is less than the exercise price of the original Stock Options, Stock Appreciation Rights or other Appreciation Awards;

(e) extend the maximum Stock Option period under Section 6.3;

(f) award any Stock Option, Stock Appreciation Right or other Appreciation Award in replacement of a canceled Stock Option, Stock Appreciation Right or other Appreciation Award with a higher exercise price;

(g) require stockholder approval in order for the Plan to continue to comply with the applicable provisions of Section 422 of the Code to the extent applicable to Incentive Stock Options or the rules of any exchange or system on which the Company’s securities are listed or traded at the request of the Company; or

(h) otherwise require stockholder approval pursuant to the rules of any stock exchange on which the Company’s securities are then listed or traded.

The Committee may amend the terms of any Award theretofore granted, prospectively or retroactively, but, subject to Article IV or as otherwise specifically provided herein, no such amendment or other action by the Committee shall adversely impair the rights of any holder without the holder’s consent. Notwithstanding anything herein to the contrary, the Board or the Committee may amend the Plan or any Award granted hereunder at any time without a Participant’s consent to comply with Section 409A of the Code or any other applicable law. Nothing in the Plan is intended to provide a guarantee of particular tax treatment to any Participant.

ARTICLE XV.

UNFUNDED PLAN

The Plan is an “unfunded” plan for incentive and deferred compensation. With respect to any payments as to which a Participant has a fixed and vested interest but that are not yet made to a

Table of Contents

Participant by the Company, nothing contained herein shall give any such Participant any rights that are greater than those of a general unsecured creditor of the Company.

ARTICLE XVI.

GENERAL PROVISIONS

16.1 Legend. The Committee may require each person receiving shares of Common Stock pursuant to an Award granted under the Plan to represent to and agree with the Company in writing that the Participant is acquiring the shares without a view to distribution thereof and such other securities law related representations as the Committee shall request. In addition to any legend required by the Plan, the certificates and/or book entry accounts for such shares may include any legend that the Committee, in its sole discretion, deems appropriate to reflect any restrictions on Transfer.

All certificates and/or book entry accounts for shares of Common Stock delivered under the Plan shall be subject to such stop transfer orders and other restrictions as the Committee may, in its sole discretion, deem advisable under the rules, regulations and other requirements of the Securities and Exchange Commission, any stock exchange upon which the Common Stock is then listed or any national automated quotation system on which the Common Stock is then quoted, any applicable Federal or state securities law, and any applicable corporate law, and the Committee may cause a legend or legends to be placed on any such certificates to make appropriate reference to such restrictions.

16.2 Other Plans. Nothing contained in the Plan shall prevent the Board from adopting other or additional compensation arrangements, subject to stockholder approval if such approval is required; and such arrangements may be either generally applicable or applicable only in specific cases.

16.3 No Right to Employment/Consultancy/Directorship. Neither the Plan nor the grant of any Award hereunder shall give any Participant or other employee, Consultant or Non-Employee Director any right with respect to continuance of employment, consultancy or directorship by the Company or any Affiliate, nor shall they be a limitation in any way on the right of the Company, its stockholders or any Affiliate by which an employee is employed or a Consultant or Non-Employee Director is retained to terminate his or her employment, consultancy or directorship at any time.

16.4 Withholding of Taxes. The Company shall have the right to deduct from any payment to be made to a Participant, or to otherwise require, prior to the issuance or delivery of any shares of Common Stock or the payment of any cash hereunder, payment by the Participant of, any Federal, state or local taxes required by law to be withheld. Upon the vesting of Restricted Stock (or other Award that is taxable upon vesting), or upon making an election under Section 83(b) of the Code, a Participant shall pay all required withholding to the Company. Any statutorily required withholding obligation with regard to any Eligible Employee may be satisfied, subject to the advanced consent of the Committee, by reducing the number of shares of Common Stock otherwise deliverable in connection with an Award or by delivering shares of Common Stock already owned. Any fraction of a share of Common Stock required to satisfy such tax obligations shall be disregarded and the amount due shall be paid instead in cash by the Participant.

16.5 Listing and Other Conditions.

(a) Unless otherwise determined by the Committee, as long as the Common Stock is listed on a national securities exchange or system sponsored by a national securities association, the issuance of any shares of Common Stock pursuant to an Award shall be conditioned upon such shares being listed on such exchange or system. The Company shall have no obligation to

Table of Contents

issue such shares unless and until such shares are so listed, and the right to exercise any Award with respect to such shares shall be suspended until such listing has been effected.

(b) If at any time counsel to the Company shall be of the opinion that any sale or delivery of shares of Common Stock pursuant to an Award is or may in the circumstances be unlawful or result in the imposition of excise taxes on the Company under the statutes, rules or regulations of any applicable jurisdiction, the Company shall have no obligation to make such sale or delivery, or to make any application or to effect or to maintain any qualification or registration under the Securities Act or otherwise with respect to shares of Common Stock or Awards, and the right to exercise any Award shall be suspended until, in the opinion of said counsel, such sale or delivery shall be lawful and will not result in the imposition of excise taxes on the Company.

(c) Upon termination of any period of suspension under this Section 16.5, an Award affected by such suspension that shall not then have expired or terminated shall be reinstated as to all shares available before such suspension and as to shares that would otherwise have become available during the period of such suspension, but no such suspension shall extend the term of any Award.

(d) A Participant shall be required to supply the Company with any certificates, representations and information that the Company requests and otherwise cooperate with the Company in obtaining any listing, registration, qualification, exemption, consent or approval the Company deems necessary or appropriate.

16.6 Choice of Forum.

(a) Unless otherwise specified in an Award agreement, it shall be a condition of each Award that the Company and the Participant irrevocably submit to the exclusive jurisdiction of any state or federal court located in Pittsburgh, Pennsylvania over any suit, action or proceeding arising out of or relating to or concerning the Plan or the Award. By accepting an Award, the Participant acknowledges that the forum designated by this Section 16.6(a) has a reasonable relation to the Plan, any applicable Award and the Participant’s relationship with the Company. Notwithstanding the foregoing, nothing herein shall preclude the Company from bringing any suit, action or proceeding in any other court for the purpose of enforcing the provisions of this Section 16.6(a).

(b) By accepting an Award, (i) the Participant waives, to the fullest extent permitted by applicable law, any objection which the Participant may have to personal jurisdiction or to the laying of venue of any such suit, action or proceeding in any court referred to in Section 16.6(a), (ii) the Participant undertakes not to commence any action arising out of or relating to or concerning any Award in any forum other than a forum described in Section 16.6(a) and (iii) the Participant agrees that, to the fullest extent permitted by applicable law, a final and non-appealable judgment in any such suit, action or proceeding in any such court shall be conclusive and binding upon the Participant and the Company.

(c) Unless otherwise specified in an Award agreement, by accepting an Award, the Participant irrevocably appoints each General Counsel of the Company as his or her agent for service of process in connection with any suit, action or proceeding arising out of or relating to or concerning this Plan or any Award, who shall promptly advise the Participant of any such service or process.

(d) Unless otherwise specified in an Award agreement, by accepting an Award, the Participant agrees to keep confidential the existence of, and any information concerning, a

Table of Contents

dispute, controversy or claim described in this Section 16.6 other than as required by law or order of court, and except that the Participant may disclose information concerning such dispute, controversy or claim to the court that is considering such dispute, controversy or claim or to his legal counsel (provided that such counsel agrees not to disclose any such information other than as necessary to the prosecution or defense of the dispute, controversy or claim).

16.7 Governing Law. The Plan and the actions taken in connection herewith shall be governed by and construed in accordance with the internal laws of the State of Delaware, without giving effect to its principles of conflict of laws.

16.8 Construction. Wherever any words are used in the Plan in the masculine gender they shall be construed as though they were also used in the feminine gender in all cases where they would so apply, and wherever any words are used herein in the singular form they shall be construed as though they were also used in the plural form in all cases where they would so apply.

16.9 Other Benefits. No Award granted or paid out under the Plan shall be deemed compensation for purposes of computing benefits under any retirement plan of the Company or its Affiliates nor affect any benefits under any other benefit plan now or subsequently in effect under which the availability or amount of benefits is related to the level of compensation.

16.10 Costs. The Company shall bear all expenses associated with administering the Plan, including expenses of issuing Common Stock pursuant to any Award granted hereunder.

16.11 No Right to Same Benefits. The provisions of Awards need not be the same with respect to each Participant, and Awards granted to individual Participants need not be the same.

16.12 Death/Disability. The Committee may in its sole discretion require the transferee of a Participant to supply it with written notice of the Participant’s death or Disability and to supply it with a copy of the Will (in the case of the Participant’s death) or such other evidence as the Committee deems necessary to establish the validity of the transfer of an Award. The Committee may, in its sole discretion, also require the agreement of the transferee to be bound by all of the terms and conditions of the Plan.

16.13 Section 16(b) of the Exchange Act. All elections and transactions under the Plan by persons subject to Section 16 of the Exchange Act involving shares of Common Stock are intended to comply with any applicable exemptive condition under Rule 16b‑3. The Committee may, in its sole discretion, establish and adopt written administrative guidelines, designed to facilitate compliance with Section 16(b) of the Exchange Act, as it may deem necessary or proper for the administration and operation of the Plan and the transaction of business thereunder.

16.14 Severability of Provisions. If any provision of the Plan shall be held invalid or unenforceable, such invalidity or unenforceability shall not affect any other provisions hereof, and the Plan shall be construed and enforced as if such provisions had not been included.

16.15 Headings and Captions. The headings and captions herein are provided for reference and convenience only, shall not be considered part of the Plan, and shall not be employed in the construction of the Plan.

16.16 Successors and Assigns. The Plan shall be binding on all successors and permitted assigns of a Participant, including, without limitation, the estate of such Participant and the executor, administrator or trustee of such estate.

Table of Contents

16.17 Payment to Minors, Etc. Any benefit payable to or for the benefit of a minor, an incompetent person or other person incapable of receipt thereof shall be deemed paid when paid to such person’s guardian or to the party providing or reasonably appearing to provide for the care of such person, and such payment shall fully discharge the Committee, the Board, the Company, its Affiliates and their employees, agents and representatives with respect thereto.

16.18 No Rights as Stockholder. Except as provided in Article VIII with respect to Restricted Stock and Restricted Stock Units, Article IX with respect to Performance Awards or Article X with respect to Other Stock-Based Awards, subject to the provisions of the Award agreement, no Participant or Permissible Transferee shall have any rights as a stockholder of the Company with respect to any Award until such individual becomes the holder of record of the shares of Common Stock underlying the Award.

16.19 Section 409A of the Code. The Company does not guarantee the particular tax treatment of an Award granted under this Plan. Awards made under this Plan are intended to comply with, or be exempt from, the applicable requirements of Section 409A of the Code and this Plan and any Award agreement hereunder shall be limited, construed and interpreted in accordance with such intent. In no event whatsoever shall the Company or any of its Affiliates be liable for any additional tax, interest or penalties that may be imposed on a Participant by Section 409A of the Code or any damages for failing to comply with Section 409A of the Code.

16.20 Consideration. Awards may be awarded in consideration for past services actually rendered to the Company or an Affiliate for its benefit; provided, however, that in the case of an Award to be made to a new Eligible Employee, Non-Employee Director, or Consultant who has not performed prior services for the Company, the Company will require payment of the par value of the Common Stock by cash or check in order to ensure proper issuance of the shares in compliance with Delaware General Corporation Law.

ARTICLE XVII.

EFFECTIVE DATE OF PLAN

The effective date and date of adoption of the Plan as amended and restated shall be March 30, 2018, provided that the adoption of the Plan by the Board is approved by a majority of the votes cast at a duly held meeting of stockholders held on or prior to March 29, 2019 at which a quorum representing a majority of the outstanding voting stock of the Company is, either in person or by proxy, present and voting.

ARTICLE XVIII.

TERM OF PLAN

No Awards may be granted under the Plan subsequent to March 29, 2028.

Table of Contents

EXHIBIT A

PERFORMANCE GOALS

A. Performance Goals. Performance goals established for purposes of the grant, vesting or payment of Awards of Restricted Stock, Restricted Stock Units, Performance Shares, Performance Share Units, Other Stock-Based Awards, or Performance-Based Cash Awards that are intended to be “performance-based” shall be based on the attainment of certain target levels of, or a specified increase or decrease (as applicable) in one or more of the following criteria (“Performance Goals”):

(a)

enterprise value or value creation targets;

(b)

after-tax or pre-tax profits, including without limitation as attributable to continuing and/or other operations of the Company;

(c)

operational cash flow or economic value added;

(d)

(e)

earnings per share or earnings per share from continuing operations;

(f)

sales (domestic and/or international), operating performance and revenues, net income, gross margin, operating income or earnings before income tax or other exclusions;

(g)

return on capital employed, return on invested capital, gross margin return on inventory, or return on assets;

(h)

total shareholder return, including after-tax or pre-tax return on stockholder equity;

(i)

the fair market value or book value of the shares of the Company’s Common Stock;

(j)

the growth in the value of an investment in the Company’s Common Stock assuming the reinvestment of dividends, dividend growth or market capitalization;

(k)

a transaction that results in the sale of stock or assets of the Company;

(l)

earnings before interest, taxes plus amortization and depreciation;

(m)

earnings before interest and taxes (EBIT);

(n)

reduction in expenses or cost savings;

(o)

strategic objectives including management development, new product development and introduction;

A- 1

Table of Contents

(p)

individual Participant goals and objectives, including management development, new product development and introduction; or

(q)

any financial metric set forth herein or in the Company’s financial statements as a percentage of another financial metric.

Unless the Committee otherwise determines, in its sole discretion, that appropriate adjustment should be made to reflect the impact of an event or occurrence, the Committee shall exclude the impact of any of the following events or occurrences:

(i)

restructurings, discontinued operations, extraordinary items or events, and other unusual or non-recurring charges;

(ii)

an event either not directly related to the operations of the Company or not within the reasonable control of the Company’s management;

(iii)

a change in tax law or accounting standards required by generally accepted accounting principles; or

(iv)

a change in the Company’s fiscal year.

Performance Goals may also be based upon individual Participant performance criteria, as determined by the Committee, in its sole discretion.

In addition, such Performance Goals may be based upon the attainment of specified levels of Company (or affiliate, subsidiary, division, other operational unit, business segment or administrative department of the Company) performance under one or more of the measures described above relative to the performance of other corporations (or an affiliate, subsidiary, division, other operational unit, business segment or administrative department of another corporation). The Committee may:

(x)

designate additional business criteria on which the performance criteria may be based; or

(y)

adjust, modify or amend the aforementioned business criteria.

B. GAAP. Except as otherwise provided herein, the measures used in Performance Goals shall be determined in accordance with generally accepted accounting principles (“GAAP”) and in a manner consistent with the methods used in the Company’s regular reports on Forms 10-K and 10-Q.

C. Deviations from GAAP. To the extent any objective Performance Goals are expressed using any measures that require deviations from GAAP, such deviations shall be at the discretion of the Committee as exercised at the time the Performance Goals are established.

A- 2

Table of Contents

			VOTE BY INTERNET - www.proxyvote.com
			Use the Internet to transmit your voting instructions and for electronic delivery of information. Vote by 11:59 P.M. ET on 05/21/2018. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form.

	GNC HOLDINGS, INC.		ELECTRONIC DELIVERY OF FUTURE PROXY MATERIALS
	300 SIXTH AVENUE PITTSBURGH, PA 15222		If you would like to reduce the costs incurred by our company in mailing proxy materials, you can consent to receiving all future proxy statements, proxy cards and annual reports electronically via e-mail or the Internet. To sign up for electronic delivery, please follow the instructions above to vote using the Internet and, when prompted, indicate that you agree to receive or access proxy materials electronically in future years.

			VOTE BY PHONE - 1-800-690-6903
			Use any touch-tone telephone to transmit your voting instructions. Vote by 11:59 P.M. ET on 05/21/2018. Have your proxy card in hand when you call and then follow the instructions.

			VOTE BY MAIL
			Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717.

TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS:	KEEP THIS PORTION FOR YOUR RECORDS
THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED.	DETACH AND RETURN THIS PORTION ONLY

	For	Withhold	For All	To withhold authority to vote for any
	All	All	Except	individual nominee(s), mark “For All
The Board of Directors recommends you vote FOR				Except” and write the number(s) of the
the following:				nominee(s) on the line below.
	☐	☐	☐


1. Election of Directors

Nominees

01 Jeffrey P. Berger	02 Alan D. Feldman	03 Michael F. Hines	04 Amy B. Lane	05 Philip E. Mallott
06 Kenneth A. Martindale	07 Robert F. Moran	08 Richard J. Wallace

The Board of Directors recommends you vote FOR the following proposals:		For	Against	Abstain

2.	The adoption, by non-binding vote, of the advisory resolution to approve the compensation paid to the Company's named executive officers in 2017, as disclosed in the proxy materials.	☐	☐	☐

3.	Approval of the adoption of the 2018 Stock and Incentive Plan.	☐	☐	☐

4.	The ratification of the appointment of PricewaterhouseCoopers LLP as independent auditors for the Company's 2018 fiscal year.	☐	☐	☐

NOTE: Such other business as may properly come before the meeting or any adjournment thereof.

Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name, by authorized officer.


Signature [PLEASE SIGN WITHIN BOX]	Date	Signature (Joint Owners)	Date

Table of Contents

Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting:

The Notice & Proxy Statement and Form 10-K are available at www.proxyvote.com

GNC HOLDINGS, INC.

Annual Meeting of Stockholders

May 22, 2018 8:00 AM ET

This proxy is solicited by the Board of Directors

The Stockholder(s) hereby appoint(s), Tricia K. Tolivar and Kevin G. Nowe, or either of them, as proxies, each with the power to appoint his or her substitute, and hereby authorize(s) them to represent and vote, as designated on the reverse side of this ballot, all of the shares of common stock of GNC HOLDINGS, INC. that the stockholder(s) is/are entitled to vote at the Annual Meeting of Stockholders to be held at 8:00 AM ET, on May 22, 2018, at the Omni William Penn Hotel, 530 William Penn Place, Pittsburgh, Pennsylvania 15219, and any adjournment or postponement thereof.

This proxy, when properly executed, will be voted in the manner directed herein. If no such direction is made, this proxy will be voted in accordance with the Board of Directors' recommendations.

Continued and to be signed on reverse side